date generated: 2022-03-15
Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch
Here is the first few lines of the input profile.
## x
## 0610009B22Rik 0.02592933
## 0610009E02Rik 0.75195906
## 0610009L18Rik -1.06444668
## 0610010K14Rik 0.44760852
## 0610012G03Rik -0.16331991
## 0610030E20Rik -0.62496606
Here are some metrics about the input data profile:
| Profile metrics | |
|---|---|
| num_genesets | 1604 |
| num_genes_in_profile | 17595 |
| duplicated_genes_present | 0 |
| num_profile_genes_in_sets | 8418 |
| num_profile_genes_not_in_sets | 9177 |
Here is a plot of the input profiles. Note the dynamic ranges.
Here is the contour plot of the profile including all detected genes.
| Gene sets metrics | |
|---|---|
| num_genesets | 1604 |
| num_genesets_excluded | 426 |
| num_genesets_included | 1178 |
Significance is calculated by -log10(p-value). All points shown are FDR<0.05.
Significance is calculated by -log10(p-value). Top N sets shown irrespective of FDR.
| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | 19 | 9.33e-08 | 0.707 | 5.50e-06 |
| ALPHA LINOLENIC OMEGA3 AND LINOLEIC OMEGA6 ACID METABOLISM | 12 | 2.65e-04 | 0.608 | 4.00e-03 |
| GOLGI CISTERNAE PERICENTRIOLAR STACK REORGANIZATION | 12 | 5.67e-04 | 0.575 | 7.04e-03 |
| PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | 12 | 7.89e-04 | 0.560 | 9.11e-03 |
| RHOBTB3 ATPASE CYCLE | 10 | 2.45e-03 | 0.553 | 2.10e-02 |
| TRANSPORT OF CONNEXONS TO THE PLASMA MEMBRANE | 13 | 8.36e-04 | 0.535 | 9.38e-03 |
| BBSOME MEDIATED CARGO TARGETING TO CILIUM | 23 | 9.28e-06 | 0.534 | 2.80e-04 |
| CITRIC ACID CYCLE TCA CYCLE | 22 | 2.49e-05 | 0.519 | 6.36e-04 |
| NUCLEOBASE BIOSYNTHESIS | 15 | 6.68e-04 | 0.507 | 8.03e-03 |
| KERATAN SULFATE BIOSYNTHESIS | 24 | 2.54e-05 | 0.497 | 6.36e-04 |
| COPI INDEPENDENT GOLGI TO ER RETROGRADE TRAFFIC | 44 | 1.48e-08 | 0.493 | 1.16e-06 |
| COOPERATION OF PREFOLDIN AND TRIC CCT IN ACTIN AND TUBULIN FOLDING | 26 | 2.52e-05 | 0.477 | 6.36e-04 |
| HSP90 CHAPERONE CYCLE FOR STEROID HORMONE RECEPTORS SHR | 48 | 2.46e-08 | 0.465 | 1.70e-06 |
| KERATAN SULFATE KERATIN METABOLISM | 30 | 1.46e-05 | 0.457 | 4.09e-04 |
| CALNEXIN CALRETICULIN CYCLE | 26 | 5.90e-05 | 0.455 | 1.20e-03 |
| GLYCOGEN STORAGE DISEASES | 12 | 6.44e-03 | 0.454 | 4.24e-02 |
| GAP JUNCTION ASSEMBLY | 21 | 3.14e-04 | 0.454 | 4.62e-03 |
| ENDOSOMAL VACUOLAR PATHWAY | 10 | 1.31e-02 | -0.453 | 6.81e-02 |
| RETROGRADE NEUROTROPHIN SIGNALLING | 13 | 4.77e-03 | 0.452 | 3.39e-02 |
| GLYCOGEN SYNTHESIS | 14 | 3.63e-03 | 0.449 | 2.74e-02 |
| SEALING OF THE NUCLEAR ENVELOPE NE BY ESCRT III | 23 | 2.65e-04 | 0.439 | 4.00e-03 |
| LDL CLEARANCE | 16 | 2.46e-03 | 0.437 | 2.10e-02 |
| CHK1 CHK2 CDS1 MEDIATED INACTIVATION OF CYCLIN B CDK1 COMPLEX | 10 | 1.69e-02 | 0.436 | 8.00e-02 |
| OLFACTORY SIGNALING PATHWAY | 40 | 2.56e-06 | -0.430 | 1.12e-04 |
| RHO GTPASES ACTIVATE IQGAPS | 23 | 3.81e-04 | 0.428 | 5.21e-03 |
| RECEPTOR MEDIATED MITOPHAGY | 11 | 1.49e-02 | 0.424 | 7.49e-02 |
| PURINE SALVAGE | 12 | 1.14e-02 | 0.422 | 6.22e-02 |
| N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | 35 | 1.74e-05 | 0.420 | 4.75e-04 |
| CD28 DEPENDENT VAV1 PATHWAY | 11 | 1.64e-02 | 0.418 | 7.89e-02 |
| ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | 11 | 1.65e-02 | 0.417 | 7.89e-02 |
| N GLYCAN ANTENNAE ELONGATION | 15 | 5.19e-03 | 0.417 | 3.56e-02 |
| TRANSLATION OF REPLICASE AND ASSEMBLY OF THE REPLICATION TRANSCRIPTION COMPLEX | 12 | 1.24e-02 | 0.417 | 6.54e-02 |
| WNT5A DEPENDENT INTERNALIZATION OF FZD2 FZD5 AND ROR2 | 13 | 9.63e-03 | 0.415 | 5.44e-02 |
| SYNTHESIS OF PYROPHOSPHATES IN THE CYTOSOL | 10 | 2.35e-02 | 0.414 | 1.00e-01 |
| GLYCOGEN METABOLISM | 25 | 3.53e-04 | 0.413 | 5.01e-03 |
| REGULATION OF TP53 ACTIVITY THROUGH ASSOCIATION WITH CO FACTORS | 14 | 8.18e-03 | 0.408 | 4.92e-02 |
| CYTOSOLIC TRNA AMINOACYLATION | 24 | 5.42e-04 | 0.408 | 6.94e-03 |
| INSERTION OF TAIL ANCHORED PROTEINS INTO THE ENDOPLASMIC RETICULUM MEMBRANE | 22 | 9.58e-04 | 0.407 | 1.05e-02 |
| GLYCOSPHINGOLIPID METABOLISM | 38 | 1.44e-05 | 0.407 | 4.09e-04 |
| WNT LIGAND BIOGENESIS AND TRAFFICKING | 21 | 1.61e-03 | 0.398 | 1.57e-02 |
| SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | 20 | 2.11e-03 | 0.397 | 1.91e-02 |
| GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | 14 | 1.08e-02 | 0.394 | 5.96e-02 |
| SUPPRESSION OF PHAGOSOMAL MATURATION | 12 | 1.83e-02 | 0.393 | 8.39e-02 |
| CS DS DEGRADATION | 14 | 1.24e-02 | 0.386 | 6.53e-02 |
| IRE1ALPHA ACTIVATES CHAPERONES | 50 | 2.69e-06 | 0.384 | 1.13e-04 |
| KERATAN SULFATE DEGRADATION | 11 | 2.84e-02 | 0.382 | 1.14e-01 |
| ACTIVATION OF AMPK DOWNSTREAM OF NMDARS | 20 | 3.36e-03 | 0.379 | 2.62e-02 |
| RECYCLING PATHWAY OF L1 | 40 | 3.41e-05 | 0.379 | 8.20e-04 |
| POST CHAPERONIN TUBULIN FOLDING PATHWAY | 17 | 7.01e-03 | 0.378 | 4.49e-02 |
| COPI MEDIATED ANTEROGRADE TRANSPORT | 91 | 5.78e-10 | 0.376 | 5.23e-08 |
| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | 19 | 9.33e-08 | 7.07e-01 | 5.50e-06 |
| ALPHA LINOLENIC OMEGA3 AND LINOLEIC OMEGA6 ACID METABOLISM | 12 | 2.65e-04 | 6.08e-01 | 4.00e-03 |
| GOLGI CISTERNAE PERICENTRIOLAR STACK REORGANIZATION | 12 | 5.67e-04 | 5.75e-01 | 7.04e-03 |
| PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | 12 | 7.89e-04 | 5.60e-01 | 9.11e-03 |
| RHOBTB3 ATPASE CYCLE | 10 | 2.45e-03 | 5.53e-01 | 2.10e-02 |
| TRANSPORT OF CONNEXONS TO THE PLASMA MEMBRANE | 13 | 8.36e-04 | 5.35e-01 | 9.38e-03 |
| BBSOME MEDIATED CARGO TARGETING TO CILIUM | 23 | 9.28e-06 | 5.34e-01 | 2.80e-04 |
| CITRIC ACID CYCLE TCA CYCLE | 22 | 2.49e-05 | 5.19e-01 | 6.36e-04 |
| NUCLEOBASE BIOSYNTHESIS | 15 | 6.68e-04 | 5.07e-01 | 8.03e-03 |
| KERATAN SULFATE BIOSYNTHESIS | 24 | 2.54e-05 | 4.97e-01 | 6.36e-04 |
| COPI INDEPENDENT GOLGI TO ER RETROGRADE TRAFFIC | 44 | 1.48e-08 | 4.93e-01 | 1.16e-06 |
| COOPERATION OF PREFOLDIN AND TRIC CCT IN ACTIN AND TUBULIN FOLDING | 26 | 2.52e-05 | 4.77e-01 | 6.36e-04 |
| HSP90 CHAPERONE CYCLE FOR STEROID HORMONE RECEPTORS SHR | 48 | 2.46e-08 | 4.65e-01 | 1.70e-06 |
| KERATAN SULFATE KERATIN METABOLISM | 30 | 1.46e-05 | 4.57e-01 | 4.09e-04 |
| CALNEXIN CALRETICULIN CYCLE | 26 | 5.90e-05 | 4.55e-01 | 1.20e-03 |
| GLYCOGEN STORAGE DISEASES | 12 | 6.44e-03 | 4.54e-01 | 4.24e-02 |
| GAP JUNCTION ASSEMBLY | 21 | 3.14e-04 | 4.54e-01 | 4.62e-03 |
| ENDOSOMAL VACUOLAR PATHWAY | 10 | 1.31e-02 | -4.53e-01 | 6.81e-02 |
| RETROGRADE NEUROTROPHIN SIGNALLING | 13 | 4.77e-03 | 4.52e-01 | 3.39e-02 |
| GLYCOGEN SYNTHESIS | 14 | 3.63e-03 | 4.49e-01 | 2.74e-02 |
| SEALING OF THE NUCLEAR ENVELOPE NE BY ESCRT III | 23 | 2.65e-04 | 4.39e-01 | 4.00e-03 |
| LDL CLEARANCE | 16 | 2.46e-03 | 4.37e-01 | 2.10e-02 |
| CHK1 CHK2 CDS1 MEDIATED INACTIVATION OF CYCLIN B CDK1 COMPLEX | 10 | 1.69e-02 | 4.36e-01 | 8.00e-02 |
| OLFACTORY SIGNALING PATHWAY | 40 | 2.56e-06 | -4.30e-01 | 1.12e-04 |
| RHO GTPASES ACTIVATE IQGAPS | 23 | 3.81e-04 | 4.28e-01 | 5.21e-03 |
| RECEPTOR MEDIATED MITOPHAGY | 11 | 1.49e-02 | 4.24e-01 | 7.49e-02 |
| PURINE SALVAGE | 12 | 1.14e-02 | 4.22e-01 | 6.22e-02 |
| N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | 35 | 1.74e-05 | 4.20e-01 | 4.75e-04 |
| CD28 DEPENDENT VAV1 PATHWAY | 11 | 1.64e-02 | 4.18e-01 | 7.89e-02 |
| ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | 11 | 1.65e-02 | 4.17e-01 | 7.89e-02 |
| N GLYCAN ANTENNAE ELONGATION | 15 | 5.19e-03 | 4.17e-01 | 3.56e-02 |
| TRANSLATION OF REPLICASE AND ASSEMBLY OF THE REPLICATION TRANSCRIPTION COMPLEX | 12 | 1.24e-02 | 4.17e-01 | 6.54e-02 |
| WNT5A DEPENDENT INTERNALIZATION OF FZD2 FZD5 AND ROR2 | 13 | 9.63e-03 | 4.15e-01 | 5.44e-02 |
| SYNTHESIS OF PYROPHOSPHATES IN THE CYTOSOL | 10 | 2.35e-02 | 4.14e-01 | 1.00e-01 |
| GLYCOGEN METABOLISM | 25 | 3.53e-04 | 4.13e-01 | 5.01e-03 |
| REGULATION OF TP53 ACTIVITY THROUGH ASSOCIATION WITH CO FACTORS | 14 | 8.18e-03 | 4.08e-01 | 4.92e-02 |
| CYTOSOLIC TRNA AMINOACYLATION | 24 | 5.42e-04 | 4.08e-01 | 6.94e-03 |
| INSERTION OF TAIL ANCHORED PROTEINS INTO THE ENDOPLASMIC RETICULUM MEMBRANE | 22 | 9.58e-04 | 4.07e-01 | 1.05e-02 |
| GLYCOSPHINGOLIPID METABOLISM | 38 | 1.44e-05 | 4.07e-01 | 4.09e-04 |
| WNT LIGAND BIOGENESIS AND TRAFFICKING | 21 | 1.61e-03 | 3.98e-01 | 1.57e-02 |
| SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | 20 | 2.11e-03 | 3.97e-01 | 1.91e-02 |
| GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | 14 | 1.08e-02 | 3.94e-01 | 5.96e-02 |
| SUPPRESSION OF PHAGOSOMAL MATURATION | 12 | 1.83e-02 | 3.93e-01 | 8.39e-02 |
| CS DS DEGRADATION | 14 | 1.24e-02 | 3.86e-01 | 6.53e-02 |
| IRE1ALPHA ACTIVATES CHAPERONES | 50 | 2.69e-06 | 3.84e-01 | 1.13e-04 |
| KERATAN SULFATE DEGRADATION | 11 | 2.84e-02 | 3.82e-01 | 1.14e-01 |
| ACTIVATION OF AMPK DOWNSTREAM OF NMDARS | 20 | 3.36e-03 | 3.79e-01 | 2.62e-02 |
| RECYCLING PATHWAY OF L1 | 40 | 3.41e-05 | 3.79e-01 | 8.20e-04 |
| POST CHAPERONIN TUBULIN FOLDING PATHWAY | 17 | 7.01e-03 | 3.78e-01 | 4.49e-02 |
| COPI MEDIATED ANTEROGRADE TRANSPORT | 91 | 5.78e-10 | 3.76e-01 | 5.23e-08 |
| BETA OXIDATION OF VERY LONG CHAIN FATTY ACIDS | 11 | 3.33e-02 | 3.71e-01 | 1.30e-01 |
| RESPONSE OF MTB TO PHAGOCYTOSIS | 21 | 3.31e-03 | 3.70e-01 | 2.60e-02 |
| CARGO TRAFFICKING TO THE PERICILIARY MEMBRANE | 49 | 7.34e-06 | 3.70e-01 | 2.34e-04 |
| ACTIVATED NTRK2 SIGNALS THROUGH FRS2 AND FRS3 | 10 | 4.51e-02 | 3.66e-01 | 1.60e-01 |
| INTERFERON ALPHA BETA SIGNALING | 53 | 4.94e-06 | -3.63e-01 | 1.71e-04 |
| BRANCHED CHAIN AMINO ACID CATABOLISM | 21 | 4.42e-03 | 3.59e-01 | 3.19e-02 |
| N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | 24 | 2.43e-03 | 3.57e-01 | 2.10e-02 |
| ATF6 ATF6 ALPHA ACTIVATES CHAPERONE GENES | 10 | 5.15e-02 | 3.56e-01 | 1.75e-01 |
| KILLING MECHANISMS | 11 | 4.23e-02 | -3.54e-01 | 1.53e-01 |
| VLDLR INTERNALISATION AND DEGRADATION | 12 | 3.50e-02 | 3.52e-01 | 1.33e-01 |
| GAP JUNCTION TRAFFICKING AND REGULATION | 33 | 4.84e-04 | 3.51e-01 | 6.34e-03 |
| ER QUALITY CONTROL COMPARTMENT ERQC | 21 | 5.66e-03 | 3.49e-01 | 3.83e-02 |
| ACTIVATION OF BAD AND TRANSLOCATION TO MITOCHONDRIA | 15 | 1.99e-02 | 3.47e-01 | 8.86e-02 |
| GOLGI TO ER RETROGRADE TRANSPORT | 119 | 6.02e-11 | 3.47e-01 | 1.01e-08 |
| INSULIN PROCESSING | 24 | 3.26e-03 | 3.47e-01 | 2.59e-02 |
| SYNTHESIS OF ACTIVE UBIQUITIN ROLES OF E1 AND E2 ENZYMES | 29 | 1.26e-03 | 3.46e-01 | 1.31e-02 |
| ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | 38 | 2.34e-04 | 3.45e-01 | 3.67e-03 |
| FATTY ACYL COA BIOSYNTHESIS | 32 | 7.84e-04 | 3.43e-01 | 9.11e-03 |
| SULFUR AMINO ACID METABOLISM | 23 | 4.78e-03 | 3.40e-01 | 3.39e-02 |
| AGGREPHAGY | 35 | 5.23e-04 | 3.39e-01 | 6.77e-03 |
| GLUCONEOGENESIS | 27 | 2.37e-03 | 3.38e-01 | 2.08e-02 |
| HYALURONAN UPTAKE AND DEGRADATION | 11 | 5.33e-02 | 3.36e-01 | 1.78e-01 |
| NUCLEAR ENVELOPE NE REASSEMBLY | 64 | 3.79e-06 | 3.34e-01 | 1.39e-04 |
| MATURATION OF SARS COV 2 SPIKE PROTEIN | 29 | 1.90e-03 | 3.33e-01 | 1.77e-02 |
| DERMATAN SULFATE BIOSYNTHESIS | 11 | 5.65e-02 | 3.32e-01 | 1.87e-01 |
| INTRAFLAGELLAR TRANSPORT | 52 | 3.49e-05 | 3.32e-01 | 8.21e-04 |
| INFECTION WITH MYCOBACTERIUM TUBERCULOSIS | 24 | 4.93e-03 | 3.32e-01 | 3.43e-02 |
| PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | 51 | 5.11e-05 | 3.28e-01 | 1.08e-03 |
| THE ROLE OF NEF IN HIV 1 REPLICATION AND DISEASE PATHOGENESIS | 27 | 3.27e-03 | 3.27e-01 | 2.59e-02 |
| INSULIN RECEPTOR RECYCLING | 20 | 1.19e-02 | 3.25e-01 | 6.41e-02 |
| HSF1 ACTIVATION | 25 | 5.38e-03 | 3.22e-01 | 3.66e-02 |
| SPRY REGULATION OF FGF SIGNALING | 16 | 2.60e-02 | 3.22e-01 | 1.07e-01 |
| GLUTAMATE AND GLUTAMINE METABOLISM | 13 | 4.53e-02 | 3.21e-01 | 1.61e-01 |
| TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | 171 | 5.69e-13 | 3.20e-01 | 1.34e-10 |
| DISEASES ASSOCIATED WITH GLYCOSAMINOGLYCAN METABOLISM | 39 | 5.54e-04 | 3.20e-01 | 7.02e-03 |
| LYSOSOME VESICLE BIOGENESIS | 33 | 1.53e-03 | 3.19e-01 | 1.52e-02 |
| MATURATION OF NUCLEOPROTEIN | 10 | 8.30e-02 | -3.17e-01 | 2.42e-01 |
| INITIATION OF NUCLEAR ENVELOPE NE REFORMATION | 17 | 2.42e-02 | 3.16e-01 | 1.02e-01 |
| MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | 15 | 3.47e-02 | -3.15e-01 | 1.32e-01 |
| ER TO GOLGI ANTEROGRADE TRANSPORT | 142 | 1.22e-10 | 3.13e-01 | 1.44e-08 |
| PEROXISOMAL LIPID METABOLISM | 27 | 4.92e-03 | 3.13e-01 | 3.43e-02 |
| PROTEIN METHYLATION | 17 | 2.56e-02 | 3.13e-01 | 1.06e-01 |
| COPI DEPENDENT GOLGI TO ER RETROGRADE TRAFFIC | 86 | 5.85e-07 | 3.12e-01 | 3.00e-05 |
| MHC CLASS II ANTIGEN PRESENTATION | 102 | 5.62e-08 | 3.11e-01 | 3.48e-06 |
| RAF ACTIVATION | 34 | 1.69e-03 | 3.11e-01 | 1.63e-02 |
| CTLA4 INHIBITORY SIGNALING | 20 | 1.65e-02 | 3.10e-01 | 7.89e-02 |
| RAP1 SIGNALLING | 15 | 3.79e-02 | 3.10e-01 | 1.41e-01 |
| TRNA AMINOACYLATION | 42 | 5.63e-04 | 3.08e-01 | 7.04e-03 |
| HSF1 DEPENDENT TRANSACTIVATION | 33 | 2.39e-03 | 3.06e-01 | 2.08e-02 |
| APOPTOSIS INDUCED DNA FRAGMENTATION | 10 | 9.44e-02 | -3.05e-01 | 2.67e-01 |
| KSRP KHSRP BINDS AND DESTABILIZES MRNA | 16 | 3.46e-02 | -3.05e-01 | 1.32e-01 |
| ASPARTATE AND ASPARAGINE METABOLISM | 10 | 9.79e-02 | 3.02e-01 | 2.72e-01 |
| GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | 30 | 4.24e-03 | 3.02e-01 | 3.08e-02 |
| SPHINGOLIPID METABOLISM | 80 | 3.33e-06 | 3.01e-01 | 1.27e-04 |
| ADENYLATE CYCLASE INHIBITORY PATHWAY | 13 | 6.12e-02 | 3.00e-01 | 1.96e-01 |
| SELECTIVE AUTOPHAGY | 72 | 1.10e-05 | 3.00e-01 | 3.24e-04 |
| EPHRIN SIGNALING | 19 | 2.41e-02 | 2.99e-01 | 1.02e-01 |
| DARPP 32 EVENTS | 23 | 1.32e-02 | 2.99e-01 | 6.82e-02 |
| PRESYNAPTIC DEPOLARIZATION AND CALCIUM CHANNEL OPENING | 11 | 8.66e-02 | -2.98e-01 | 2.49e-01 |
| CARGO CONCENTRATION IN THE ER | 31 | 4.21e-03 | 2.97e-01 | 3.08e-02 |
| NUCLEOTIDE LIKE PURINERGIC RECEPTORS | 13 | 6.65e-02 | 2.94e-01 | 2.08e-01 |
| CREB1 PHOSPHORYLATION THROUGH THE ACTIVATION OF ADENYLATE CYCLASE | 11 | 9.15e-02 | 2.94e-01 | 2.60e-01 |
| VEGFR2 MEDIATED VASCULAR PERMEABILITY | 27 | 8.69e-03 | 2.92e-01 | 5.11e-02 |
| ASPARAGINE N LINKED GLYCOSYLATION | 285 | 2.66e-17 | 2.91e-01 | 1.57e-14 |
| PTK6 REGULATES RHO GTPASES RAS GTPASE AND MAP KINASES | 13 | 6.91e-02 | 2.91e-01 | 2.14e-01 |
| PEROXISOMAL PROTEIN IMPORT | 59 | 1.12e-04 | 2.91e-01 | 2.07e-03 |
| RESOLUTION OF D LOOP STRUCTURES THROUGH SYNTHESIS DEPENDENT STRAND ANNEALING SDSA | 25 | 1.21e-02 | -2.90e-01 | 6.47e-02 |
| ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 12 | 20 | 2.52e-02 | 2.89e-01 | 1.05e-01 |
| HDMS DEMETHYLATE HISTONES | 30 | 6.22e-03 | -2.89e-01 | 4.17e-02 |
| CARBOXYTERMINAL POST TRANSLATIONAL MODIFICATIONS OF TUBULIN | 36 | 2.75e-03 | 2.88e-01 | 2.28e-02 |
| REGULATION OF MECP2 EXPRESSION AND ACTIVITY | 29 | 7.83e-03 | -2.85e-01 | 4.81e-02 |
| NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | 14 | 6.46e-02 | 2.85e-01 | 2.02e-01 |
| PKA MEDIATED PHOSPHORYLATION OF CREB | 19 | 3.14e-02 | 2.85e-01 | 1.24e-01 |
| IRON UPTAKE AND TRANSPORT | 51 | 4.52e-04 | 2.84e-01 | 5.99e-03 |
| TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN G2 CELL CYCLE ARREST | 15 | 5.73e-02 | 2.84e-01 | 1.88e-01 |
| DEFECTIVE CFTR CAUSES CYSTIC FIBROSIS | 59 | 1.71e-04 | 2.83e-01 | 2.93e-03 |
| AUTOPHAGY | 139 | 9.74e-09 | 2.82e-01 | 8.20e-07 |
| COOPERATION OF PDCL PHLP1 AND TRIC CCT IN G PROTEIN BETA FOLDING | 36 | 3.56e-03 | 2.81e-01 | 2.73e-02 |
| ACYL CHAIN REMODELLING OF PE | 17 | 4.78e-02 | 2.77e-01 | 1.66e-01 |
| SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | 16 | 5.49e-02 | 2.77e-01 | 1.83e-01 |
| INTERFERON GAMMA SIGNALING | 74 | 3.78e-05 | -2.77e-01 | 8.73e-04 |
| RAB GERANYLGERANYLATION | 57 | 3.61e-04 | 2.73e-01 | 5.07e-03 |
| PKMTS METHYLATE HISTONE LYSINES | 51 | 7.53e-04 | -2.73e-01 | 8.87e-03 |
| LYSINE CATABOLISM | 11 | 1.18e-01 | 2.72e-01 | 3.08e-01 |
| SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | 13 | 8.98e-02 | 2.72e-01 | 2.57e-01 |
| RESOLUTION OF D LOOP STRUCTURES | 31 | 9.15e-03 | -2.71e-01 | 5.23e-02 |
| CHOLESTEROL BIOSYNTHESIS | 24 | 2.20e-02 | 2.70e-01 | 9.61e-02 |
| RUNX1 REGULATES GENES INVOLVED IN MEGAKARYOCYTE DIFFERENTIATION AND PLATELET FUNCTION | 54 | 5.98e-04 | -2.70e-01 | 7.26e-03 |
| GAP JUNCTION DEGRADATION | 11 | 1.21e-01 | 2.70e-01 | 3.12e-01 |
| COPII MEDIATED VESICLE TRANSPORT | 66 | 1.70e-04 | 2.68e-01 | 2.93e-03 |
| THE ROLE OF GTSE1 IN G2 M PROGRESSION AFTER G2 CHECKPOINT | 66 | 1.73e-04 | 2.67e-01 | 2.93e-03 |
| SIGNAL AMPLIFICATION | 31 | 1.00e-02 | 2.67e-01 | 5.58e-02 |
| GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | 16 | 6.42e-02 | 2.67e-01 | 2.02e-01 |
| DEGRADATION OF CYSTEINE AND HOMOCYSTEINE | 13 | 9.58e-02 | 2.67e-01 | 2.70e-01 |
| INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | 13 | 9.61e-02 | 2.67e-01 | 2.70e-01 |
| INTRA GOLGI AND RETROGRADE GOLGI TO ER TRAFFIC | 185 | 4.87e-10 | 2.65e-01 | 4.78e-08 |
| BUDDING AND MATURATION OF HIV VIRION | 27 | 1.71e-02 | 2.65e-01 | 8.01e-02 |
| SIGNALING BY HEDGEHOG | 141 | 5.58e-08 | 2.65e-01 | 3.48e-06 |
| DEPOLYMERISATION OF THE NUCLEAR LAMINA | 13 | 9.80e-02 | 2.65e-01 | 2.72e-01 |
| ROS AND RNS PRODUCTION IN PHAGOCYTES | 28 | 1.53e-02 | 2.65e-01 | 7.60e-02 |
| G ALPHA Z SIGNALLING EVENTS | 45 | 2.20e-03 | 2.64e-01 | 1.98e-02 |
| G1 S SPECIFIC TRANSCRIPTION | 26 | 2.08e-02 | 2.62e-01 | 9.25e-02 |
| NUCLEOTIDE SALVAGE | 21 | 3.78e-02 | 2.62e-01 | 1.40e-01 |
| TRANSCRIPTION OF E2F TARGETS UNDER NEGATIVE CONTROL BY P107 RBL1 AND P130 RBL2 IN COMPLEX WITH HDAC1 | 15 | 7.92e-02 | 2.62e-01 | 2.34e-01 |
| FORMATION OF APOPTOSOME | 10 | 1.52e-01 | 2.62e-01 | 3.69e-01 |
| TRANSLOCATION OF SLC2A4 GLUT4 TO THE PLASMA MEMBRANE | 63 | 3.32e-04 | 2.61e-01 | 4.77e-03 |
| PENTOSE PHOSPHATE PATHWAY | 13 | 1.03e-01 | 2.61e-01 | 2.84e-01 |
| NEUROTOXICITY OF CLOSTRIDIUM TOXINS | 10 | 1.53e-01 | 2.61e-01 | 3.70e-01 |
| SEROTONIN RECEPTORS | 10 | 1.55e-01 | 2.60e-01 | 3.71e-01 |
| PKA ACTIVATION IN GLUCAGON SIGNALLING | 16 | 7.18e-02 | 2.60e-01 | 2.19e-01 |
| LAMININ INTERACTIONS | 29 | 1.56e-02 | -2.59e-01 | 7.69e-02 |
| HEDGEHOG OFF STATE | 106 | 3.98e-06 | 2.59e-01 | 1.42e-04 |
| ERKS ARE INACTIVATED | 13 | 1.06e-01 | 2.59e-01 | 2.86e-01 |
| UPTAKE AND ACTIONS OF BACTERIAL TOXINS | 28 | 1.81e-02 | 2.58e-01 | 8.35e-02 |
| DEFECTIVE B4GALT7 CAUSES EDS PROGEROID TYPE | 20 | 4.62e-02 | 2.57e-01 | 1.63e-01 |
| TRANSCRIPTION OF E2F TARGETS UNDER NEGATIVE CONTROL BY DREAM COMPLEX | 18 | 5.97e-02 | 2.56e-01 | 1.93e-01 |
| ACTIVATION OF RAC1 | 13 | 1.10e-01 | 2.56e-01 | 2.93e-01 |
| TRANSFERRIN ENDOCYTOSIS AND RECYCLING | 26 | 2.39e-02 | 2.56e-01 | 1.01e-01 |
| FGFR2 LIGAND BINDING AND ACTIVATION | 12 | 1.25e-01 | -2.56e-01 | 3.20e-01 |
| GLYCOSAMINOGLYCAN METABOLISM | 113 | 2.78e-06 | 2.55e-01 | 1.13e-04 |
| UPTAKE AND FUNCTION OF ANTHRAX TOXINS | 11 | 1.45e-01 | 2.54e-01 | 3.59e-01 |
| GLUCAGON SIGNALING IN METABOLIC REGULATION | 30 | 1.64e-02 | 2.53e-01 | 7.89e-02 |
| PROCESSING AND ACTIVATION OF SUMO | 10 | 1.66e-01 | 2.53e-01 | 3.88e-01 |
| RHO GTPASES ACTIVATE WASPS AND WAVES | 36 | 8.71e-03 | 2.53e-01 | 5.11e-02 |
| LOSS OF FUNCTION OF MECP2 IN RETT SYNDROME | 13 | 1.15e-01 | -2.53e-01 | 3.01e-01 |
| CHONDROITIN SULFATE BIOSYNTHESIS | 18 | 6.42e-02 | 2.52e-01 | 2.02e-01 |
| WNT5A DEPENDENT INTERNALIZATION OF FZD4 | 15 | 9.13e-02 | 2.52e-01 | 2.60e-01 |
| MITOPHAGY | 29 | 1.94e-02 | 2.51e-01 | 8.74e-02 |
| REGULATION OF FOXO TRANSCRIPTIONAL ACTIVITY BY ACETYLATION | 10 | 1.70e-01 | -2.51e-01 | 3.93e-01 |
| PROTEIN FOLDING | 90 | 4.10e-05 | 2.50e-01 | 9.11e-04 |
| O LINKED GLYCOSYLATION OF MUCINS | 40 | 6.63e-03 | 2.48e-01 | 4.30e-02 |
| TELOMERE C STRAND SYNTHESIS INITIATION | 13 | 1.24e-01 | 2.46e-01 | 3.18e-01 |
| METABOLISM OF POLYAMINES | 57 | 1.34e-03 | 2.46e-01 | 1.39e-02 |
| CREB1 PHOSPHORYLATION THROUGH NMDA RECEPTOR MEDIATED ACTIVATION OF RAS SIGNALING | 28 | 2.51e-02 | 2.45e-01 | 1.05e-01 |
| RHOBTB2 GTPASE CYCLE | 23 | 4.24e-02 | 2.45e-01 | 1.53e-01 |
| REGULATION OF INSULIN LIKE GROWTH FACTOR IGF TRANSPORT AND UPTAKE BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | 92 | 5.23e-05 | 2.44e-01 | 1.08e-03 |
| INTERACTION BETWEEN L1 AND ANKYRINS | 27 | 2.84e-02 | -2.44e-01 | 1.14e-01 |
| HEDGEHOG LIGAND BIOGENESIS | 61 | 1.02e-03 | 2.43e-01 | 1.12e-02 |
| PROLACTIN RECEPTOR SIGNALING | 11 | 1.63e-01 | 2.43e-01 | 3.83e-01 |
| ATTENUATION PHASE | 23 | 4.41e-02 | 2.43e-01 | 1.58e-01 |
| PROTEIN LOCALIZATION | 158 | 1.54e-07 | 2.42e-01 | 8.66e-06 |
| ACTIVATION OF THE AP 1 FAMILY OF TRANSCRIPTION FACTORS | 10 | 1.87e-01 | 2.41e-01 | 4.19e-01 |
| TP53 REGULATES TRANSCRIPTION OF SEVERAL ADDITIONAL CELL DEATH GENES WHOSE SPECIFIC ROLES IN P53 DEPENDENT APOPTOSIS REMAIN UNCERTAIN | 12 | 1.50e-01 | 2.40e-01 | 3.67e-01 |
| REGULATION OF LOCALIZATION OF FOXO TRANSCRIPTION FACTORS | 12 | 1.51e-01 | 2.40e-01 | 3.69e-01 |
| TP53 REGULATES TRANSCRIPTION OF CASPASE ACTIVATORS AND CASPASES | 11 | 1.69e-01 | -2.39e-01 | 3.93e-01 |
| NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | 21 | 5.79e-02 | 2.39e-01 | 1.90e-01 |
| METABOLISM OF CARBOHYDRATES | 260 | 3.79e-11 | 2.38e-01 | 7.43e-09 |
| GABA RECEPTOR ACTIVATION | 55 | 2.25e-03 | 2.38e-01 | 1.99e-02 |
| PLATELET ADHESION TO EXPOSED COLLAGEN | 13 | 1.37e-01 | -2.38e-01 | 3.43e-01 |
| POSTMITOTIC NUCLEAR PORE COMPLEX NPC REFORMATION | 26 | 3.57e-02 | 2.38e-01 | 1.34e-01 |
| SIGNALING BY NODAL | 15 | 1.11e-01 | -2.38e-01 | 2.93e-01 |
| O GLYCOSYLATION OF TSR DOMAIN CONTAINING PROTEINS | 35 | 1.54e-02 | -2.37e-01 | 7.60e-02 |
| G0 AND EARLY G1 | 25 | 4.06e-02 | 2.37e-01 | 1.48e-01 |
| TP53 REGULATES TRANSCRIPTION OF ADDITIONAL CELL CYCLE GENES WHOSE EXACT ROLE IN THE P53 PATHWAY REMAIN UNCERTAIN | 20 | 6.88e-02 | 2.35e-01 | 2.13e-01 |
| TRIGLYCERIDE CATABOLISM | 14 | 1.29e-01 | 2.34e-01 | 3.28e-01 |
| REGULATION OF IFNG SIGNALING | 13 | 1.44e-01 | 2.34e-01 | 3.58e-01 |
| ABC TRANSPORTER DISORDERS | 70 | 7.36e-04 | 2.33e-01 | 8.76e-03 |
| CHEMOKINE RECEPTORS BIND CHEMOKINES | 17 | 9.62e-02 | -2.33e-01 | 2.70e-01 |
| DEFECTS OF CONTACT ACTIVATION SYSTEM CAS AND KALLIKREIN KININ SYSTEM KKS | 11 | 1.81e-01 | -2.33e-01 | 4.09e-01 |
| REGULATION OF HMOX1 EXPRESSION AND ACTIVITY | 63 | 1.43e-03 | 2.32e-01 | 1.44e-02 |
| UNFOLDED PROTEIN RESPONSE UPR | 85 | 2.14e-04 | 2.32e-01 | 3.46e-03 |
| PLASMA LIPOPROTEIN CLEARANCE | 28 | 3.40e-02 | 2.32e-01 | 1.31e-01 |
| TRISTETRAPROLIN TTP ZFP36 BINDS AND DESTABILIZES MRNA | 16 | 1.11e-01 | -2.30e-01 | 2.93e-01 |
| THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | 28 | 3.56e-02 | 2.29e-01 | 1.34e-01 |
| GLUTATHIONE SYNTHESIS AND RECYCLING | 11 | 1.88e-01 | 2.29e-01 | 4.19e-01 |
| SYNTHESIS OF PROSTAGLANDINS PG AND THROMBOXANES TX | 12 | 1.70e-01 | 2.29e-01 | 3.93e-01 |
| CYCLIN A CDK2 ASSOCIATED EVENTS AT S PHASE ENTRY | 84 | 3.04e-04 | 2.28e-01 | 4.54e-03 |
| CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | 48 | 6.48e-03 | 2.27e-01 | 4.24e-02 |
| EXTRA NUCLEAR ESTROGEN SIGNALING | 68 | 1.20e-03 | 2.27e-01 | 1.28e-02 |
| ATF6 ATF6 ALPHA ACTIVATES CHAPERONES | 12 | 1.73e-01 | 2.27e-01 | 3.97e-01 |
| CLASS B 2 SECRETIN FAMILY RECEPTORS | 73 | 8.08e-04 | 2.27e-01 | 9.16e-03 |
| ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | 30 | 3.22e-02 | 2.26e-01 | 1.27e-01 |
| REGULATION OF TP53 EXPRESSION AND DEGRADATION | 34 | 2.27e-02 | 2.26e-01 | 9.78e-02 |
| INTEGRATION OF ENERGY METABOLISM | 100 | 9.94e-05 | 2.25e-01 | 1.89e-03 |
| METABOLISM OF NUCLEOTIDES | 92 | 1.97e-04 | 2.25e-01 | 3.23e-03 |
| PLATELET SENSITIZATION BY LDL | 15 | 1.34e-01 | 2.23e-01 | 3.37e-01 |
| NEGATIVE REGULATION OF FGFR3 SIGNALING | 24 | 5.84e-02 | 2.23e-01 | 1.90e-01 |
| A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | 26 | 4.94e-02 | 2.23e-01 | 1.70e-01 |
| REGULATION OF RUNX1 EXPRESSION AND ACTIVITY | 17 | 1.13e-01 | -2.22e-01 | 2.97e-01 |
| SYNTHESIS OF PA | 29 | 3.93e-02 | 2.21e-01 | 1.44e-01 |
| CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | 46 | 9.64e-03 | 2.21e-01 | 5.44e-02 |
| SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | 18 | 1.05e-01 | 2.20e-01 | 2.85e-01 |
| TRANSCRIPTIONAL REGULATION OF PLURIPOTENT STEM CELLS | 18 | 1.07e-01 | 2.20e-01 | 2.87e-01 |
| HEPARAN SULFATE HEPARIN HS GAG METABOLISM | 52 | 6.27e-03 | 2.19e-01 | 4.18e-02 |
| TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | 13 | 1.72e-01 | -2.19e-01 | 3.96e-01 |
| ASSEMBLY AND CELL SURFACE PRESENTATION OF NMDA RECEPTORS | 36 | 2.33e-02 | 2.18e-01 | 1.00e-01 |
| SCAVENGING OF HEME FROM PLASMA | 12 | 1.91e-01 | -2.18e-01 | 4.24e-01 |
| SIGNAL TRANSDUCTION BY L1 | 21 | 8.47e-02 | 2.17e-01 | 2.46e-01 |
| HOMOLOGOUS DNA PAIRING AND STRAND EXCHANGE | 41 | 1.61e-02 | -2.17e-01 | 7.85e-02 |
| FOXO MEDIATED TRANSCRIPTION OF CELL DEATH GENES | 15 | 1.45e-01 | -2.17e-01 | 3.59e-01 |
| RESPONSE OF EIF2AK1 HRI TO HEME DEFICIENCY | 15 | 1.48e-01 | 2.16e-01 | 3.64e-01 |
| DISEASES ASSOCIATED WITH N GLYCOSYLATION OF PROTEINS | 17 | 1.23e-01 | 2.16e-01 | 3.17e-01 |
| VEGFR2 MEDIATED CELL PROLIFERATION | 19 | 1.04e-01 | 2.15e-01 | 2.85e-01 |
| PYRUVATE METABOLISM | 27 | 5.33e-02 | 2.15e-01 | 1.78e-01 |
| INTERLEUKIN 10 SIGNALING | 19 | 1.05e-01 | -2.15e-01 | 2.85e-01 |
| SARS COV 2 INFECTION | 65 | 2.78e-03 | 2.15e-01 | 2.29e-02 |
| PROTEIN UBIQUITINATION | 70 | 1.93e-03 | 2.14e-01 | 1.78e-02 |
| MITOCHONDRIAL TRNA AMINOACYLATION | 21 | 8.95e-02 | 2.14e-01 | 2.57e-01 |
| SIALIC ACID METABOLISM | 32 | 3.64e-02 | 2.14e-01 | 1.36e-01 |
| PI 3K CASCADE FGFR2 | 17 | 1.27e-01 | -2.14e-01 | 3.24e-01 |
| STAT5 ACTIVATION DOWNSTREAM OF FLT3 ITD MUTANTS | 10 | 2.43e-01 | -2.13e-01 | 4.84e-01 |
| NEGATIVE REGULATION OF FGFR4 SIGNALING | 24 | 7.15e-02 | 2.13e-01 | 2.19e-01 |
| REGULATION OF PTEN STABILITY AND ACTIVITY | 66 | 2.88e-03 | 2.12e-01 | 2.36e-02 |
| DISASSEMBLY OF THE DESTRUCTION COMPLEX AND RECRUITMENT OF AXIN TO THE MEMBRANE | 26 | 6.20e-02 | 2.11e-01 | 1.98e-01 |
| GLUCAGON LIKE PEPTIDE 1 GLP1 REGULATES INSULIN SECRETION | 39 | 2.26e-02 | 2.11e-01 | 9.78e-02 |
| HS GAG BIOSYNTHESIS | 30 | 4.57e-02 | 2.11e-01 | 1.62e-01 |
| HDR THROUGH HOMOLOGOUS RECOMBINATION HRR | 64 | 3.75e-03 | -2.10e-01 | 2.82e-02 |
| REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | 15 | 1.60e-01 | 2.09e-01 | 3.79e-01 |
| MTORC1 MEDIATED SIGNALLING | 24 | 7.66e-02 | 2.09e-01 | 2.30e-01 |
| HDACS DEACETYLATE HISTONES | 50 | 1.09e-02 | -2.08e-01 | 6.03e-02 |
| CGMP EFFECTS | 15 | 1.65e-01 | -2.07e-01 | 3.85e-01 |
| DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | 78 | 1.61e-03 | 2.07e-01 | 1.57e-02 |
| REGULATION OF GENE EXPRESSION IN LATE STAGE BRANCHING MORPHOGENESIS PANCREATIC BUD PRECURSOR CELLS | 15 | 1.66e-01 | -2.07e-01 | 3.88e-01 |
| ACYL CHAIN REMODELLING OF PG | 10 | 2.59e-01 | 2.06e-01 | 5.02e-01 |
| FERTILIZATION | 13 | 1.98e-01 | -2.06e-01 | 4.32e-01 |
| INTEGRIN CELL SURFACE INTERACTIONS | 75 | 2.02e-03 | -2.06e-01 | 1.85e-02 |
| G BETA GAMMA SIGNALLING THROUGH CDC42 | 19 | 1.20e-01 | 2.06e-01 | 3.10e-01 |
| FCERI MEDIATED NF KB ACTIVATION | 76 | 1.90e-03 | 2.06e-01 | 1.77e-02 |
| SIGNALING BY CTNNB1 PHOSPHO SITE MUTANTS | 15 | 1.67e-01 | 2.06e-01 | 3.90e-01 |
| INTRA GOLGI TRAFFIC | 43 | 1.96e-02 | 2.06e-01 | 8.81e-02 |
| TRANS GOLGI NETWORK VESICLE BUDDING | 70 | 2.94e-03 | 2.06e-01 | 2.39e-02 |
| PROCESSING OF SMDT1 | 16 | 1.55e-01 | 2.06e-01 | 3.71e-01 |
| BETA CATENIN PHOSPHORYLATION CASCADE | 16 | 1.55e-01 | 2.05e-01 | 3.71e-01 |
| SYNTHESIS OF PC | 26 | 7.09e-02 | 2.05e-01 | 2.19e-01 |
| GLYCEROPHOSPHOLIPID BIOSYNTHESIS | 109 | 2.30e-04 | 2.04e-01 | 3.66e-03 |
| AMINE LIGAND BINDING RECEPTORS | 29 | 5.70e-02 | 2.04e-01 | 1.88e-01 |
| SPHINGOLIPID DE NOVO BIOSYNTHESIS | 42 | 2.24e-02 | 2.04e-01 | 9.75e-02 |
| GABA B RECEPTOR ACTIVATION | 40 | 2.62e-02 | 2.03e-01 | 1.07e-01 |
| NR1H3 NR1H2 REGULATE GENE EXPRESSION LINKED TO CHOLESTEROL TRANSPORT AND EFFLUX | 32 | 4.69e-02 | -2.03e-01 | 1.64e-01 |
| REGULATION OF INSULIN SECRETION | 72 | 2.98e-03 | 2.02e-01 | 2.41e-02 |
| MTOR SIGNALLING | 40 | 2.69e-02 | 2.02e-01 | 1.09e-01 |
| VASOPRESSIN REGULATES RENAL WATER HOMEOSTASIS VIA AQUAPORINS | 37 | 3.35e-02 | 2.02e-01 | 1.30e-01 |
| BUTYRATE RESPONSE FACTOR 1 BRF1 BINDS AND DESTABILIZES MRNA | 16 | 1.63e-01 | -2.01e-01 | 3.83e-01 |
| LATE ENDOSOMAL MICROAUTOPHAGY | 32 | 4.89e-02 | 2.01e-01 | 1.69e-01 |
| RETROGRADE TRANSPORT AT THE TRANS GOLGI NETWORK | 48 | 1.61e-02 | 2.01e-01 | 7.85e-02 |
| KINESINS | 47 | 1.77e-02 | 2.00e-01 | 8.20e-02 |
| ACTIVATION OF NMDA RECEPTORS AND POSTSYNAPTIC EVENTS | 84 | 1.55e-03 | 2.00e-01 | 1.53e-02 |
| PROLONGED ERK ACTIVATION EVENTS | 13 | 2.13e-01 | 1.99e-01 | 4.51e-01 |
| NCAM1 INTERACTIONS | 42 | 2.55e-02 | -1.99e-01 | 1.06e-01 |
| DISEASES ASSOCIATED WITH GLYCOSYLATION PRECURSOR BIOSYNTHESIS | 18 | 1.44e-01 | 1.99e-01 | 3.58e-01 |
| ERYTHROPOIETIN ACTIVATES RAS | 13 | 2.14e-01 | 1.99e-01 | 4.51e-01 |
| MEMBRANE TRAFFICKING | 582 | 2.93e-16 | 1.99e-01 | 1.15e-13 |
| PEPTIDE HORMONE METABOLISM | 60 | 7.82e-03 | 1.99e-01 | 4.81e-02 |
| SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | 14 | 1.98e-01 | 1.99e-01 | 4.32e-01 |
| CELLULAR RESPONSE TO HEAT STRESS | 94 | 9.54e-04 | 1.97e-01 | 1.05e-02 |
| IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | 51 | 1.51e-02 | -1.97e-01 | 7.57e-02 |
| ACTIVATION OF BH3 ONLY PROTEINS | 30 | 6.25e-02 | 1.97e-01 | 1.99e-01 |
| DEGRADATION OF GLI1 BY THE PROTEASOME | 57 | 1.04e-02 | 1.96e-01 | 5.75e-02 |
| HDR THROUGH SINGLE STRAND ANNEALING SSA | 37 | 3.92e-02 | -1.96e-01 | 1.44e-01 |
| THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | 23 | 1.04e-01 | 1.96e-01 | 2.85e-01 |
| DISEASES OF DNA REPAIR | 11 | 2.62e-01 | 1.95e-01 | 5.03e-01 |
| NEGATIVE REGULATION OF NOTCH4 SIGNALING | 54 | 1.31e-02 | 1.95e-01 | 6.81e-02 |
| REGULATION OF KIT SIGNALING | 16 | 1.77e-01 | 1.95e-01 | 4.04e-01 |
| CLATHRIN MEDIATED ENDOCYTOSIS | 134 | 1.01e-04 | 1.95e-01 | 1.89e-03 |
| NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | 20 | 1.32e-01 | -1.94e-01 | 3.34e-01 |
| STABILIZATION OF P53 | 54 | 1.36e-02 | 1.94e-01 | 6.93e-02 |
| CA DEPENDENT EVENTS | 36 | 4.38e-02 | 1.94e-01 | 1.57e-01 |
| CLASS I PEROXISOMAL MEMBRANE PROTEIN IMPORT | 20 | 1.33e-01 | 1.94e-01 | 3.35e-01 |
| CD28 CO STIMULATION | 31 | 6.21e-02 | 1.94e-01 | 1.98e-01 |
| NEUROTRANSMITTER RECEPTORS AND POSTSYNAPTIC SIGNAL TRANSMISSION | 182 | 6.78e-06 | 1.94e-01 | 2.22e-04 |
| RAB GEFS EXCHANGE GTP FOR GDP ON RABS | 88 | 1.72e-03 | 1.93e-01 | 1.65e-02 |
| ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | 28 | 7.71e-02 | 1.93e-01 | 2.30e-01 |
| MITOTIC METAPHASE AND ANAPHASE | 207 | 1.79e-06 | 1.93e-01 | 8.44e-05 |
| FATTY ACID METABOLISM | 146 | 6.12e-05 | 1.92e-01 | 1.21e-03 |
| B WICH COMPLEX POSITIVELY REGULATES RRNA EXPRESSION | 51 | 1.76e-02 | -1.92e-01 | 8.20e-02 |
| NEUTROPHIL DEGRANULATION | 386 | 1.15e-10 | 1.91e-01 | 1.44e-08 |
| REGULATION OF RAS BY GAPS | 66 | 7.18e-03 | 1.91e-01 | 4.57e-02 |
| REGULATION OF HSF1 MEDIATED HEAT SHOCK RESPONSE | 75 | 4.23e-03 | 1.91e-01 | 3.08e-02 |
| PINK1 PRKN MEDIATED MITOPHAGY | 22 | 1.21e-01 | 1.91e-01 | 3.12e-01 |
| APC C MEDIATED DEGRADATION OF CELL CYCLE PROTEINS | 81 | 3.11e-03 | 1.90e-01 | 2.49e-02 |
| E2F MEDIATED REGULATION OF DNA REPLICATION | 19 | 1.52e-01 | 1.90e-01 | 3.69e-01 |
| ACTIVATION OF THE TFAP2 AP 2 FAMILY OF TRANSCRIPTION FACTORS | 10 | 2.99e-01 | -1.90e-01 | 5.46e-01 |
| NEDDYLATION | 219 | 1.33e-06 | 1.90e-01 | 6.54e-05 |
| METHYLATION | 11 | 2.77e-01 | 1.89e-01 | 5.19e-01 |
| VXPX CARGO TARGETING TO CILIUM | 19 | 1.53e-01 | 1.89e-01 | 3.70e-01 |
| HEME SIGNALING | 46 | 2.64e-02 | -1.89e-01 | 1.07e-01 |
| ADENYLATE CYCLASE ACTIVATING PATHWAY | 10 | 3.03e-01 | 1.88e-01 | 5.50e-01 |
| FC EPSILON RECEPTOR FCERI SIGNALING | 123 | 3.19e-04 | 1.88e-01 | 4.65e-03 |
| DSCAM INTERACTIONS | 11 | 2.83e-01 | -1.87e-01 | 5.24e-01 |
| DISEASES OF CARBOHYDRATE METABOLISM | 29 | 8.12e-02 | 1.87e-01 | 2.39e-01 |
| SYNTHESIS OF PE | 13 | 2.44e-01 | 1.87e-01 | 4.84e-01 |
| TBC RABGAPS | 43 | 3.43e-02 | 1.87e-01 | 1.31e-01 |
| AMINO ACIDS REGULATE MTORC1 | 51 | 2.15e-02 | 1.86e-01 | 9.47e-02 |
| CYCLIN A B1 B2 ASSOCIATED EVENTS DURING G2 M TRANSITION | 22 | 1.32e-01 | 1.86e-01 | 3.32e-01 |
| VESICLE MEDIATED TRANSPORT | 615 | 4.82e-15 | 1.85e-01 | 1.42e-12 |
| NUCLEOBASE CATABOLISM | 31 | 7.40e-02 | 1.85e-01 | 2.23e-01 |
| SCF SKP2 MEDIATED DEGRADATION OF P27 P21 | 59 | 1.39e-02 | 1.85e-01 | 7.05e-02 |
| NEGATIVE REGULATION OF MET ACTIVITY | 20 | 1.52e-01 | 1.85e-01 | 3.70e-01 |
| RHOF GTPASE CYCLE | 41 | 4.11e-02 | 1.84e-01 | 1.49e-01 |
| SYNTHESIS OF BILE ACIDS AND BILE SALTS | 23 | 1.27e-01 | 1.84e-01 | 3.24e-01 |
| RESOLUTION OF SISTER CHROMATID COHESION | 102 | 1.37e-03 | 1.83e-01 | 1.40e-02 |
| REGULATION OF RUNX3 EXPRESSION AND ACTIVITY | 53 | 2.09e-02 | 1.83e-01 | 9.27e-02 |
| FCGR3A MEDIATED IL10 SYNTHESIS | 32 | 7.32e-02 | 1.83e-01 | 2.22e-01 |
| PHOSPHOLIPASE C MEDIATED CASCADE FGFR2 | 12 | 2.74e-01 | -1.83e-01 | 5.15e-01 |
| APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | 70 | 8.32e-03 | 1.82e-01 | 4.98e-02 |
| GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | 18 | 1.81e-01 | 1.82e-01 | 4.09e-01 |
| METAL ION SLC TRANSPORTERS | 25 | 1.16e-01 | 1.82e-01 | 3.03e-01 |
| INTERFERON SIGNALING | 162 | 6.96e-05 | -1.81e-01 | 1.34e-03 |
| DEFECTS IN COBALAMIN B12 METABOLISM | 13 | 2.59e-01 | 1.81e-01 | 5.02e-01 |
| COBALAMIN CBL VITAMIN B12 TRANSPORT AND METABOLISM | 14 | 2.42e-01 | 1.81e-01 | 4.82e-01 |
| RORA ACTIVATES GENE EXPRESSION | 18 | 1.85e-01 | -1.81e-01 | 4.15e-01 |
| HEDGEHOG ON STATE | 82 | 4.83e-03 | 1.80e-01 | 3.40e-02 |
| METABOLISM OF FAT SOLUBLE VITAMINS | 32 | 7.81e-02 | 1.80e-01 | 2.32e-01 |
| CRMPS IN SEMA3A SIGNALING | 16 | 2.14e-01 | -1.80e-01 | 4.51e-01 |
| PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | 17 | 2.00e-01 | 1.79e-01 | 4.36e-01 |
| CILIUM ASSEMBLY | 192 | 1.94e-05 | 1.79e-01 | 5.19e-04 |
| CLEC7A DECTIN 1 INDUCES NFAT ACTIVATION | 11 | 3.04e-01 | 1.79e-01 | 5.50e-01 |
| MITOCHONDRIAL FATTY ACID BETA OXIDATION | 34 | 7.12e-02 | 1.79e-01 | 2.19e-01 |
| RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | 107 | 1.40e-03 | 1.79e-01 | 1.42e-02 |
| REDUCTION OF CYTOSOLIC CA LEVELS | 12 | 2.87e-01 | -1.77e-01 | 5.28e-01 |
| GPCR LIGAND BINDING | 271 | 5.44e-07 | 1.77e-01 | 2.91e-05 |
| ASSEMBLY OF THE HIV VIRION | 16 | 2.21e-01 | 1.77e-01 | 4.57e-01 |
| LISTERIA MONOCYTOGENES ENTRY INTO HOST CELLS | 20 | 1.72e-01 | 1.76e-01 | 3.96e-01 |
| BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN GENE EXPRESSION | 26 | 1.21e-01 | -1.76e-01 | 3.12e-01 |
| EPHB MEDIATED FORWARD SIGNALING | 42 | 4.93e-02 | 1.75e-01 | 1.70e-01 |
| COMPLEX I BIOGENESIS | 56 | 2.34e-02 | -1.75e-01 | 1.00e-01 |
| COLLAGEN CHAIN TRIMERIZATION | 41 | 5.26e-02 | -1.75e-01 | 1.77e-01 |
| FCERI MEDIATED MAPK ACTIVATION | 28 | 1.10e-01 | 1.74e-01 | 2.93e-01 |
| G ALPHA Q SIGNALLING EVENTS | 155 | 1.82e-04 | 1.74e-01 | 3.02e-03 |
| RAS ACTIVATION UPON CA2 INFLUX THROUGH NMDA RECEPTOR | 20 | 1.77e-01 | 1.74e-01 | 4.04e-01 |
| CARGO RECOGNITION FOR CLATHRIN MEDIATED ENDOCYTOSIS | 94 | 3.56e-03 | 1.74e-01 | 2.73e-02 |
| EGFR DOWNREGULATION | 28 | 1.11e-01 | 1.74e-01 | 2.94e-01 |
| PI 3K CASCADE FGFR1 | 16 | 2.29e-01 | -1.74e-01 | 4.69e-01 |
| TRANSMISSION ACROSS CHEMICAL SYNAPSES | 243 | 3.18e-06 | 1.74e-01 | 1.25e-04 |
| STRIATED MUSCLE CONTRACTION | 27 | 1.19e-01 | -1.74e-01 | 3.08e-01 |
| ABC FAMILY PROTEINS MEDIATED TRANSPORT | 95 | 3.56e-03 | 1.73e-01 | 2.73e-02 |
| SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | 62 | 1.84e-02 | 1.73e-01 | 8.41e-02 |
| SARS COV 1 INFECTION | 48 | 3.84e-02 | 1.73e-01 | 1.42e-01 |
| PCP CE PATHWAY | 89 | 4.99e-03 | 1.72e-01 | 3.46e-02 |
| SIGNALING BY FGFR3 | 34 | 8.24e-02 | 1.72e-01 | 2.41e-01 |
| ACYL CHAIN REMODELLING OF PC | 17 | 2.21e-01 | 1.72e-01 | 4.57e-01 |
| SEPARATION OF SISTER CHROMATIDS | 166 | 1.41e-04 | 1.71e-01 | 2.56e-03 |
| PHOSPHOLIPID METABOLISM | 188 | 5.25e-05 | 1.71e-01 | 1.08e-03 |
| MITOTIC G1 PHASE AND G1 S TRANSITION | 142 | 4.36e-04 | 1.71e-01 | 5.91e-03 |
| AUF1 HNRNP D0 BINDS AND DESTABILIZES MRNA | 53 | 3.13e-02 | 1.71e-01 | 1.24e-01 |
| BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | 76 | 9.98e-03 | 1.71e-01 | 5.58e-02 |
| DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | 23 | 1.58e-01 | -1.70e-01 | 3.75e-01 |
| G1 S DNA DAMAGE CHECKPOINTS | 65 | 1.78e-02 | 1.70e-01 | 8.21e-02 |
| GLUCOSE METABOLISM | 81 | 8.68e-03 | 1.69e-01 | 5.11e-02 |
| ADRENALINE NORADRENALINE INHIBITS INSULIN SECRETION | 27 | 1.30e-01 | 1.68e-01 | 3.29e-01 |
| TERMINATION OF TRANSLESION DNA SYNTHESIS | 32 | 9.98e-02 | -1.68e-01 | 2.77e-01 |
| TRANSCRIPTIONAL REGULATION BY MECP2 | 59 | 2.63e-02 | -1.67e-01 | 1.07e-01 |
| TRANSPORT OF BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | 68 | 1.74e-02 | 1.67e-01 | 8.14e-02 |
| ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 1 | 24 | 1.57e-01 | 1.67e-01 | 3.74e-01 |
| ANCHORING FIBRIL FORMATION | 14 | 2.81e-01 | -1.67e-01 | 5.22e-01 |
| TIGHT JUNCTION INTERACTIONS | 16 | 2.51e-01 | 1.66e-01 | 4.94e-01 |
| NEGATIVE REGULATION OF MAPK PATHWAY | 42 | 6.36e-02 | 1.65e-01 | 2.01e-01 |
| BLOOD GROUP SYSTEMS BIOSYNTHESIS | 15 | 2.68e-01 | 1.65e-01 | 5.08e-01 |
| SIGNALING BY FLT3 FUSION PROTEINS | 19 | 2.13e-01 | -1.65e-01 | 4.51e-01 |
| SIGNALING BY FGFR4 | 34 | 9.67e-02 | 1.65e-01 | 2.70e-01 |
| METABOLISM OF NITRIC OXIDE NOS3 ACTIVATION AND REGULATION | 15 | 2.70e-01 | 1.65e-01 | 5.11e-01 |
| POST TRANSLATIONAL PROTEIN MODIFICATION | 1230 | 4.88e-22 | 1.65e-01 | 5.75e-19 |
| PRC2 METHYLATES HISTONES AND DNA | 33 | 1.02e-01 | -1.65e-01 | 2.81e-01 |
| GENE AND PROTEIN EXPRESSION BY JAK STAT SIGNALING AFTER INTERLEUKIN 12 STIMULATION | 31 | 1.14e-01 | 1.64e-01 | 2.98e-01 |
| CASPASE ACTIVATION VIA DEATH RECEPTORS IN THE PRESENCE OF LIGAND | 13 | 3.06e-01 | -1.64e-01 | 5.51e-01 |
| INTERLEUKIN 12 FAMILY SIGNALING | 43 | 6.30e-02 | 1.64e-01 | 2.00e-01 |
| GOLGI ASSOCIATED VESICLE BIOGENESIS | 55 | 3.56e-02 | 1.64e-01 | 1.34e-01 |
| JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | 22 | 1.84e-01 | 1.64e-01 | 4.14e-01 |
| PLATELET ACTIVATION SIGNALING AND AGGREGATION | 224 | 2.59e-05 | 1.63e-01 | 6.36e-04 |
| INTERLEUKIN 12 SIGNALING | 37 | 8.60e-02 | 1.63e-01 | 2.48e-01 |
| TERMINATION OF O GLYCAN BIOSYNTHESIS | 10 | 3.73e-01 | 1.63e-01 | 6.07e-01 |
| OPIOID SIGNALLING | 87 | 8.99e-03 | 1.62e-01 | 5.21e-02 |
| ACTIVATED PKN1 STIMULATES TRANSCRIPTION OF AR ANDROGEN RECEPTOR REGULATED GENES KLK2 AND KLK3 | 25 | 1.61e-01 | -1.62e-01 | 3.80e-01 |
| ZINC INFLUX INTO CELLS BY THE SLC39 GENE FAMILY | 10 | 3.78e-01 | 1.61e-01 | 6.07e-01 |
| COMMON PATHWAY OF FIBRIN CLOT FORMATION | 11 | 3.55e-01 | 1.61e-01 | 5.98e-01 |
| CLASS A 1 RHODOPSIN LIKE RECEPTORS | 187 | 1.58e-04 | 1.60e-01 | 2.82e-03 |
| DEGRADATION OF BETA CATENIN BY THE DESTRUCTION COMPLEX | 82 | 1.23e-02 | 1.60e-01 | 6.52e-02 |
| ORC1 REMOVAL FROM CHROMATIN | 67 | 2.36e-02 | 1.60e-01 | 1.00e-01 |
| REGULATION OF GLYCOLYSIS BY FRUCTOSE 2 6 BISPHOSPHATE METABOLISM | 11 | 3.60e-01 | 1.60e-01 | 6.01e-01 |
| PRE NOTCH PROCESSING IN GOLGI | 18 | 2.42e-01 | 1.59e-01 | 4.82e-01 |
| MET ACTIVATES RAP1 AND RAC1 | 10 | 3.83e-01 | 1.59e-01 | 6.09e-01 |
| RHO GTPASES ACTIVATE FORMINS | 119 | 2.72e-03 | 1.59e-01 | 2.27e-02 |
| FRS MEDIATED FGFR3 SIGNALING | 15 | 2.86e-01 | 1.59e-01 | 5.26e-01 |
| PIWI INTERACTING RNA PIRNA BIOGENESIS | 19 | 2.30e-01 | -1.59e-01 | 4.71e-01 |
| MITOCHONDRIAL PROTEIN IMPORT | 63 | 2.94e-02 | 1.59e-01 | 1.17e-01 |
| MUCOPOLYSACCHARIDOSES | 11 | 3.63e-01 | 1.58e-01 | 6.02e-01 |
| INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | 19 | 2.32e-01 | 1.58e-01 | 4.72e-01 |
| HOST INTERACTIONS OF HIV FACTORS | 125 | 2.25e-03 | 1.58e-01 | 1.99e-02 |
| EPH EPHRIN SIGNALING | 92 | 8.94e-03 | 1.58e-01 | 5.21e-02 |
| DEFECTIVE EXT2 CAUSES EXOSTOSES 2 | 14 | 3.08e-01 | 1.57e-01 | 5.52e-01 |
| E3 UBIQUITIN LIGASES UBIQUITINATE TARGET PROTEINS | 51 | 5.21e-02 | 1.57e-01 | 1.76e-01 |
| SIGNALING BY HIPPO | 20 | 2.24e-01 | 1.57e-01 | 4.61e-01 |
| SWITCHING OF ORIGINS TO A POST REPLICATIVE STATE | 86 | 1.20e-02 | 1.57e-01 | 6.43e-02 |
| ENOS ACTIVATION | 11 | 3.68e-01 | 1.57e-01 | 6.06e-01 |
| TRANSLATION OF SARS COV 2 STRUCTURAL PROTEINS | 44 | 7.25e-02 | 1.57e-01 | 2.21e-01 |
| DNA METHYLATION | 24 | 1.85e-01 | -1.56e-01 | 4.15e-01 |
| TRANSLESION SYNTHESIS BY Y FAMILY DNA POLYMERASES BYPASSES LESIONS ON DNA TEMPLATE | 39 | 9.16e-02 | -1.56e-01 | 2.60e-01 |
| PARASITE INFECTION | 54 | 4.74e-02 | 1.56e-01 | 1.66e-01 |
| SIGNALING BY THE B CELL RECEPTOR BCR | 103 | 6.35e-03 | 1.56e-01 | 4.20e-02 |
| CHAPERONE MEDIATED AUTOPHAGY | 21 | 2.17e-01 | 1.56e-01 | 4.53e-01 |
| DNA REPLICATION PRE INITIATION | 80 | 1.67e-02 | 1.55e-01 | 7.91e-02 |
| DEGRADATION OF AXIN | 53 | 5.13e-02 | 1.55e-01 | 1.75e-01 |
| FCGAMMA RECEPTOR FCGR DEPENDENT PHAGOCYTOSIS | 81 | 1.61e-02 | 1.55e-01 | 7.85e-02 |
| SHC1 EVENTS IN EGFR SIGNALING | 11 | 3.74e-01 | 1.55e-01 | 6.07e-01 |
| DEGRADATION OF DVL | 55 | 4.82e-02 | 1.54e-01 | 1.67e-01 |
| PHASE 2 PLATEAU PHASE | 10 | 3.99e-01 | -1.54e-01 | 6.24e-01 |
| CELL EXTRACELLULAR MATRIX INTERACTIONS | 18 | 2.59e-01 | 1.54e-01 | 5.02e-01 |
| TCR SIGNALING | 101 | 7.61e-03 | 1.54e-01 | 4.78e-02 |
| COHESIN LOADING ONTO CHROMATIN | 10 | 4.00e-01 | -1.54e-01 | 6.24e-01 |
| INOSITOL PHOSPHATE METABOLISM | 46 | 7.16e-02 | 1.54e-01 | 2.19e-01 |
| ROLE OF PHOSPHOLIPIDS IN PHAGOCYTOSIS | 22 | 2.13e-01 | 1.54e-01 | 4.51e-01 |
| VITAMIN B5 PANTOTHENATE METABOLISM | 15 | 3.04e-01 | 1.53e-01 | 5.50e-01 |
| EUKARYOTIC TRANSLATION ELONGATION | 88 | 1.30e-02 | -1.53e-01 | 6.80e-02 |
| RAB REGULATION OF TRAFFICKING | 119 | 3.91e-03 | 1.53e-01 | 2.92e-02 |
| TNF RECEPTOR SUPERFAMILY TNFSF MEMBERS MEDIATING NON CANONICAL NF KB PATHWAY | 12 | 3.59e-01 | -1.53e-01 | 6.01e-01 |
| GROWTH HORMONE RECEPTOR SIGNALING | 20 | 2.37e-01 | 1.53e-01 | 4.78e-01 |
| METABOLISM OF LIPIDS | 619 | 1.05e-10 | 1.53e-01 | 1.44e-08 |
| THE NLRP3 INFLAMMASOME | 15 | 3.08e-01 | -1.52e-01 | 5.52e-01 |
| G ALPHA I SIGNALLING EVENTS | 207 | 1.74e-04 | 1.52e-01 | 2.93e-03 |
| G PROTEIN MEDIATED EVENTS | 52 | 5.97e-02 | 1.51e-01 | 1.93e-01 |
| C TYPE LECTIN RECEPTORS CLRS | 112 | 5.80e-03 | 1.51e-01 | 3.90e-02 |
| TRAF6 MEDIATED IRF7 ACTIVATION | 15 | 3.14e-01 | -1.50e-01 | 5.57e-01 |
| SYNAPTIC ADHESION LIKE MOLECULES | 21 | 2.33e-01 | 1.50e-01 | 4.73e-01 |
| NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | 17 | 2.84e-01 | 1.50e-01 | 5.25e-01 |
| MET ACTIVATES PTK2 SIGNALING | 29 | 1.62e-01 | -1.50e-01 | 3.83e-01 |
| GP1B IX V ACTIVATION SIGNALLING | 11 | 3.90e-01 | -1.50e-01 | 6.16e-01 |
| AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | 25 | 1.97e-01 | 1.49e-01 | 4.30e-01 |
| TP53 REGULATES TRANSCRIPTION OF CELL CYCLE GENES | 45 | 8.49e-02 | 1.48e-01 | 2.46e-01 |
| HYALURONAN METABOLISM | 15 | 3.20e-01 | 1.48e-01 | 5.64e-01 |
| INTERLEUKIN 15 SIGNALING | 12 | 3.74e-01 | -1.48e-01 | 6.07e-01 |
| CLEC7A DECTIN 1 SIGNALING | 94 | 1.33e-02 | 1.48e-01 | 6.83e-02 |
| DEADENYLATION OF MRNA | 25 | 2.02e-01 | 1.48e-01 | 4.36e-01 |
| L1CAM INTERACTIONS | 108 | 8.17e-03 | 1.47e-01 | 4.92e-02 |
| AQUAPORIN MEDIATED TRANSPORT | 41 | 1.04e-01 | 1.47e-01 | 2.84e-01 |
| CELLULAR RESPONSE TO HYPOXIA | 72 | 3.17e-02 | 1.46e-01 | 1.25e-01 |
| DAG AND IP3 SIGNALING | 40 | 1.13e-01 | 1.45e-01 | 2.97e-01 |
| G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | 24 | 2.19e-01 | 1.45e-01 | 4.57e-01 |
| FGFR1 LIGAND BINDING AND ACTIVATION | 10 | 4.28e-01 | -1.45e-01 | 6.46e-01 |
| CYTOCHROME C MEDIATED APOPTOTIC RESPONSE | 12 | 3.87e-01 | 1.44e-01 | 6.13e-01 |
| ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | 10 | 4.32e-01 | 1.44e-01 | 6.49e-01 |
| HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | 10 | 4.32e-01 | 1.44e-01 | 6.49e-01 |
| RHO GTPASES ACTIVATE NADPH OXIDASES | 20 | 2.67e-01 | 1.43e-01 | 5.08e-01 |
| INTRINSIC PATHWAY FOR APOPTOSIS | 52 | 7.42e-02 | 1.43e-01 | 2.23e-01 |
| SIGNALLING TO ERKS | 33 | 1.55e-01 | 1.43e-01 | 3.71e-01 |
| TNF SIGNALING | 43 | 1.05e-01 | 1.43e-01 | 2.85e-01 |
| POSITIVE EPIGENETIC REGULATION OF RRNA EXPRESSION | 66 | 4.47e-02 | -1.43e-01 | 1.60e-01 |
| INTERLEUKIN 6 SIGNALING | 10 | 4.34e-01 | 1.43e-01 | 6.50e-01 |
| METABOLISM OF STEROIDS | 117 | 7.75e-03 | 1.43e-01 | 4.81e-02 |
| REGULATION OF INNATE IMMUNE RESPONSES TO CYTOSOLIC DNA | 13 | 3.74e-01 | 1.42e-01 | 6.07e-01 |
| GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | 23 | 2.38e-01 | 1.42e-01 | 4.78e-01 |
| FRS MEDIATED FGFR4 SIGNALING | 15 | 3.41e-01 | 1.42e-01 | 5.84e-01 |
| CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | 19 | 2.85e-01 | 1.42e-01 | 5.25e-01 |
| DECTIN 1 MEDIATED NONCANONICAL NF KB SIGNALING | 59 | 6.00e-02 | 1.42e-01 | 1.93e-01 |
| ASSEMBLY OF THE PRE REPLICATIVE COMPLEX | 64 | 5.12e-02 | 1.41e-01 | 1.75e-01 |
| CONSTITUTIVE SIGNALING BY AKT1 E17K IN CANCER | 26 | 2.14e-01 | 1.41e-01 | 4.51e-01 |
| POLO LIKE KINASE MEDIATED EVENTS | 14 | 3.66e-01 | 1.40e-01 | 6.05e-01 |
| ADORA2B MEDIATED ANTI INFLAMMATORY CYTOKINES PRODUCTION | 95 | 1.89e-02 | 1.39e-01 | 8.61e-02 |
| TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | 17 | 3.20e-01 | 1.39e-01 | 5.64e-01 |
| SIGNALING BY FLT3 ITD AND TKD MUTANTS | 16 | 3.36e-01 | -1.39e-01 | 5.79e-01 |
| FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | 119 | 9.07e-03 | 1.39e-01 | 5.21e-02 |
| GLUTATHIONE CONJUGATION | 30 | 1.89e-01 | 1.39e-01 | 4.20e-01 |
| NF KB ACTIVATION THROUGH FADD RIP 1 PATHWAY MEDIATED BY CASPASE 8 AND 10 | 11 | 4.26e-01 | -1.39e-01 | 6.46e-01 |
| DISEASES OF GLYCOSYLATION | 123 | 8.06e-03 | 1.38e-01 | 4.89e-02 |
| EPIGENETIC REGULATION OF GENE EXPRESSION | 107 | 1.35e-02 | -1.38e-01 | 6.92e-02 |
| PURINE CATABOLISM | 16 | 3.39e-01 | 1.38e-01 | 5.84e-01 |
| PHASE II CONJUGATION OF COMPOUNDS | 64 | 5.64e-02 | 1.38e-01 | 1.87e-01 |
| PEPTIDE LIGAND BINDING RECEPTORS | 112 | 1.19e-02 | 1.38e-01 | 6.42e-02 |
| UNWINDING OF DNA | 12 | 4.09e-01 | 1.38e-01 | 6.28e-01 |
| ACTIVATION OF ANTERIOR HOX GENES IN HINDBRAIN DEVELOPMENT DURING EARLY EMBRYOGENESIS | 69 | 4.85e-02 | -1.37e-01 | 1.68e-01 |
| SARS COV INFECTIONS | 140 | 5.05e-03 | 1.37e-01 | 3.48e-02 |
| SEMA3A PAK DEPENDENT AXON REPULSION | 16 | 3.42e-01 | 1.37e-01 | 5.85e-01 |
| NEURONAL SYSTEM | 370 | 6.14e-06 | 1.37e-01 | 2.07e-04 |
| INTERLEUKIN 20 FAMILY SIGNALING | 14 | 3.76e-01 | -1.37e-01 | 6.07e-01 |
| SIGNALING BY NTRKS | 129 | 7.43e-03 | 1.37e-01 | 4.71e-02 |
| ZINC TRANSPORTERS | 16 | 3.46e-01 | 1.36e-01 | 5.88e-01 |
| RMTS METHYLATE HISTONE ARGININES | 47 | 1.08e-01 | -1.36e-01 | 2.88e-01 |
| DISORDERS OF TRANSMEMBRANE TRANSPORTERS | 146 | 4.69e-03 | 1.36e-01 | 3.37e-02 |
| SIGNALING BY NOTCH1 HD DOMAIN MUTANTS IN CANCER | 15 | 3.63e-01 | 1.36e-01 | 6.02e-01 |
| PLASMA LIPOPROTEIN ASSEMBLY REMODELING AND CLEARANCE | 49 | 1.01e-01 | 1.36e-01 | 2.78e-01 |
| RESPONSE OF EIF2AK4 GCN2 TO AMINO ACID DEFICIENCY | 96 | 2.22e-02 | -1.35e-01 | 9.67e-02 |
| INNATE IMMUNE SYSTEM | 779 | 1.71e-10 | 1.35e-01 | 1.83e-08 |
| SIGNALING BY RETINOIC ACID | 33 | 1.80e-01 | 1.35e-01 | 4.09e-01 |
| METABOLISM OF AMINO ACIDS AND DERIVATIVES | 316 | 3.92e-05 | 1.35e-01 | 8.88e-04 |
| BIOLOGICAL OXIDATIONS | 126 | 9.06e-03 | 1.35e-01 | 5.21e-02 |
| SHC MEDIATED CASCADE FGFR3 | 13 | 4.01e-01 | 1.35e-01 | 6.24e-01 |
| LYSOSPHINGOLIPID AND LPA RECEPTORS | 13 | 4.02e-01 | 1.34e-01 | 6.24e-01 |
| NONSENSE MEDIATED DECAY NMD | 110 | 1.52e-02 | -1.34e-01 | 7.60e-02 |
| INLB MEDIATED ENTRY OF LISTERIA MONOCYTOGENES INTO HOST CELL | 15 | 3.70e-01 | 1.34e-01 | 6.07e-01 |
| RAS PROCESSING | 24 | 2.58e-01 | 1.33e-01 | 5.02e-01 |
| SHC1 EVENTS IN ERBB4 SIGNALING | 13 | 4.05e-01 | 1.33e-01 | 6.24e-01 |
| DNA REPLICATION | 122 | 1.10e-02 | 1.33e-01 | 6.05e-02 |
| SUMOYLATION OF INTRACELLULAR RECEPTORS | 27 | 2.31e-01 | 1.33e-01 | 4.71e-01 |
| IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | 10 | 4.66e-01 | 1.33e-01 | 6.77e-01 |
| INTERLEUKIN 1 SIGNALING | 96 | 2.43e-02 | 1.33e-01 | 1.02e-01 |
| ADAPTIVE IMMUNE SYSTEM | 611 | 2.37e-08 | 1.33e-01 | 1.70e-06 |
| ABERRANT REGULATION OF MITOTIC EXIT IN CANCER DUE TO RB1 DEFECTS | 19 | 3.17e-01 | 1.33e-01 | 5.62e-01 |
| SIGNALING BY EGFR | 47 | 1.16e-01 | 1.32e-01 | 3.03e-01 |
| GPVI MEDIATED ACTIVATION CASCADE | 31 | 2.02e-01 | 1.32e-01 | 4.36e-01 |
| ASYMMETRIC LOCALIZATION OF PCP PROTEINS | 62 | 7.34e-02 | 1.32e-01 | 2.22e-01 |
| REGULATION OF CHOLESTEROL BIOSYNTHESIS BY SREBP SREBF | 56 | 8.88e-02 | 1.31e-01 | 2.55e-01 |
| PHASE I FUNCTIONALIZATION OF COMPOUNDS | 59 | 8.08e-02 | 1.31e-01 | 2.39e-01 |
| CD209 DC SIGN SIGNALING | 18 | 3.35e-01 | 1.31e-01 | 5.78e-01 |
| CYTOSOLIC IRON SULFUR CLUSTER ASSEMBLY | 13 | 4.14e-01 | -1.31e-01 | 6.32e-01 |
| OTHER SEMAPHORIN INTERACTIONS | 19 | 3.26e-01 | -1.30e-01 | 5.69e-01 |
| CYTOSOLIC SULFONATION OF SMALL MOLECULES | 15 | 3.82e-01 | 1.30e-01 | 6.09e-01 |
| HOMOLOGY DIRECTED REPAIR | 111 | 1.93e-02 | -1.29e-01 | 8.72e-02 |
| TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | 11 | 4.61e-01 | 1.28e-01 | 6.74e-01 |
| MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | 31 | 2.17e-01 | 1.28e-01 | 4.53e-01 |
| ESTROGEN DEPENDENT GENE EXPRESSION | 108 | 2.15e-02 | -1.28e-01 | 9.47e-02 |
| DAP12 INTERACTIONS | 30 | 2.25e-01 | -1.28e-01 | 4.63e-01 |
| PI3K EVENTS IN ERBB2 SIGNALING | 15 | 3.91e-01 | -1.28e-01 | 6.16e-01 |
| NR1H2 AND NR1H3 MEDIATED SIGNALING | 38 | 1.72e-01 | -1.28e-01 | 3.96e-01 |
| HIV INFECTION | 221 | 1.07e-03 | 1.28e-01 | 1.14e-02 |
| SIGNALING BY PDGFRA TRANSMEMBRANE JUXTAMEMBRANE AND KINASE DOMAIN MUTANTS | 12 | 4.44e-01 | 1.28e-01 | 6.57e-01 |
| SIRT1 NEGATIVELY REGULATES RRNA EXPRESSION | 28 | 2.45e-01 | -1.27e-01 | 4.85e-01 |
| GLYOXYLATE METABOLISM AND GLYCINE DEGRADATION | 26 | 2.63e-01 | 1.27e-01 | 5.03e-01 |
| SIGNALING BY VEGF | 103 | 2.63e-02 | 1.27e-01 | 1.07e-01 |
| S PHASE | 154 | 6.68e-03 | 1.27e-01 | 4.30e-02 |
| ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | 29 | 2.38e-01 | 1.27e-01 | 4.78e-01 |
| NUCLEAR SIGNALING BY ERBB4 | 31 | 2.23e-01 | 1.27e-01 | 4.60e-01 |
| PI METABOLISM | 80 | 5.04e-02 | 1.27e-01 | 1.73e-01 |
| NEGATIVE REGULATION OF FGFR1 SIGNALING | 27 | 2.56e-01 | 1.26e-01 | 5.01e-01 |
| REGULATION OF TNFR1 SIGNALING | 34 | 2.03e-01 | 1.26e-01 | 4.36e-01 |
| REGULATION OF BACH1 ACTIVITY | 11 | 4.69e-01 | 1.26e-01 | 6.78e-01 |
| TICAM1 RIP1 MEDIATED IKK COMPLEX RECRUITMENT | 18 | 3.55e-01 | 1.26e-01 | 5.98e-01 |
| PEXOPHAGY | 11 | 4.71e-01 | 1.26e-01 | 6.79e-01 |
| SIGNALING BY GPCR | 487 | 2.25e-06 | 1.25e-01 | 1.02e-04 |
| FORMATION OF INCISION COMPLEX IN GG NER | 43 | 1.56e-01 | 1.25e-01 | 3.71e-01 |
| FGFR2 MUTANT RECEPTOR ACTIVATION | 27 | 2.61e-01 | -1.25e-01 | 5.02e-01 |
| TIE2 SIGNALING | 17 | 3.73e-01 | 1.25e-01 | 6.07e-01 |
| FORMATION OF THE CORNIFIED ENVELOPE | 32 | 2.23e-01 | 1.24e-01 | 4.60e-01 |
| JOSEPHIN DOMAIN DUBS | 11 | 4.75e-01 | 1.24e-01 | 6.80e-01 |
| CD28 DEPENDENT PI3K AKT SIGNALING | 21 | 3.24e-01 | 1.24e-01 | 5.69e-01 |
| TRANSLESION SYNTHESIS BY POLK | 17 | 3.75e-01 | -1.24e-01 | 6.07e-01 |
| SIGNALING BY ERBB4 | 57 | 1.05e-01 | 1.24e-01 | 2.85e-01 |
| DISEASES OF IMMUNE SYSTEM | 25 | 2.83e-01 | -1.24e-01 | 5.25e-01 |
| PROGRAMMED CELL DEATH | 186 | 3.60e-03 | 1.24e-01 | 2.73e-02 |
| RHOBTB GTPASE CYCLE | 35 | 2.05e-01 | 1.24e-01 | 4.38e-01 |
| RHOV GTPASE CYCLE | 33 | 2.20e-01 | 1.24e-01 | 4.57e-01 |
| TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | 10 | 4.99e-01 | 1.23e-01 | 7.04e-01 |
| POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | 62 | 9.34e-02 | 1.23e-01 | 2.64e-01 |
| GLYCOLYSIS | 67 | 8.15e-02 | 1.23e-01 | 2.39e-01 |
| REGULATION OF FZD BY UBIQUITINATION | 19 | 3.55e-01 | 1.22e-01 | 5.98e-01 |
| HS GAG DEGRADATION | 20 | 3.43e-01 | 1.22e-01 | 5.86e-01 |
| FOXO MEDIATED TRANSCRIPTION OF OXIDATIVE STRESS METABOLIC AND NEURONAL GENES | 24 | 3.00e-01 | -1.22e-01 | 5.47e-01 |
| ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | 288 | 3.76e-04 | 1.22e-01 | 5.21e-03 |
| RESPIRATORY ELECTRON TRANSPORT | 102 | 3.36e-02 | -1.22e-01 | 1.30e-01 |
| CHROMATIN MODIFYING ENZYMES | 223 | 1.77e-03 | -1.22e-01 | 1.68e-02 |
| REGULATION OF IFNA SIGNALING | 12 | 4.67e-01 | -1.21e-01 | 6.77e-01 |
| MITOTIC SPINDLE CHECKPOINT | 97 | 3.96e-02 | 1.21e-01 | 1.45e-01 |
| APOPTOSIS | 164 | 7.63e-03 | 1.21e-01 | 4.78e-02 |
| REGULATION OF RUNX2 EXPRESSION AND ACTIVITY | 68 | 8.58e-02 | 1.21e-01 | 2.48e-01 |
| PYRIMIDINE SALVAGE | 10 | 5.10e-01 | 1.20e-01 | 7.11e-01 |
| CONDENSATION OF PROPHASE CHROMOSOMES | 31 | 2.47e-01 | -1.20e-01 | 4.88e-01 |
| ACTIVATION OF SMO | 16 | 4.05e-01 | 1.20e-01 | 6.24e-01 |
| RHO GTPASE EFFECTORS | 253 | 1.05e-03 | 1.20e-01 | 1.13e-02 |
| NOTCH2 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 23 | 3.20e-01 | 1.20e-01 | 5.64e-01 |
| MYD88 INDEPENDENT TLR4 CASCADE | 93 | 4.62e-02 | 1.20e-01 | 1.63e-01 |
| OTHER INTERLEUKIN SIGNALING | 20 | 3.56e-01 | 1.19e-01 | 5.98e-01 |
| CASPASE ACTIVATION VIA DEPENDENCE RECEPTORS IN THE ABSENCE OF LIGAND | 10 | 5.14e-01 | 1.19e-01 | 7.13e-01 |
| DNA DAMAGE RECOGNITION IN GG NER | 38 | 2.03e-01 | 1.19e-01 | 4.36e-01 |
| RNA POLYMERASE III TRANSCRIPTION TERMINATION | 23 | 3.24e-01 | -1.19e-01 | 5.69e-01 |
| DISEASES OF METABOLISM | 197 | 4.19e-03 | 1.18e-01 | 3.08e-02 |
| ESTROGEN DEPENDENT NUCLEAR EVENTS DOWNSTREAM OF ESR MEMBRANE SIGNALING | 21 | 3.48e-01 | 1.18e-01 | 5.90e-01 |
| SIGNALING BY WNT IN CANCER | 31 | 2.55e-01 | 1.18e-01 | 4.99e-01 |
| IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | 21 | 3.49e-01 | 1.18e-01 | 5.90e-01 |
| APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | 34 | 2.35e-01 | 1.18e-01 | 4.75e-01 |
| CONSTITUTIVE SIGNALING BY OVEREXPRESSED ERBB2 | 11 | 4.99e-01 | 1.18e-01 | 7.04e-01 |
| FORMATION OF SENESCENCE ASSOCIATED HETEROCHROMATIN FOCI SAHF | 14 | 4.46e-01 | -1.18e-01 | 6.59e-01 |
| SUMOYLATION OF IMMUNE RESPONSE PROTEINS | 11 | 5.00e-01 | 1.17e-01 | 7.04e-01 |
| TELOMERE EXTENSION BY TELOMERASE | 22 | 3.46e-01 | 1.16e-01 | 5.88e-01 |
| TNFR1 INDUCED NFKAPPAB SIGNALING PATHWAY | 29 | 2.80e-01 | 1.16e-01 | 5.22e-01 |
| METABOLISM OF FOLATE AND PTERINES | 15 | 4.37e-01 | 1.16e-01 | 6.54e-01 |
| TRIGLYCERIDE METABOLISM | 24 | 3.27e-01 | 1.16e-01 | 5.70e-01 |
| INTRINSIC PATHWAY OF FIBRIN CLOT FORMATION | 15 | 4.39e-01 | -1.15e-01 | 6.55e-01 |
| METABOLISM OF VITAMINS AND COFACTORS | 152 | 1.43e-02 | 1.15e-01 | 7.22e-02 |
| ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | 32 | 2.59e-01 | 1.15e-01 | 5.02e-01 |
| TNFR2 NON CANONICAL NF KB PATHWAY | 79 | 7.77e-02 | 1.15e-01 | 2.31e-01 |
| SHC MEDIATED CASCADE FGFR4 | 13 | 4.73e-01 | 1.15e-01 | 6.80e-01 |
| M PHASE | 344 | 2.63e-04 | 1.15e-01 | 4.00e-03 |
| INFLUENZA INFECTION | 146 | 1.70e-02 | -1.15e-01 | 8.00e-02 |
| DNA DOUBLE STRAND BREAK REPAIR | 140 | 1.98e-02 | -1.14e-01 | 8.85e-02 |
| MITOCHONDRIAL CALCIUM ION TRANSPORT | 23 | 3.44e-01 | 1.14e-01 | 5.87e-01 |
| MITOTIC G2 G2 M PHASES | 184 | 7.80e-03 | 1.14e-01 | 4.81e-02 |
| GENE SILENCING BY RNA | 86 | 6.84e-02 | -1.14e-01 | 2.13e-01 |
| NOTCH3 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 23 | 3.47e-01 | -1.13e-01 | 5.88e-01 |
| MITOTIC TELOPHASE CYTOKINESIS | 13 | 4.81e-01 | -1.13e-01 | 6.84e-01 |
| SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | 20 | 3.82e-01 | -1.13e-01 | 6.09e-01 |
| MAPK6 MAPK4 SIGNALING | 83 | 7.69e-02 | 1.12e-01 | 2.30e-01 |
| SIGNALING BY SCF KIT | 41 | 2.13e-01 | 1.12e-01 | 4.51e-01 |
| SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | 53 | 1.59e-01 | 1.12e-01 | 3.77e-01 |
| ORGANELLE BIOGENESIS AND MAINTENANCE | 284 | 1.22e-03 | 1.12e-01 | 1.29e-02 |
| CYCLIN D ASSOCIATED EVENTS IN G1 | 45 | 1.96e-01 | 1.11e-01 | 4.30e-01 |
| COSTIMULATION BY THE CD28 FAMILY | 51 | 1.71e-01 | 1.11e-01 | 3.94e-01 |
| BILE ACID AND BILE SALT METABOLISM | 26 | 3.28e-01 | 1.11e-01 | 5.72e-01 |
| INWARDLY RECTIFYING K CHANNELS | 32 | 2.78e-01 | 1.11e-01 | 5.21e-01 |
| KERATINIZATION | 33 | 2.72e-01 | 1.11e-01 | 5.13e-01 |
| SYNTHESIS OF LEUKOTRIENES LT AND EOXINS EX | 12 | 5.07e-01 | -1.11e-01 | 7.10e-01 |
| SYNTHESIS OF IP3 AND IP4 IN THE CYTOSOL | 25 | 3.41e-01 | 1.10e-01 | 5.84e-01 |
| TRAF6 MEDIATED NF KB ACTIVATION | 22 | 3.72e-01 | -1.10e-01 | 6.07e-01 |
| INTERLEUKIN 1 FAMILY SIGNALING | 123 | 3.59e-02 | 1.10e-01 | 1.34e-01 |
| EPHA MEDIATED GROWTH CONE COLLAPSE | 29 | 3.07e-01 | -1.10e-01 | 5.52e-01 |
| EGR2 AND SOX10 MEDIATED INITIATION OF SCHWANN CELL MYELINATION | 27 | 3.25e-01 | 1.09e-01 | 5.69e-01 |
| MAP3K8 TPL2 DEPENDENT MAPK1 3 ACTIVATION | 16 | 4.50e-01 | 1.09e-01 | 6.62e-01 |
| SIGNALING BY FGFR2 IN DISEASE | 37 | 2.52e-01 | -1.09e-01 | 4.94e-01 |
| HEMOSTASIS | 478 | 4.81e-05 | 1.09e-01 | 1.05e-03 |
| TRANSPORT OF SMALL MOLECULES | 584 | 7.99e-06 | 1.08e-01 | 2.48e-04 |
| METABOLISM OF WATER SOLUBLE VITAMINS AND COFACTORS | 102 | 5.92e-02 | 1.08e-01 | 1.92e-01 |
| CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | 348 | 5.91e-04 | 1.07e-01 | 7.25e-03 |
| CELL CYCLE MITOTIC | 479 | 6.17e-05 | 1.07e-01 | 1.21e-03 |
| NOTCH4 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 20 | 4.08e-01 | -1.07e-01 | 6.27e-01 |
| PTEN REGULATION | 133 | 3.35e-02 | 1.07e-01 | 1.30e-01 |
| ASSEMBLY OF COLLAGEN FIBRILS AND OTHER MULTIMERIC STRUCTURES | 52 | 1.85e-01 | -1.06e-01 | 4.16e-01 |
| RHOBTB1 GTPASE CYCLE | 23 | 3.78e-01 | 1.06e-01 | 6.07e-01 |
| BETA CATENIN INDEPENDENT WNT SIGNALING | 140 | 3.07e-02 | 1.06e-01 | 1.22e-01 |
| SIGNALING BY WNT | 274 | 2.66e-03 | 1.06e-01 | 2.24e-02 |
| FLT3 SIGNALING IN DISEASE | 28 | 3.35e-01 | -1.05e-01 | 5.78e-01 |
| DEACTIVATION OF THE BETA CATENIN TRANSACTIVATING COMPLEX | 41 | 2.45e-01 | 1.05e-01 | 4.85e-01 |
| BIOTIN TRANSPORT AND METABOLISM | 11 | 5.47e-01 | -1.05e-01 | 7.40e-01 |
| SIGNALING BY PTK6 | 50 | 2.03e-01 | 1.04e-01 | 4.36e-01 |
| TRNA MODIFICATION IN THE NUCLEUS AND CYTOSOL | 43 | 2.40e-01 | -1.04e-01 | 4.80e-01 |
| RNA POLYMERASE I TRANSCRIPTION TERMINATION | 31 | 3.19e-01 | -1.03e-01 | 5.64e-01 |
| EPH EPHRIN MEDIATED REPULSION OF CELLS | 51 | 2.03e-01 | 1.03e-01 | 4.36e-01 |
| MITOCHONDRIAL IRON SULFUR CLUSTER BIOGENESIS | 13 | 5.20e-01 | -1.03e-01 | 7.17e-01 |
| RUNX3 REGULATES NOTCH SIGNALING | 13 | 5.21e-01 | -1.03e-01 | 7.17e-01 |
| ACTIVATION OF MATRIX METALLOPROTEINASES | 15 | 4.90e-01 | 1.03e-01 | 6.94e-01 |
| INITIAL TRIGGERING OF COMPLEMENT | 12 | 5.38e-01 | 1.03e-01 | 7.35e-01 |
| ACTIVATION OF THE PRE REPLICATIVE COMPLEX | 30 | 3.32e-01 | 1.02e-01 | 5.75e-01 |
| SENSORY PERCEPTION | 162 | 2.56e-02 | -1.02e-01 | 1.06e-01 |
| RHOH GTPASE CYCLE | 37 | 2.86e-01 | 1.01e-01 | 5.26e-01 |
| SIGNALING BY NOTCH4 | 83 | 1.11e-01 | 1.01e-01 | 2.93e-01 |
| SIGNALING BY MODERATE KINASE ACTIVITY BRAF MUTANTS | 41 | 2.63e-01 | 1.01e-01 | 5.03e-01 |
| ECM PROTEOGLYCANS | 68 | 1.51e-01 | -1.01e-01 | 3.69e-01 |
| PHASE 0 RAPID DEPOLARISATION | 28 | 3.58e-01 | -1.00e-01 | 6.00e-01 |
| SIGNALING BY TYPE 1 INSULIN LIKE GROWTH FACTOR 1 RECEPTOR IGF1R | 46 | 2.39e-01 | -1.00e-01 | 4.79e-01 |
| INTERLEUKIN 7 SIGNALING | 19 | 4.49e-01 | -1.00e-01 | 6.62e-01 |
| ANTI INFLAMMATORY RESPONSE FAVOURING LEISHMANIA PARASITE INFECTION | 119 | 5.91e-02 | 1.00e-01 | 1.92e-01 |
| RAC2 GTPASE CYCLE | 87 | 1.07e-01 | 1.00e-01 | 2.87e-01 |
| MEIOTIC RECOMBINATION | 42 | 2.64e-01 | -9.97e-02 | 5.03e-01 |
| PHASE 4 RESTING MEMBRANE POTENTIAL | 14 | 5.19e-01 | -9.95e-02 | 7.17e-01 |
| MISCELLANEOUS TRANSPORT AND BINDING EVENTS | 21 | 4.30e-01 | 9.94e-02 | 6.49e-01 |
| RHOG GTPASE CYCLE | 74 | 1.40e-01 | 9.93e-02 | 3.49e-01 |
| VIRAL MESSENGER RNA SYNTHESIS | 42 | 2.67e-01 | -9.91e-02 | 5.08e-01 |
| FANCONI ANEMIA PATHWAY | 36 | 3.06e-01 | -9.86e-02 | 5.51e-01 |
| CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | 11 | 5.72e-01 | 9.84e-02 | 7.61e-01 |
| REGULATION OF PTEN GENE TRANSCRIPTION | 58 | 1.96e-01 | 9.83e-02 | 4.29e-01 |
| NOTCH3 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 26 | 3.87e-01 | 9.80e-02 | 6.13e-01 |
| SIGNALING BY CSF3 G CSF | 29 | 3.62e-01 | 9.79e-02 | 6.02e-01 |
| INFLAMMASOMES | 19 | 4.63e-01 | -9.74e-02 | 6.76e-01 |
| APC CDC20 MEDIATED DEGRADATION OF NEK2A | 24 | 4.11e-01 | 9.69e-02 | 6.28e-01 |
| METABOLISM OF STEROID HORMONES | 22 | 4.32e-01 | 9.68e-02 | 6.49e-01 |
| POLYMERASE SWITCHING ON THE C STRAND OF THE TELOMERE | 25 | 4.03e-01 | 9.66e-02 | 6.24e-01 |
| ABC TRANSPORTERS IN LIPID HOMEOSTASIS | 14 | 5.33e-01 | 9.62e-02 | 7.31e-01 |
| RUNX1 INTERACTS WITH CO FACTORS WHOSE PRECISE EFFECT ON RUNX1 TARGETS IS NOT KNOWN | 37 | 3.12e-01 | -9.61e-02 | 5.55e-01 |
| TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | 16 | 5.07e-01 | 9.58e-02 | 7.10e-01 |
| TNFR1 INDUCED PROAPOPTOTIC SIGNALING | 12 | 5.67e-01 | 9.55e-02 | 7.56e-01 |
| UB SPECIFIC PROCESSING PROTEASES | 169 | 3.34e-02 | 9.50e-02 | 1.30e-01 |
| HEME BIOSYNTHESIS | 13 | 5.55e-01 | 9.46e-02 | 7.49e-01 |
| DNA DAMAGE BYPASS | 47 | 2.63e-01 | -9.44e-02 | 5.03e-01 |
| RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | 125 | 6.86e-02 | -9.44e-02 | 2.13e-01 |
| G PROTEIN BETA GAMMA SIGNALLING | 31 | 3.64e-01 | 9.42e-02 | 6.02e-01 |
| NGF STIMULATED TRANSCRIPTION | 36 | 3.30e-01 | 9.39e-02 | 5.73e-01 |
| ERYTHROPOIETIN ACTIVATES PHOSPHOINOSITIDE 3 KINASE PI3K | 11 | 5.90e-01 | -9.38e-02 | 7.77e-01 |
| ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | 16 | 5.16e-01 | 9.38e-02 | 7.14e-01 |
| ONCOGENIC MAPK SIGNALING | 77 | 1.55e-01 | 9.37e-02 | 3.71e-01 |
| ORGANIC CATION ANION ZWITTERION TRANSPORT | 11 | 5.92e-01 | -9.32e-02 | 7.78e-01 |
| TRANSLATION | 287 | 6.66e-03 | 9.32e-02 | 4.30e-02 |
| REPRODUCTION | 81 | 1.49e-01 | -9.28e-02 | 3.66e-01 |
| SCAVENGING BY CLASS A RECEPTORS | 14 | 5.48e-01 | 9.27e-02 | 7.40e-01 |
| CELL CELL JUNCTION ORGANIZATION | 48 | 2.67e-01 | 9.27e-02 | 5.08e-01 |
| REGULATED PROTEOLYSIS OF P75NTR | 12 | 5.79e-01 | 9.26e-02 | 7.67e-01 |
| NEGATIVE REGULATION OF NMDA RECEPTOR MEDIATED NEURONAL TRANSMISSION | 21 | 4.66e-01 | 9.19e-02 | 6.77e-01 |
| NON INTEGRIN MEMBRANE ECM INTERACTIONS | 57 | 2.31e-01 | -9.18e-02 | 4.71e-01 |
| SHC1 EVENTS IN ERBB2 SIGNALING | 21 | 4.66e-01 | 9.18e-02 | 6.77e-01 |
| NOTCH HLH TRANSCRIPTION PATHWAY | 28 | 4.01e-01 | -9.18e-02 | 6.24e-01 |
| NEGATIVE REGULATION OF FGFR2 SIGNALING | 28 | 4.03e-01 | 9.14e-02 | 6.24e-01 |
| SIGNALING BY INSULIN RECEPTOR | 65 | 2.03e-01 | 9.13e-02 | 4.36e-01 |
| INTERLEUKIN 17 SIGNALING | 68 | 1.93e-01 | 9.12e-02 | 4.26e-01 |
| TRANSCRIPTIONAL REGULATION BY SMALL RNAS | 65 | 2.04e-01 | -9.12e-02 | 4.37e-01 |
| RNA POLYMERASE I PROMOTER ESCAPE | 51 | 2.61e-01 | -9.10e-02 | 5.02e-01 |
| RHOJ GTPASE CYCLE | 54 | 2.48e-01 | 9.10e-02 | 4.89e-01 |
| HIV ELONGATION ARREST AND RECOVERY | 32 | 3.73e-01 | -9.09e-02 | 6.07e-01 |
| NEGATIVE EPIGENETIC REGULATION OF RRNA EXPRESSION | 69 | 1.92e-01 | -9.09e-02 | 4.24e-01 |
| NICOTINAMIDE SALVAGING | 14 | 5.58e-01 | -9.05e-02 | 7.51e-01 |
| SIGNALING BY NTRK2 TRKB | 24 | 4.43e-01 | 9.04e-02 | 6.57e-01 |
| ACTIVATION OF GENE EXPRESSION BY SREBF SREBP | 43 | 3.07e-01 | 9.01e-02 | 5.51e-01 |
| METABOLISM OF ANGIOTENSINOGEN TO ANGIOTENSINS | 10 | 6.23e-01 | 8.99e-02 | 7.98e-01 |
| PRESYNAPTIC FUNCTION OF KAINATE RECEPTORS | 20 | 4.87e-01 | 8.98e-02 | 6.91e-01 |
| INTRACELLULAR SIGNALING BY SECOND MESSENGERS | 284 | 9.58e-03 | 8.95e-02 | 5.44e-02 |
| RAF INDEPENDENT MAPK1 3 ACTIVATION | 21 | 4.78e-01 | 8.95e-02 | 6.82e-01 |
| SUMOYLATION OF DNA DAMAGE RESPONSE AND REPAIR PROTEINS | 73 | 1.87e-01 | -8.94e-02 | 4.18e-01 |
| INTERLEUKIN 4 AND INTERLEUKIN 13 SIGNALING | 77 | 1.75e-01 | 8.94e-02 | 4.01e-01 |
| SIGNALING BY BRAF AND RAF FUSIONS | 60 | 2.32e-01 | 8.93e-02 | 4.72e-01 |
| CELL CYCLE CHECKPOINTS | 245 | 1.65e-02 | 8.90e-02 | 7.89e-02 |
| SLC MEDIATED TRANSMEMBRANE TRANSPORT | 192 | 3.42e-02 | 8.87e-02 | 1.31e-01 |
| NEUROTRANSMITTER RELEASE CYCLE | 48 | 2.89e-01 | 8.86e-02 | 5.29e-01 |
| NEGATIVE REGULATION OF FLT3 | 14 | 5.66e-01 | -8.85e-02 | 7.56e-01 |
| SIGNALING BY FGFR1 | 44 | 3.10e-01 | 8.85e-02 | 5.53e-01 |
| BASE EXCISION REPAIR AP SITE FORMATION | 33 | 3.83e-01 | -8.78e-02 | 6.09e-01 |
| GAP FILLING DNA REPAIR SYNTHESIS AND LIGATION IN GG NER | 25 | 4.48e-01 | -8.76e-02 | 6.62e-01 |
| ALPHA PROTEIN KINASE 1 SIGNALING PATHWAY | 11 | 6.16e-01 | 8.74e-02 | 7.95e-01 |
| MITOTIC PROPHASE | 98 | 1.36e-01 | 8.73e-02 | 3.40e-01 |
| CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | 31 | 4.01e-01 | -8.72e-02 | 6.24e-01 |
| TCF DEPENDENT SIGNALING IN RESPONSE TO WNT | 181 | 4.33e-02 | 8.72e-02 | 1.56e-01 |
| TRAFFICKING OF AMPA RECEPTORS | 31 | 4.02e-01 | 8.70e-02 | 6.24e-01 |
| FORMATION OF TC NER PRE INCISION COMPLEX | 53 | 2.74e-01 | 8.69e-02 | 5.15e-01 |
| NOTCH2 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 11 | 6.19e-01 | -8.66e-02 | 7.96e-01 |
| INTEGRIN SIGNALING | 24 | 4.63e-01 | 8.65e-02 | 6.76e-01 |
| RESOLUTION OF ABASIC SITES AP SITES | 38 | 3.59e-01 | -8.60e-02 | 6.01e-01 |
| G PROTEIN ACTIVATION | 23 | 4.76e-01 | 8.59e-02 | 6.80e-01 |
| INTERLEUKIN 2 FAMILY SIGNALING | 32 | 4.01e-01 | -8.58e-02 | 6.24e-01 |
| TRANSCRIPTIONAL REGULATION BY E2F6 | 34 | 3.91e-01 | 8.51e-02 | 6.16e-01 |
| MUSCLE CONTRACTION | 161 | 6.33e-02 | -8.49e-02 | 2.00e-01 |
| TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | 13 | 5.97e-01 | -8.47e-02 | 7.82e-01 |
| MITOTIC PROMETAPHASE | 177 | 5.22e-02 | 8.47e-02 | 1.76e-01 |
| SIGNALING BY RECEPTOR TYROSINE KINASES | 462 | 1.90e-03 | 8.45e-02 | 1.77e-02 |
| NEGATIVE REGULATION OF TCF DEPENDENT SIGNALING BY WNT LIGAND ANTAGONISTS | 12 | 6.14e-01 | 8.42e-02 | 7.95e-01 |
| INTERLEUKIN 6 FAMILY SIGNALING | 20 | 5.16e-01 | 8.39e-02 | 7.14e-01 |
| PI 3K CASCADE FGFR4 | 13 | 6.01e-01 | -8.37e-02 | 7.83e-01 |
| ADHERENS JUNCTIONS INTERACTIONS | 30 | 4.32e-01 | 8.29e-02 | 6.49e-01 |
| AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | 14 | 5.92e-01 | 8.26e-02 | 7.78e-01 |
| INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | 29 | 4.42e-01 | 8.26e-02 | 6.57e-01 |
| SIGNALING BY INTERLEUKINS | 349 | 8.51e-03 | 8.21e-02 | 5.06e-02 |
| GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR GG NER | 84 | 1.94e-01 | 8.21e-02 | 4.26e-01 |
| RRNA PROCESSING IN THE MITOCHONDRION | 10 | 6.53e-01 | 8.20e-02 | 8.18e-01 |
| RA BIOSYNTHESIS PATHWAY | 13 | 6.11e-01 | -8.14e-02 | 7.94e-01 |
| NEPHRIN FAMILY INTERACTIONS | 23 | 5.00e-01 | 8.12e-02 | 7.04e-01 |
| TOLL LIKE RECEPTOR CASCADES | 138 | 1.02e-01 | 8.07e-02 | 2.81e-01 |
| DEREGULATED CDK5 TRIGGERS MULTIPLE NEURODEGENERATIVE PATHWAYS IN ALZHEIMER S DISEASE MODELS | 19 | 5.43e-01 | 8.06e-02 | 7.37e-01 |
| TRNA PROCESSING IN THE NUCLEUS | 56 | 2.97e-01 | 8.06e-02 | 5.43e-01 |
| HDR THROUGH MMEJ ALT NHEJ | 10 | 6.59e-01 | -8.05e-02 | 8.21e-01 |
| CELL CYCLE | 598 | 8.01e-04 | 8.05e-02 | 9.16e-03 |
| HCMV INFECTION | 107 | 1.52e-01 | 8.02e-02 | 3.69e-01 |
| PLATELET CALCIUM HOMEOSTASIS | 26 | 4.80e-01 | -8.00e-02 | 6.84e-01 |
| DOWNSTREAM SIGNAL TRANSDUCTION | 29 | 4.57e-01 | 7.99e-02 | 6.70e-01 |
| RHOD GTPASE CYCLE | 51 | 3.24e-01 | 7.98e-02 | 5.69e-01 |
| ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | 23 | 5.08e-01 | 7.97e-02 | 7.10e-01 |
| ENDOGENOUS STEROLS | 20 | 5.37e-01 | -7.97e-02 | 7.35e-01 |
| PROCESSING OF DNA DOUBLE STRAND BREAK ENDS | 74 | 2.40e-01 | -7.90e-02 | 4.80e-01 |
| ATF4 ACTIVATES GENES IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 23 | 5.14e-01 | -7.87e-02 | 7.13e-01 |
| NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | 58 | 3.01e-01 | 7.85e-02 | 5.49e-01 |
| ERCC6 CSB AND EHMT2 G9A POSITIVELY REGULATE RRNA EXPRESSION | 36 | 4.17e-01 | -7.81e-02 | 6.35e-01 |
| O LINKED GLYCOSYLATION | 85 | 2.15e-01 | 7.79e-02 | 4.51e-01 |
| TRANSCRIPTIONAL REGULATION BY RUNX3 | 94 | 1.92e-01 | 7.79e-02 | 4.24e-01 |
| MAP2K AND MAPK ACTIVATION | 36 | 4.19e-01 | 7.78e-02 | 6.37e-01 |
| TRANSCRIPTIONAL REGULATION BY RUNX1 | 183 | 7.28e-02 | -7.70e-02 | 2.21e-01 |
| IL 6 TYPE CYTOKINE RECEPTOR LIGAND INTERACTIONS | 14 | 6.18e-01 | 7.69e-02 | 7.96e-01 |
| TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN G1 CELL CYCLE ARREST | 13 | 6.32e-01 | -7.66e-02 | 8.03e-01 |
| DISEASES OF SIGNAL TRANSDUCTION BY GROWTH FACTOR RECEPTORS AND SECOND MESSENGERS | 369 | 1.17e-02 | 7.66e-02 | 6.34e-02 |
| METABOLISM OF COFACTORS | 19 | 5.64e-01 | 7.65e-02 | 7.56e-01 |
| NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | 44 | 3.81e-01 | 7.64e-02 | 6.09e-01 |
| IRS MEDIATED SIGNALLING | 41 | 3.98e-01 | -7.64e-02 | 6.24e-01 |
| INFECTIOUS DISEASE | 739 | 4.47e-04 | 7.62e-02 | 5.98e-03 |
| MYOGENESIS | 25 | 5.11e-01 | -7.59e-02 | 7.11e-01 |
| APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | 21 | 5.48e-01 | 7.58e-02 | 7.40e-01 |
| RAC3 GTPASE CYCLE | 90 | 2.20e-01 | 7.49e-02 | 4.57e-01 |
| IRAK4 DEFICIENCY TLR2 4 | 14 | 6.29e-01 | -7.45e-02 | 8.02e-01 |
| RND3 GTPASE CYCLE | 38 | 4.27e-01 | 7.44e-02 | 6.46e-01 |
| PRE NOTCH EXPRESSION AND PROCESSING | 68 | 2.90e-01 | -7.42e-02 | 5.32e-01 |
| FOXO MEDIATED TRANSCRIPTION | 57 | 3.34e-01 | -7.41e-02 | 5.78e-01 |
| RHO GTPASES ACTIVATE CIT | 18 | 5.88e-01 | -7.38e-02 | 7.76e-01 |
| SUMOYLATION OF DNA REPLICATION PROTEINS | 43 | 4.04e-01 | 7.35e-02 | 6.24e-01 |
| P38MAPK EVENTS | 13 | 6.48e-01 | 7.31e-02 | 8.15e-01 |
| G ALPHA S SIGNALLING EVENTS | 108 | 1.90e-01 | 7.30e-02 | 4.22e-01 |
| FOXO MEDIATED TRANSCRIPTION OF CELL CYCLE GENES | 15 | 6.27e-01 | 7.24e-02 | 8.01e-01 |
| TRP CHANNELS | 20 | 5.75e-01 | -7.23e-02 | 7.64e-01 |
| MICRORNA MIRNA BIOGENESIS | 24 | 5.40e-01 | -7.22e-02 | 7.36e-01 |
| NS1 MEDIATED EFFECTS ON HOST PATHWAYS | 37 | 4.50e-01 | -7.17e-02 | 6.62e-01 |
| FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | 18 | 5.99e-01 | -7.17e-02 | 7.82e-01 |
| RHOU GTPASE CYCLE | 34 | 4.72e-01 | 7.14e-02 | 6.79e-01 |
| BINDING AND UPTAKE OF LIGANDS BY SCAVENGER RECEPTORS | 35 | 4.66e-01 | -7.12e-02 | 6.77e-01 |
| DEUBIQUITINATION | 243 | 5.68e-02 | 7.10e-02 | 1.87e-01 |
| MEIOSIS | 68 | 3.12e-01 | -7.10e-02 | 5.55e-01 |
| ONCOGENE INDUCED SENESCENCE | 32 | 4.88e-01 | 7.09e-02 | 6.91e-01 |
| SUMOYLATION OF DNA METHYLATION PROTEINS | 16 | 6.24e-01 | -7.09e-02 | 7.98e-01 |
| RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | 85 | 2.60e-01 | 7.07e-02 | 5.02e-01 |
| RNA POLYMERASE I TRANSCRIPTION | 71 | 3.04e-01 | -7.06e-02 | 5.50e-01 |
| SIGNALING BY RHO GTPASES MIRO GTPASES AND RHOBTB3 | 630 | 2.58e-03 | 7.06e-02 | 2.19e-02 |
| NEGATIVE REGULATION OF THE PI3K AKT NETWORK | 97 | 2.33e-01 | 7.01e-02 | 4.73e-01 |
| TRANSCRIPTIONAL REGULATION BY THE AP 2 TFAP2 FAMILY OF TRANSCRIPTION FACTORS | 33 | 4.87e-01 | 7.00e-02 | 6.91e-01 |
| SUMOYLATION OF CHROMATIN ORGANIZATION PROTEINS | 60 | 3.49e-01 | -6.99e-02 | 5.90e-01 |
| REGULATION OF GENE EXPRESSION IN BETA CELLS | 12 | 6.76e-01 | 6.98e-02 | 8.33e-01 |
| HATS ACETYLATE HISTONES | 97 | 2.36e-01 | -6.97e-02 | 4.77e-01 |
| TRANSCRIPTIONAL ACTIVATION OF MITOCHONDRIAL BIOGENESIS | 54 | 3.78e-01 | -6.94e-02 | 6.07e-01 |
| GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTEGRINS | 12 | 6.78e-01 | -6.92e-02 | 8.33e-01 |
| SUMOYLATION OF TRANSCRIPTION COFACTORS | 42 | 4.41e-01 | -6.87e-02 | 6.57e-01 |
| LEISHMANIA INFECTION | 199 | 9.66e-02 | 6.84e-02 | 2.70e-01 |
| NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | 16 | 6.37e-01 | 6.82e-02 | 8.06e-01 |
| SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | 11 | 6.97e-01 | 6.79e-02 | 8.48e-01 |
| DOWNSTREAM SIGNALING OF ACTIVATED FGFR2 | 24 | 5.66e-01 | -6.76e-02 | 7.56e-01 |
| GAB1 SIGNALOSOME | 14 | 6.61e-01 | -6.76e-02 | 8.23e-01 |
| TICAM1 DEPENDENT ACTIVATION OF IRF3 IRF7 | 12 | 6.85e-01 | 6.76e-02 | 8.40e-01 |
| DEFECTS IN VITAMIN AND COFACTOR METABOLISM | 21 | 5.98e-01 | 6.65e-02 | 7.82e-01 |
| ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | 59 | 3.78e-01 | 6.63e-02 | 6.07e-01 |
| SIGNALING BY NOTCH2 | 33 | 5.10e-01 | 6.62e-02 | 7.11e-01 |
| MAPK FAMILY SIGNALING CASCADES | 290 | 5.28e-02 | 6.62e-02 | 1.77e-01 |
| POTASSIUM CHANNELS | 90 | 2.79e-01 | 6.60e-02 | 5.22e-01 |
| NOTCH4 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 12 | 6.93e-01 | 6.58e-02 | 8.45e-01 |
| INTERLEUKIN 37 SIGNALING | 18 | 6.30e-01 | 6.57e-02 | 8.02e-01 |
| THE PHOTOTRANSDUCTION CASCADE | 22 | 5.94e-01 | -6.56e-02 | 7.79e-01 |
| TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | 33 | 5.15e-01 | 6.55e-02 | 7.14e-01 |
| RNA POLYMERASE III TRANSCRIPTION | 41 | 4.70e-01 | -6.52e-02 | 6.79e-01 |
| SEROTONIN NEUROTRANSMITTER RELEASE CYCLE | 18 | 6.33e-01 | 6.50e-02 | 8.03e-01 |
| MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | 15 | 6.66e-01 | -6.45e-02 | 8.24e-01 |
| RHOA GTPASE CYCLE | 141 | 1.88e-01 | 6.42e-02 | 4.19e-01 |
| PI 3K CASCADE FGFR3 | 13 | 6.89e-01 | -6.40e-02 | 8.43e-01 |
| PLATELET AGGREGATION PLUG FORMATION | 32 | 5.33e-01 | 6.38e-02 | 7.31e-01 |
| POTENTIAL THERAPEUTICS FOR SARS | 77 | 3.34e-01 | 6.37e-02 | 5.78e-01 |
| METABOLISM OF PORPHYRINS | 19 | 6.31e-01 | 6.36e-02 | 8.02e-01 |
| CRISTAE FORMATION | 31 | 5.40e-01 | 6.36e-02 | 7.36e-01 |
| DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | 42 | 4.76e-01 | -6.36e-02 | 6.80e-01 |
| DUAL INCISION IN TC NER | 65 | 3.76e-01 | -6.35e-02 | 6.07e-01 |
| SIGNALING BY BMP | 25 | 5.84e-01 | 6.33e-02 | 7.73e-01 |
| PURINERGIC SIGNALING IN LEISHMANIASIS INFECTION | 23 | 5.99e-01 | -6.33e-02 | 7.82e-01 |
| MEIOTIC SYNAPSIS | 44 | 4.68e-01 | -6.33e-02 | 6.77e-01 |
| LONG TERM POTENTIATION | 23 | 6.00e-01 | 6.32e-02 | 7.82e-01 |
| CELLULAR RESPONSES TO EXTERNAL STIMULI | 607 | 8.06e-03 | 6.32e-02 | 4.89e-02 |
| CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | 12 | 7.06e-01 | 6.29e-02 | 8.56e-01 |
| PROTEIN PROTEIN INTERACTIONS AT SYNAPSES | 85 | 3.17e-01 | 6.28e-02 | 5.62e-01 |
| TP53 REGULATES TRANSCRIPTION OF DNA REPAIR GENES | 61 | 4.05e-01 | -6.16e-02 | 6.24e-01 |
| CARDIAC CONDUCTION | 107 | 2.71e-01 | -6.16e-02 | 5.13e-01 |
| CELL JUNCTION ORGANIZATION | 73 | 3.64e-01 | 6.15e-02 | 6.02e-01 |
| HIV LIFE CYCLE | 142 | 2.07e-01 | 6.15e-02 | 4.41e-01 |
| G2 M CHECKPOINTS | 136 | 2.16e-01 | 6.14e-02 | 4.53e-01 |
| TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | 43 | 4.88e-01 | -6.12e-02 | 6.91e-01 |
| BASE EXCISION REPAIR | 61 | 4.09e-01 | -6.11e-02 | 6.28e-01 |
| SEMAPHORIN INTERACTIONS | 64 | 3.99e-01 | -6.10e-02 | 6.24e-01 |
| SELENOAMINO ACID METABOLISM | 109 | 2.74e-01 | -6.07e-02 | 5.15e-01 |
| REGULATION OF COMMISSURAL AXON PATHFINDING BY SLIT AND ROBO | 10 | 7.41e-01 | 6.03e-02 | 8.70e-01 |
| FGFRL1 MODULATION OF FGFR1 SIGNALING | 10 | 7.42e-01 | -6.01e-02 | 8.70e-01 |
| TRANSCRIPTIONAL REGULATION BY RUNX2 | 108 | 2.81e-01 | 6.01e-02 | 5.22e-01 |
| SIGNALING BY FGFR | 74 | 3.74e-01 | 5.98e-02 | 6.07e-01 |
| P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | 12 | 7.22e-01 | -5.93e-02 | 8.67e-01 |
| DNA REPAIR | 296 | 8.12e-02 | -5.90e-02 | 2.39e-01 |
| PLASMA LIPOPROTEIN ASSEMBLY | 12 | 7.24e-01 | 5.88e-02 | 8.67e-01 |
| DOWNSTREAM SIGNALING OF ACTIVATED FGFR3 | 20 | 6.49e-01 | 5.88e-02 | 8.15e-01 |
| SODIUM CALCIUM EXCHANGERS | 10 | 7.48e-01 | -5.87e-02 | 8.72e-01 |
| SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | 11 | 7.37e-01 | 5.85e-02 | 8.68e-01 |
| PHOSPHORYLATION OF THE APC C | 17 | 6.79e-01 | 5.81e-02 | 8.33e-01 |
| REGULATION OF SIGNALING BY CBL | 22 | 6.38e-01 | 5.80e-02 | 8.06e-01 |
| DISEASES OF MITOTIC CELL CYCLE | 37 | 5.43e-01 | 5.78e-02 | 7.37e-01 |
| ANTIGEN PROCESSING CROSS PRESENTATION | 96 | 3.29e-01 | 5.77e-02 | 5.72e-01 |
| COLLAGEN DEGRADATION | 52 | 4.74e-01 | -5.74e-02 | 6.80e-01 |
| CELL CELL COMMUNICATION | 106 | 3.09e-01 | 5.72e-02 | 5.53e-01 |
| INHIBITION OF DNA RECOMBINATION AT TELOMERE | 39 | 5.37e-01 | -5.71e-02 | 7.35e-01 |
| OVARIAN TUMOR DOMAIN PROTEASES | 36 | 5.56e-01 | 5.68e-02 | 7.49e-01 |
| NF KB IS ACTIVATED AND SIGNALS SURVIVAL | 12 | 7.37e-01 | -5.61e-02 | 8.68e-01 |
| RHO GTPASES ACTIVATE KTN1 | 11 | 7.48e-01 | 5.60e-02 | 8.72e-01 |
| RRNA PROCESSING | 195 | 1.79e-01 | -5.58e-02 | 4.08e-01 |
| SUMOYLATION | 168 | 2.13e-01 | -5.57e-02 | 4.51e-01 |
| RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | 28 | 6.15e-01 | -5.50e-02 | 7.95e-01 |
| DUAL INCISION IN GG NER | 41 | 5.43e-01 | -5.49e-02 | 7.37e-01 |
| TRANSLATION OF SARS COV 1 STRUCTURAL PROTEINS | 28 | 6.17e-01 | 5.47e-02 | 7.96e-01 |
| COLLAGEN FORMATION | 79 | 4.02e-01 | -5.45e-02 | 6.24e-01 |
| DEATH RECEPTOR SIGNALLING | 132 | 2.82e-01 | 5.43e-02 | 5.24e-01 |
| SIGNALING BY TGFB FAMILY MEMBERS | 96 | 3.63e-01 | 5.37e-02 | 6.02e-01 |
| RET SIGNALING | 38 | 5.69e-01 | 5.34e-02 | 7.58e-01 |
| COLLAGEN BIOSYNTHESIS AND MODIFYING ENZYMES | 63 | 4.64e-01 | -5.34e-02 | 6.76e-01 |
| TOLL LIKE RECEPTOR TLR1 TLR2 CASCADE | 94 | 3.73e-01 | 5.32e-02 | 6.07e-01 |
| APOPTOTIC EXECUTION PHASE | 45 | 5.37e-01 | 5.31e-02 | 7.35e-01 |
| MITOCHONDRIAL TRANSLATION | 93 | 3.77e-01 | 5.31e-02 | 6.07e-01 |
| PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | 15 | 7.23e-01 | 5.29e-02 | 8.67e-01 |
| UCH PROTEINASES | 90 | 3.87e-01 | 5.28e-02 | 6.13e-01 |
| PCNA DEPENDENT LONG PATCH BASE EXCISION REPAIR | 21 | 6.76e-01 | -5.28e-02 | 8.33e-01 |
| SIGNALING BY FGFR2 | 63 | 4.73e-01 | 5.23e-02 | 6.80e-01 |
| NUCLEAR ENVELOPE BREAKDOWN | 49 | 5.28e-01 | 5.21e-02 | 7.26e-01 |
| G2 M DNA DAMAGE CHECKPOINT | 69 | 4.56e-01 | -5.19e-02 | 6.70e-01 |
| FREE FATTY ACIDS REGULATE INSULIN SECRETION | 10 | 7.77e-01 | 5.18e-02 | 8.94e-01 |
| THE CANONICAL RETINOID CYCLE IN RODS TWILIGHT VISION | 14 | 7.39e-01 | 5.13e-02 | 8.68e-01 |
| INACTIVATION OF CSF3 G CSF SIGNALING | 24 | 6.65e-01 | 5.11e-02 | 8.24e-01 |
| TFAP2 AP 2 FAMILY REGULATES TRANSCRIPTION OF GROWTH FACTORS AND THEIR RECEPTORS | 11 | 7.70e-01 | 5.10e-02 | 8.89e-01 |
| CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | 92 | 3.98e-01 | 5.10e-02 | 6.24e-01 |
| REGULATION OF TP53 ACTIVITY THROUGH METHYLATION | 18 | 7.09e-01 | -5.09e-02 | 8.58e-01 |
| REGULATION OF TP53 ACTIVITY THROUGH PHOSPHORYLATION | 88 | 4.11e-01 | -5.07e-02 | 6.28e-01 |
| TRANSPORT OF THE SLBP DEPENDANT MATURE MRNA | 34 | 6.09e-01 | 5.07e-02 | 7.92e-01 |
| TRIGLYCERIDE BIOSYNTHESIS | 10 | 7.82e-01 | -5.05e-02 | 8.98e-01 |
| MET PROMOTES CELL MOTILITY | 39 | 5.87e-01 | -5.03e-02 | 7.75e-01 |
| COMPLEMENT CASCADE | 26 | 6.62e-01 | 4.95e-02 | 8.23e-01 |
| TOLL LIKE RECEPTOR 9 TLR9 CASCADE | 91 | 4.17e-01 | 4.93e-02 | 6.35e-01 |
| TRANSPORT OF MATURE MRNAS DERIVED FROM INTRONLESS TRANSCRIPTS | 41 | 5.86e-01 | 4.92e-02 | 7.75e-01 |
| EFFECTS OF PIP2 HYDROLYSIS | 27 | 6.59e-01 | -4.91e-02 | 8.21e-01 |
| MRNA SPLICING | 188 | 2.49e-01 | 4.88e-02 | 4.90e-01 |
| REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | 83 | 4.42e-01 | 4.88e-02 | 6.57e-01 |
| NCAM SIGNALING FOR NEURITE OUT GROWTH | 62 | 5.08e-01 | -4.87e-02 | 7.10e-01 |
| PI3K AKT SIGNALING IN CANCER | 91 | 4.23e-01 | 4.87e-02 | 6.42e-01 |
| EUKARYOTIC TRANSLATION INITIATION | 115 | 3.68e-01 | -4.86e-02 | 6.06e-01 |
| IRF3 MEDIATED INDUCTION OF TYPE I IFN | 11 | 7.82e-01 | 4.82e-02 | 8.98e-01 |
| INCRETIN SYNTHESIS SECRETION AND INACTIVATION | 14 | 7.56e-01 | 4.80e-02 | 8.77e-01 |
| RHOC GTPASE CYCLE | 73 | 4.80e-01 | 4.78e-02 | 6.84e-01 |
| REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | 29 | 6.58e-01 | -4.75e-02 | 8.21e-01 |
| CYTOPROTECTION BY HMOX1 | 119 | 3.72e-01 | 4.74e-02 | 6.07e-01 |
| SURFACTANT METABOLISM | 16 | 7.43e-01 | 4.74e-02 | 8.70e-01 |
| TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | 83 | 4.59e-01 | 4.70e-02 | 6.73e-01 |
| VISUAL PHOTOTRANSDUCTION | 62 | 5.23e-01 | 4.69e-02 | 7.20e-01 |
| FORMATION OF THE BETA CATENIN TCF TRANSACTIVATING COMPLEX | 50 | 5.74e-01 | -4.60e-02 | 7.63e-01 |
| DOWNSTREAM SIGNALING OF ACTIVATED FGFR4 | 20 | 7.22e-01 | 4.60e-02 | 8.67e-01 |
| REGULATION OF LIPID METABOLISM BY PPARALPHA | 108 | 4.11e-01 | -4.58e-02 | 6.28e-01 |
| BASIGIN INTERACTIONS | 22 | 7.12e-01 | 4.55e-02 | 8.61e-01 |
| ANCHORING OF THE BASAL BODY TO THE PLASMA MEMBRANE | 96 | 4.43e-01 | 4.53e-02 | 6.57e-01 |
| SUMOYLATION OF UBIQUITINYLATION PROTEINS | 37 | 6.34e-01 | -4.52e-02 | 8.03e-01 |
| RHO GTPASES ACTIVATE ROCKS | 19 | 7.33e-01 | -4.52e-02 | 8.68e-01 |
| ERBB2 REGULATES CELL MOTILITY | 14 | 7.71e-01 | 4.49e-02 | 8.90e-01 |
| SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 107 | 4.23e-01 | -4.48e-02 | 6.42e-01 |
| REGULATION OF TP53 ACTIVITY | 152 | 3.41e-01 | 4.48e-02 | 5.84e-01 |
| SLC TRANSPORTER DISORDERS | 76 | 5.02e-01 | 4.45e-02 | 7.06e-01 |
| EXPORT OF VIRAL RIBONUCLEOPROTEINS FROM NUCLEUS | 31 | 6.68e-01 | -4.45e-02 | 8.27e-01 |
| NICOTINATE METABOLISM | 23 | 7.13e-01 | 4.44e-02 | 8.61e-01 |
| STIMULI SENSING CHANNELS | 76 | 5.10e-01 | -4.38e-02 | 7.11e-01 |
| RND1 GTPASE CYCLE | 38 | 6.42e-01 | 4.35e-02 | 8.09e-01 |
| ERK MAPK TARGETS | 22 | 7.26e-01 | 4.31e-02 | 8.67e-01 |
| TNFS BIND THEIR PHYSIOLOGICAL RECEPTORS | 12 | 7.96e-01 | 4.30e-02 | 9.06e-01 |
| RHO GTPASES ACTIVATE PAKS | 21 | 7.34e-01 | 4.29e-02 | 8.68e-01 |
| SIGNALING BY CYTOSOLIC FGFR1 FUSION MUTANTS | 18 | 7.53e-01 | -4.29e-02 | 8.76e-01 |
| STING MEDIATED INDUCTION OF HOST IMMUNE RESPONSES | 14 | 7.82e-01 | 4.27e-02 | 8.98e-01 |
| SIGNALING BY ACTIVIN | 11 | 8.10e-01 | 4.19e-02 | 9.13e-01 |
| CELLULAR RESPONSE TO CHEMICAL STRESS | 150 | 3.77e-01 | 4.19e-02 | 6.07e-01 |
| SYNTHESIS OF IP2 IP AND INS IN THE CYTOSOL | 13 | 7.94e-01 | -4.17e-02 | 9.06e-01 |
| EARLY PHASE OF HIV LIFE CYCLE | 13 | 7.95e-01 | 4.16e-02 | 9.06e-01 |
| SIGNALING BY ERBB2 | 48 | 6.19e-01 | 4.16e-02 | 7.96e-01 |
| RHO GTPASE CYCLE | 423 | 1.44e-01 | 4.15e-02 | 3.58e-01 |
| EXTRACELLULAR MATRIX ORGANIZATION | 250 | 2.60e-01 | -4.14e-02 | 5.02e-01 |
| CASPASE ACTIVATION VIA EXTRINSIC APOPTOTIC SIGNALLING PATHWAY | 23 | 7.34e-01 | -4.09e-02 | 8.68e-01 |
| BIOSYNTHESIS OF SPECIALIZED PRORESOLVING MEDIATORS SPMS | 11 | 8.15e-01 | -4.08e-02 | 9.16e-01 |
| TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | 30 | 7.00e-01 | 4.06e-02 | 8.50e-01 |
| RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | 25 | 7.25e-01 | -4.06e-02 | 8.67e-01 |
| SIGNALING BY NOTCH1 | 75 | 5.47e-01 | 4.02e-02 | 7.40e-01 |
| MOLECULES ASSOCIATED WITH ELASTIC FIBRES | 33 | 6.91e-01 | -4.00e-02 | 8.44e-01 |
| ELASTIC FIBRE FORMATION | 38 | 6.72e-01 | -3.96e-02 | 8.31e-01 |
| RNA POLYMERASE II TRANSCRIBES SNRNA GENES | 74 | 5.61e-01 | 3.91e-02 | 7.55e-01 |
| DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | 26 | 7.32e-01 | 3.89e-02 | 8.68e-01 |
| NEGATIVE REGULATORS OF DDX58 IFIH1 SIGNALING | 33 | 6.99e-01 | 3.89e-02 | 8.50e-01 |
| REGULATION OF BETA CELL DEVELOPMENT | 30 | 7.14e-01 | -3.87e-02 | 8.62e-01 |
| TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | 74 | 5.66e-01 | -3.86e-02 | 7.56e-01 |
| LGI ADAM INTERACTIONS | 14 | 8.04e-01 | 3.84e-02 | 9.11e-01 |
| DISEASES ASSOCIATED WITH O GLYCOSYLATION OF PROTEINS | 50 | 6.40e-01 | -3.82e-02 | 8.07e-01 |
| GLUCAGON TYPE LIGAND RECEPTORS | 26 | 7.39e-01 | 3.77e-02 | 8.68e-01 |
| SMOOTH MUSCLE CONTRACTION | 33 | 7.08e-01 | -3.77e-02 | 8.58e-01 |
| VOLTAGE GATED POTASSIUM CHANNELS | 38 | 6.88e-01 | 3.77e-02 | 8.42e-01 |
| CHROMOSOME MAINTENANCE | 106 | 5.04e-01 | -3.75e-02 | 7.08e-01 |
| MRNA CAPPING | 29 | 7.27e-01 | 3.74e-02 | 8.67e-01 |
| SIGNALING BY ERYTHROPOIETIN | 24 | 7.54e-01 | -3.70e-02 | 8.76e-01 |
| RIPK1 MEDIATED REGULATED NECROSIS | 25 | 7.49e-01 | 3.70e-02 | 8.72e-01 |
| SIGNALING BY NOTCH1 PEST DOMAIN MUTANTS IN CANCER | 59 | 6.26e-01 | 3.67e-02 | 8.00e-01 |
| DEADENYLATION DEPENDENT MRNA DECAY | 55 | 6.40e-01 | -3.65e-02 | 8.07e-01 |
| ERBB2 ACTIVATES PTK6 SIGNALING | 11 | 8.34e-01 | -3.64e-02 | 9.22e-01 |
| DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | 13 | 8.20e-01 | -3.64e-02 | 9.17e-01 |
| SIGNALING BY MET | 74 | 5.90e-01 | 3.63e-02 | 7.77e-01 |
| POLYMERASE SWITCHING | 14 | 8.15e-01 | -3.62e-02 | 9.16e-01 |
| CROSSLINKING OF COLLAGEN FIBRILS | 15 | 8.09e-01 | -3.61e-02 | 9.13e-01 |
| NRAGE SIGNALS DEATH THROUGH JNK | 54 | 6.48e-01 | -3.60e-02 | 8.15e-01 |
| ROLE OF SECOND MESSENGERS IN NETRIN 1 SIGNALING | 10 | 8.45e-01 | -3.57e-02 | 9.24e-01 |
| SIGNALING BY LEPTIN | 10 | 8.45e-01 | -3.57e-02 | 9.24e-01 |
| REGULATION OF TLR BY ENDOGENOUS LIGAND | 13 | 8.24e-01 | 3.56e-02 | 9.20e-01 |
| DOWNSTREAM SIGNALING OF ACTIVATED FGFR1 | 26 | 7.55e-01 | -3.54e-02 | 8.77e-01 |
| AMYLOID FIBER FORMATION | 62 | 6.31e-01 | -3.52e-02 | 8.02e-01 |
| GENERATION OF SECOND MESSENGER MOLECULES | 19 | 7.91e-01 | -3.51e-02 | 9.04e-01 |
| TICAM1 TRAF6 DEPENDENT INDUCTION OF TAK1 COMPLEX | 11 | 8.41e-01 | 3.49e-02 | 9.24e-01 |
| DNA STRAND ELONGATION | 32 | 7.34e-01 | 3.47e-02 | 8.68e-01 |
| SIGNALING BY PDGF | 56 | 6.54e-01 | -3.47e-02 | 8.18e-01 |
| SIGNALING BY ERBB2 ECD MUTANTS | 16 | 8.11e-01 | -3.46e-02 | 9.13e-01 |
| FLT3 SIGNALING | 36 | 7.20e-01 | -3.46e-02 | 8.67e-01 |
| CELLULAR HEXOSE TRANSPORT | 12 | 8.36e-01 | 3.45e-02 | 9.22e-01 |
| PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | 237 | 3.63e-01 | 3.44e-02 | 6.02e-01 |
| SIGNALING BY FGFR2 IIIA TM | 19 | 7.95e-01 | -3.44e-02 | 9.06e-01 |
| INTERACTIONS OF REV WITH HOST CELLULAR PROTEINS | 35 | 7.29e-01 | 3.39e-02 | 8.67e-01 |
| METABOLISM OF AMINE DERIVED HORMONES | 10 | 8.53e-01 | 3.39e-02 | 9.29e-01 |
| RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN DIFFERENTIATION OF HSCS | 87 | 5.85e-01 | 3.39e-02 | 7.75e-01 |
| RNA POLYMERASE I TRANSCRIPTION INITIATION | 47 | 6.90e-01 | -3.36e-02 | 8.43e-01 |
| ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | 73 | 6.20e-01 | -3.36e-02 | 7.97e-01 |
| MRNA SPLICING MINOR PATHWAY | 52 | 6.78e-01 | 3.33e-02 | 8.33e-01 |
| HCMV EARLY EVENTS | 84 | 6.01e-01 | 3.30e-02 | 7.83e-01 |
| SIGNALING BY NOTCH | 193 | 4.37e-01 | 3.25e-02 | 6.54e-01 |
| TELOMERE MAINTENANCE | 82 | 6.14e-01 | -3.22e-02 | 7.95e-01 |
| REGULATION OF TP53 ACTIVITY THROUGH ACETYLATION | 30 | 7.61e-01 | 3.21e-02 | 8.81e-01 |
| NUCLEOTIDE EXCISION REPAIR | 110 | 5.63e-01 | 3.19e-02 | 7.56e-01 |
| DEGRADATION OF THE EXTRACELLULAR MATRIX | 110 | 5.64e-01 | -3.18e-02 | 7.56e-01 |
| HCMV LATE EVENTS | 69 | 6.50e-01 | -3.16e-02 | 8.15e-01 |
| RND2 GTPASE CYCLE | 39 | 7.39e-01 | 3.09e-02 | 8.68e-01 |
| CYTOSOLIC SENSORS OF PATHOGEN ASSOCIATED DNA | 59 | 6.84e-01 | -3.06e-02 | 8.40e-01 |
| TP53 REGULATES TRANSCRIPTION OF CELL DEATH GENES | 37 | 7.48e-01 | -3.05e-02 | 8.72e-01 |
| HIV TRANSCRIPTION INITIATION | 45 | 7.25e-01 | -3.04e-02 | 8.67e-01 |
| MITOCHONDRIAL BIOGENESIS | 92 | 6.15e-01 | -3.03e-02 | 7.95e-01 |
| FCERI MEDIATED CA 2 MOBILIZATION | 26 | 7.91e-01 | 3.00e-02 | 9.04e-01 |
| RECEPTOR TYPE TYROSINE PROTEIN PHOSPHATASES | 20 | 8.18e-01 | 2.98e-02 | 9.16e-01 |
| CA2 PATHWAY | 59 | 6.93e-01 | 2.97e-02 | 8.45e-01 |
| INSULIN RECEPTOR SIGNALLING CASCADE | 46 | 7.28e-01 | -2.97e-02 | 8.67e-01 |
| SIGNALING BY NUCLEAR RECEPTORS | 229 | 4.44e-01 | 2.94e-02 | 6.57e-01 |
| FORMATION OF FIBRIN CLOT CLOTTING CASCADE | 23 | 8.07e-01 | -2.94e-02 | 9.13e-01 |
| EXTENSION OF TELOMERES | 49 | 7.22e-01 | 2.94e-02 | 8.67e-01 |
| TRANSCRIPTIONAL REGULATION OF GRANULOPOIESIS | 48 | 7.26e-01 | -2.93e-02 | 8.67e-01 |
| APOPTOTIC FACTOR MEDIATED RESPONSE | 18 | 8.30e-01 | 2.92e-02 | 9.21e-01 |
| NONHOMOLOGOUS END JOINING NHEJ | 46 | 7.32e-01 | -2.92e-02 | 8.68e-01 |
| REGULATED NECROSIS | 46 | 7.35e-01 | 2.88e-02 | 8.68e-01 |
| ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | 24 | 8.08e-01 | 2.87e-02 | 9.13e-01 |
| OXIDATIVE STRESS INDUCED SENESCENCE | 82 | 6.57e-01 | -2.84e-02 | 8.20e-01 |
| SIGNALING BY KIT IN DISEASE | 20 | 8.27e-01 | 2.82e-02 | 9.21e-01 |
| G ALPHA 12 13 SIGNALLING EVENTS | 75 | 6.77e-01 | 2.79e-02 | 8.33e-01 |
| PREGNENOLONE BIOSYNTHESIS | 12 | 8.69e-01 | -2.75e-02 | 9.38e-01 |
| LAGGING STRAND SYNTHESIS | 20 | 8.34e-01 | -2.70e-02 | 9.22e-01 |
| SUMOYLATION OF TRANSCRIPTION FACTORS | 18 | 8.45e-01 | 2.66e-02 | 9.24e-01 |
| TRANSLESION SYNTHESIS BY POLH | 19 | 8.43e-01 | -2.63e-02 | 9.24e-01 |
| GRB2 EVENTS IN ERBB2 SIGNALING | 15 | 8.60e-01 | 2.62e-02 | 9.34e-01 |
| INTERLEUKIN 3 INTERLEUKIN 5 AND GM CSF SIGNALING | 41 | 7.76e-01 | 2.57e-02 | 8.94e-01 |
| TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN CYTOCHROME C RELEASE | 19 | 8.46e-01 | 2.57e-02 | 9.25e-01 |
| NEUREXINS AND NEUROLIGINS | 54 | 7.44e-01 | 2.57e-02 | 8.71e-01 |
| PROCESSING OF CAPPED INTRONLESS PRE MRNA | 28 | 8.17e-01 | -2.53e-02 | 9.16e-01 |
| RNA POLYMERASE III CHAIN ELONGATION | 18 | 8.53e-01 | -2.52e-02 | 9.29e-01 |
| DETOXIFICATION OF REACTIVE OXYGEN SPECIES | 32 | 8.09e-01 | 2.47e-02 | 9.13e-01 |
| CIRCADIAN CLOCK | 68 | 7.28e-01 | -2.44e-02 | 8.67e-01 |
| FRS MEDIATED FGFR1 SIGNALING | 18 | 8.58e-01 | 2.43e-02 | 9.33e-01 |
| REGULATION OF GENE EXPRESSION BY HYPOXIA INDUCIBLE FACTOR | 10 | 8.95e-01 | -2.41e-02 | 9.46e-01 |
| SIGNALING BY FGFR1 IN DISEASE | 33 | 8.11e-01 | 2.41e-02 | 9.13e-01 |
| RUNX2 REGULATES OSTEOBLAST DIFFERENTIATION | 23 | 8.42e-01 | 2.41e-02 | 9.24e-01 |
| RECOGNITION AND ASSOCIATION OF DNA GLYCOSYLASE WITH SITE CONTAINING AN AFFECTED PURINE | 26 | 8.32e-01 | -2.41e-02 | 9.22e-01 |
| SIGNALING BY FGFR3 FUSIONS IN CANCER | 10 | 8.95e-01 | 2.40e-02 | 9.46e-01 |
| METABOLISM OF RNA | 645 | 3.02e-01 | 2.39e-02 | 5.49e-01 |
| ION CHANNEL TRANSPORT | 143 | 6.23e-01 | 2.38e-02 | 7.98e-01 |
| CELLULAR RESPONSE TO STARVATION | 147 | 6.22e-01 | -2.36e-02 | 7.98e-01 |
| SIGNALING BY FGFR4 IN DISEASE | 11 | 8.94e-01 | 2.32e-02 | 9.46e-01 |
| P75NTR RECRUITS SIGNALLING COMPLEXES | 12 | 8.92e-01 | 2.26e-02 | 9.46e-01 |
| ACYL CHAIN REMODELLING OF PS | 14 | 8.84e-01 | 2.26e-02 | 9.45e-01 |
| ANTIMICROBIAL PEPTIDES | 15 | 8.82e-01 | 2.22e-02 | 9.45e-01 |
| TRANSCRIPTIONAL REGULATION BY VENTX | 35 | 8.21e-01 | -2.21e-02 | 9.17e-01 |
| DDX58 IFIH1 MEDIATED INDUCTION OF INTERFERON ALPHA BETA | 63 | 7.62e-01 | -2.21e-02 | 8.81e-01 |
| TELOMERE C STRAND LAGGING STRAND SYNTHESIS | 33 | 8.27e-01 | 2.20e-02 | 9.21e-01 |
| METABOLIC DISORDERS OF BIOLOGICAL OXIDATION ENZYMES | 20 | 8.65e-01 | 2.19e-02 | 9.38e-01 |
| NERVOUS SYSTEM DEVELOPMENT | 554 | 3.80e-01 | 2.19e-02 | 6.08e-01 |
| ROLE OF LAT2 NTAL LAB ON CALCIUM MOBILIZATION | 14 | 8.88e-01 | 2.18e-02 | 9.46e-01 |
| FRS MEDIATED FGFR2 SIGNALING | 19 | 8.70e-01 | -2.16e-02 | 9.39e-01 |
| ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | 33 | 8.30e-01 | -2.16e-02 | 9.21e-01 |
| SIGNALING BY NTRK3 TRKC | 17 | 8.78e-01 | -2.16e-02 | 9.43e-01 |
| ACETYLCHOLINE REGULATES INSULIN SECRETION | 10 | 9.09e-01 | -2.09e-02 | 9.52e-01 |
| RHOQ GTPASE CYCLE | 58 | 7.85e-01 | 2.07e-02 | 8.99e-01 |
| FORMATION OF THE EARLY ELONGATION COMPLEX | 33 | 8.37e-01 | 2.07e-02 | 9.22e-01 |
| RNA POLYMERASE II TRANSCRIPTION | 1098 | 2.55e-01 | -2.05e-02 | 4.99e-01 |
| CDC42 GTPASE CYCLE | 153 | 6.63e-01 | -2.04e-02 | 8.23e-01 |
| P75 NTR RECEPTOR MEDIATED SIGNALLING | 93 | 7.36e-01 | 2.02e-02 | 8.68e-01 |
| PLATELET HOMEOSTASIS | 78 | 7.58e-01 | 2.02e-02 | 8.78e-01 |
| IRAK1 RECRUITS IKK COMPLEX | 14 | 8.97e-01 | 2.00e-02 | 9.47e-01 |
| PROCESSIVE SYNTHESIS ON THE C STRAND OF THE TELOMERE | 19 | 8.81e-01 | -1.98e-02 | 9.45e-01 |
| RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | 78 | 7.63e-01 | 1.98e-02 | 8.82e-01 |
| THE CITRIC ACID TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | 172 | 6.56e-01 | 1.97e-02 | 8.20e-01 |
| RNA POLYMERASE II TRANSCRIPTION TERMINATION | 65 | 7.86e-01 | -1.95e-02 | 9.00e-01 |
| SUMOYLATION OF SUMOYLATION PROTEINS | 33 | 8.48e-01 | -1.93e-02 | 9.25e-01 |
| ABERRANT REGULATION OF MITOTIC G1 S TRANSITION IN CANCER DUE TO RB1 DEFECTS | 17 | 8.92e-01 | 1.91e-02 | 9.46e-01 |
| PYROPTOSIS | 21 | 8.80e-01 | 1.90e-02 | 9.45e-01 |
| NETRIN 1 SIGNALING | 50 | 8.16e-01 | 1.90e-02 | 9.16e-01 |
| DNA DAMAGE TELOMERE STRESS INDUCED SENESCENCE | 48 | 8.28e-01 | -1.81e-02 | 9.21e-01 |
| SNRNP ASSEMBLY | 51 | 8.25e-01 | 1.79e-02 | 9.20e-01 |
| CARNITINE METABOLISM | 14 | 9.08e-01 | -1.79e-02 | 9.52e-01 |
| NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 48 | 8.33e-01 | -1.76e-02 | 9.22e-01 |
| CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | 72 | 7.98e-01 | -1.75e-02 | 9.06e-01 |
| SIGNALING BY EGFR IN CANCER | 22 | 8.88e-01 | 1.74e-02 | 9.46e-01 |
| TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | 79 | 7.96e-01 | 1.69e-02 | 9.06e-01 |
| TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX WITHIN TLR4 COMPLEX | 15 | 9.10e-01 | -1.68e-02 | 9.52e-01 |
| NOD1 2 SIGNALING PATHWAY | 35 | 8.65e-01 | 1.66e-02 | 9.38e-01 |
| SIGNALING BY ERBB2 IN CANCER | 25 | 8.87e-01 | 1.65e-02 | 9.46e-01 |
| DAP12 SIGNALING | 24 | 8.90e-01 | -1.63e-02 | 9.46e-01 |
| ABORTIVE ELONGATION OF HIV 1 TRANSCRIPT IN THE ABSENCE OF TAT | 23 | 8.93e-01 | -1.62e-02 | 9.46e-01 |
| RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 1 PROMOTER | 28 | 8.83e-01 | -1.60e-02 | 9.45e-01 |
| CAMK IV MEDIATED PHOSPHORYLATION OF CREB | 10 | 9.32e-01 | -1.57e-02 | 9.64e-01 |
| NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | 53 | 8.48e-01 | -1.52e-02 | 9.25e-01 |
| CONSTITUTIVE SIGNALING BY LIGAND RESPONSIVE EGFR CANCER VARIANTS | 19 | 9.09e-01 | -1.52e-02 | 9.52e-01 |
| HIV TRANSCRIPTION ELONGATION | 42 | 8.67e-01 | -1.50e-02 | 9.38e-01 |
| SENESCENCE ASSOCIATED SECRETORY PHENOTYPE SASP | 67 | 8.35e-01 | -1.47e-02 | 9.22e-01 |
| SENSORY PROCESSING OF SOUND BY OUTER HAIR CELLS OF THE COCHLEA | 41 | 8.73e-01 | -1.45e-02 | 9.41e-01 |
| MECP2 REGULATES NEURONAL RECEPTORS AND CHANNELS | 18 | 9.16e-01 | -1.44e-02 | 9.56e-01 |
| SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | 16 | 9.23e-01 | 1.40e-02 | 9.60e-01 |
| IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX | 10 | 9.40e-01 | -1.37e-02 | 9.70e-01 |
| FGFR2 ALTERNATIVE SPLICING | 25 | 9.06e-01 | 1.36e-02 | 9.52e-01 |
| SEMA4D IN SEMAPHORIN SIGNALING | 24 | 9.09e-01 | -1.36e-02 | 9.52e-01 |
| TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR TC NER | 78 | 8.37e-01 | 1.35e-02 | 9.22e-01 |
| ZBP1 DAI MEDIATED INDUCTION OF TYPE I IFNS | 18 | 9.21e-01 | 1.35e-02 | 9.59e-01 |
| NUCLEAR PORE COMPLEX NPC DISASSEMBLY | 32 | 8.95e-01 | -1.35e-02 | 9.46e-01 |
| SYNDECAN INTERACTIONS | 27 | 9.07e-01 | 1.30e-02 | 9.52e-01 |
| SIGNAL REGULATORY PROTEIN FAMILY INTERACTIONS | 11 | 9.41e-01 | 1.29e-02 | 9.70e-01 |
| SIGNALING BY FGFR IN DISEASE | 57 | 8.67e-01 | -1.28e-02 | 9.38e-01 |
| DCC MEDIATED ATTRACTIVE SIGNALING | 14 | 9.34e-01 | 1.27e-02 | 9.65e-01 |
| SHC MEDIATED CASCADE FGFR1 | 16 | 9.31e-01 | -1.25e-02 | 9.64e-01 |
| DOWNREGULATION OF ERBB2 SIGNALING | 28 | 9.09e-01 | -1.25e-02 | 9.52e-01 |
| AKT PHOSPHORYLATES TARGETS IN THE NUCLEUS | 10 | 9.48e-01 | 1.20e-02 | 9.74e-01 |
| FGFR1 MUTANT RECEPTOR ACTIVATION | 26 | 9.19e-01 | 1.15e-02 | 9.59e-01 |
| TP53 REGULATES METABOLIC GENES | 85 | 8.55e-01 | -1.14e-02 | 9.30e-01 |
| NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | 13 | 9.43e-01 | -1.14e-02 | 9.71e-01 |
| ION HOMEOSTASIS | 50 | 8.91e-01 | -1.12e-02 | 9.46e-01 |
| SIGNALING BY ROBO RECEPTORS | 208 | 7.84e-01 | 1.10e-02 | 8.99e-01 |
| PERK REGULATES GENE EXPRESSION | 28 | 9.20e-01 | 1.09e-02 | 9.59e-01 |
| YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | 12 | 9.49e-01 | -1.06e-02 | 9.75e-01 |
| METALLOPROTEASE DUBS | 27 | 9.25e-01 | 1.05e-02 | 9.61e-01 |
| RHOB GTPASE CYCLE | 67 | 8.83e-01 | 1.04e-02 | 9.45e-01 |
| RAC1 GTPASE CYCLE | 177 | 8.17e-01 | 1.01e-02 | 9.16e-01 |
| TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | 32 | 9.21e-01 | 1.01e-02 | 9.59e-01 |
| CONSTITUTIVE SIGNALING BY EGFRVIII | 15 | 9.46e-01 | -1.00e-02 | 9.74e-01 |
| DNA DOUBLE STRAND BREAK RESPONSE | 55 | 8.98e-01 | 1.00e-02 | 9.47e-01 |
| TRANSCRIPTION OF THE HIV GENOME | 67 | 8.91e-01 | 9.73e-03 | 9.46e-01 |
| SENSORY PROCESSING OF SOUND | 62 | 9.03e-01 | -8.92e-03 | 9.52e-01 |
| SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | 31 | 9.33e-01 | -8.77e-03 | 9.65e-01 |
| ESR MEDIATED SIGNALING | 172 | 8.44e-01 | 8.72e-03 | 9.24e-01 |
| TRNA PROCESSING | 105 | 8.78e-01 | 8.70e-03 | 9.43e-01 |
| ARACHIDONIC ACID METABOLISM | 38 | 9.26e-01 | 8.67e-03 | 9.61e-01 |
| SUMOYLATION OF RNA BINDING PROTEINS | 45 | 9.28e-01 | -7.76e-03 | 9.63e-01 |
| REGULATION OF EXPRESSION OF SLITS AND ROBOS | 163 | 8.68e-01 | -7.58e-03 | 9.38e-01 |
| SIGNALING BY TGF BETA RECEPTOR COMPLEX | 72 | 9.15e-01 | 7.23e-03 | 9.56e-01 |
| CYTOKINE SIGNALING IN IMMUNE SYSTEM | 542 | 7.98e-01 | -6.43e-03 | 9.06e-01 |
| SYNTHESIS SECRETION AND INACTIVATION OF GLUCAGON LIKE PEPTIDE 1 GLP 1 | 13 | 9.70e-01 | 5.99e-03 | 9.90e-01 |
| RECOGNITION OF DNA DAMAGE BY PCNA CONTAINING REPLICATION COMPLEX | 29 | 9.57e-01 | -5.72e-03 | 9.81e-01 |
| DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | 23 | 9.63e-01 | 5.59e-03 | 9.85e-01 |
| P75NTR SIGNALS VIA NF KB | 15 | 9.72e-01 | -5.17e-03 | 9.91e-01 |
| REGULATION OF PLK1 ACTIVITY AT G2 M TRANSITION | 85 | 9.38e-01 | 4.91e-03 | 9.68e-01 |
| TRANSCRIPTIONAL REGULATION BY TP53 | 343 | 8.77e-01 | 4.85e-03 | 9.43e-01 |
| SIGNALING BY PDGFR IN DISEASE | 20 | 9.70e-01 | -4.78e-03 | 9.90e-01 |
| FORMATION OF RNA POL II ELONGATION COMPLEX | 57 | 9.51e-01 | -4.74e-03 | 9.76e-01 |
| RHO GTPASES ACTIVATE PKNS | 51 | 9.56e-01 | 4.49e-03 | 9.80e-01 |
| DEVELOPMENTAL BIOLOGY | 833 | 8.29e-01 | 4.43e-03 | 9.21e-01 |
| SIGNALLING TO RAS | 19 | 9.76e-01 | 4.00e-03 | 9.93e-01 |
| ELEVATION OF CYTOSOLIC CA2 LEVELS | 14 | 9.81e-01 | 3.69e-03 | 9.94e-01 |
| INTERLEUKIN RECEPTOR SHC SIGNALING | 20 | 9.78e-01 | 3.52e-03 | 9.94e-01 |
| PROCESSING OF INTRONLESS PRE MRNAS | 19 | 9.79e-01 | -3.41e-03 | 9.94e-01 |
| DISEASES OF PROGRAMMED CELL DEATH | 58 | 9.66e-01 | -3.28e-03 | 9.87e-01 |
| ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | 17 | 9.81e-01 | 3.27e-03 | 9.94e-01 |
| AURKA ACTIVATION BY TPX2 | 71 | 9.63e-01 | -3.16e-03 | 9.85e-01 |
| INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | 34 | 9.76e-01 | 3.00e-03 | 9.93e-01 |
| MISMATCH REPAIR | 15 | 9.85e-01 | -2.80e-03 | 9.95e-01 |
| RIP MEDIATED NFKB ACTIVATION VIA ZBP1 | 15 | 9.87e-01 | -2.43e-03 | 9.95e-01 |
| NUCLEAR IMPORT OF REV PROTEIN | 32 | 9.81e-01 | 2.37e-03 | 9.94e-01 |
| UNBLOCKING OF NMDA RECEPTORS GLUTAMATE BINDING AND ACTIVATION | 21 | 9.86e-01 | 2.28e-03 | 9.95e-01 |
| RUNX2 REGULATES BONE DEVELOPMENT | 29 | 9.87e-01 | -1.70e-03 | 9.95e-01 |
| RRNA MODIFICATION IN THE NUCLEUS AND CYTOSOL | 59 | 9.82e-01 | 1.69e-03 | 9.94e-01 |
| PECAM1 INTERACTIONS | 12 | 9.92e-01 | 1.61e-03 | 9.99e-01 |
| ION TRANSPORT BY P TYPE ATPASES | 50 | 9.88e-01 | -1.27e-03 | 9.95e-01 |
| REPRESSION OF WNT TARGET GENES | 14 | 9.94e-01 | -1.11e-03 | 1.00e+00 |
| PYRIMIDINE CATABOLISM | 10 | 9.95e-01 | 1.09e-03 | 1.00e+00 |
| CONSTITUTIVE SIGNALING BY ABERRANT PI3K IN CANCER | 64 | 9.96e-01 | -3.96e-04 | 1.00e+00 |
| PLASMA LIPOPROTEIN REMODELING | 14 | 9.99e-01 | -2.36e-04 | 1.00e+00 |
| ANTIGEN ACTIVATES B CELL RECEPTOR BCR LEADING TO GENERATION OF SECOND MESSENGERS | 26 | 9.98e-01 | -2.15e-04 | 1.00e+00 |
| SIGNALING BY NOTCH3 | 48 | 9.98e-01 | -1.97e-04 | 1.00e+00 |
| CELLULAR SENESCENCE | 146 | 9.99e-01 | 8.71e-05 | 1.00e+00 |
| SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | 14 | 1.00e+00 | 1.63e-05 | 1.00e+00 |
FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC
| 340 | |
|---|---|
| set | FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC |
| setSize | 19 |
| pANOVA | 9.33e-08 |
| s.dist | 0.707 |
| p.adjustANOVA | 5.5e-06 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Cct6a | 8139 |
| Tubb2a | 8130 |
| Tuba1b | 7873 |
| Tubb4b | 7622 |
| Tubb4a | 7517 |
| Tubb2b | 7504 |
| Cct5 | 7328 |
| Tuba4a | 7208 |
| Cct3 | 7150 |
| Tuba1a | 7067 |
| Tcp1 | 6639 |
| Cct8 | 6486 |
| Cct4 | 6252 |
| Tubb3 | 5842 |
| Cct7 | 4843 |
| Tuba1c | 4485 |
| Cct2 | 3832 |
| Tubb6 | 1806 |
| Tuba8 | -5577 |
| GeneID | Gene Rank |
|---|---|
| Cct6a | 8139 |
| Tubb2a | 8130 |
| Tuba1b | 7873 |
| Tubb4b | 7622 |
| Tubb4a | 7517 |
| Tubb2b | 7504 |
| Cct5 | 7328 |
| Tuba4a | 7208 |
| Cct3 | 7150 |
| Tuba1a | 7067 |
| Tcp1 | 6639 |
| Cct8 | 6486 |
| Cct4 | 6252 |
| Tubb3 | 5842 |
| Cct7 | 4843 |
| Tuba1c | 4485 |
| Cct2 | 3832 |
| Tubb6 | 1806 |
| Tuba8 | -5577 |
ALPHA LINOLENIC OMEGA3 AND LINOLEIC OMEGA6 ACID METABOLISM
| 47 | |
|---|---|
| set | ALPHA LINOLENIC OMEGA3 AND LINOLEIC OMEGA6 ACID METABOLISM |
| setSize | 12 |
| pANOVA | 0.000265 |
| s.dist | 0.608 |
| p.adjustANOVA | 0.004 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Fads2 | 8315 |
| Fads1 | 8229 |
| Elovl1 | 7473 |
| Hsd17b4 | 6568 |
| Acox1 | 6066 |
| Acaa1a | 5291 |
| Scp2 | 3811 |
| Acot8 | 3545 |
| Acsl1 | 2715 |
| Elovl5 | 2632 |
| Elovl2 | 2613 |
| Abcd1 | 1865 |
| GeneID | Gene Rank |
|---|---|
| Fads2 | 8315 |
| Fads1 | 8229 |
| Elovl1 | 7473 |
| Hsd17b4 | 6568 |
| Acox1 | 6066 |
| Acaa1a | 5291 |
| Scp2 | 3811 |
| Acot8 | 3545 |
| Acsl1 | 2715 |
| Elovl5 | 2632 |
| Elovl2 | 2613 |
| Abcd1 | 1865 |
GOLGI CISTERNAE PERICENTRIOLAR STACK REORGANIZATION
| 398 | |
|---|---|
| set | GOLGI CISTERNAE PERICENTRIOLAR STACK REORGANIZATION |
| setSize | 12 |
| pANOVA | 0.000567 |
| s.dist | 0.575 |
| p.adjustANOVA | 0.00704 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Mapk3 | 7701 |
| Gorasp2 | 7540 |
| Mapk1 | 7097 |
| Uso1 | 6853 |
| Rab2a | 6470 |
| Rab1b | 6316 |
| Rab1a | 6145 |
| Ccnb2 | 5891 |
| Blzf1 | 4985 |
| Gorasp1 | 4112 |
| Golga2 | -3175 |
| Plk1 | -4344 |
| GeneID | Gene Rank |
|---|---|
| Mapk3 | 7701 |
| Gorasp2 | 7540 |
| Mapk1 | 7097 |
| Uso1 | 6853 |
| Rab2a | 6470 |
| Rab1b | 6316 |
| Rab1a | 6145 |
| Ccnb2 | 5891 |
| Blzf1 | 4985 |
| Gorasp1 | 4112 |
| Golga2 | -3175 |
| Plk1 | -4344 |
PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS
| 757 | |
|---|---|
| set | PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS |
| setSize | 12 |
| pANOVA | 0.000789 |
| s.dist | 0.56 |
| p.adjustANOVA | 0.00911 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Impdh2 | 7591 |
| Gart | 7383 |
| Paics | 7071 |
| Adss | 6927 |
| Gmps | 6784 |
| Atic | 6715 |
| Adsl | 5423 |
| Adssl1 | 5346 |
| Impdh1 | 3125 |
| Ppat | 1917 |
| Lhpp | 1163 |
| Pfas | -5437 |
| GeneID | Gene Rank |
|---|---|
| Impdh2 | 7591 |
| Gart | 7383 |
| Paics | 7071 |
| Adss | 6927 |
| Gmps | 6784 |
| Atic | 6715 |
| Adsl | 5423 |
| Adssl1 | 5346 |
| Impdh1 | 3125 |
| Ppat | 1917 |
| Lhpp | 1163 |
| Pfas | -5437 |
RHOBTB3 ATPASE CYCLE
| 860 | |
|---|---|
| set | RHOBTB3 ATPASE CYCLE |
| setSize | 10 |
| pANOVA | 0.00245 |
| s.dist | 0.553 |
| p.adjustANOVA | 0.021 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Htr7 | 7894 |
| Ccne1 | 7431 |
| Rab9b | 5924 |
| Cul3 | 5822 |
| Hgs | 5340 |
| Plin3 | 5265 |
| Lrrc41 | 4586 |
| Vhl | 2253 |
| Rhobtb3 | 402 |
| Rab9 | -457 |
| GeneID | Gene Rank |
|---|---|
| Htr7 | 7894 |
| Ccne1 | 7431 |
| Rab9b | 5924 |
| Cul3 | 5822 |
| Hgs | 5340 |
| Plin3 | 5265 |
| Lrrc41 | 4586 |
| Vhl | 2253 |
| Rhobtb3 | 402 |
| Rab9 | -457 |
TRANSPORT OF CONNEXONS TO THE PLASMA MEMBRANE
| 1138 | |
|---|---|
| set | TRANSPORT OF CONNEXONS TO THE PLASMA MEMBRANE |
| setSize | 13 |
| pANOVA | 0.000836 |
| s.dist | 0.535 |
| p.adjustANOVA | 0.00938 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Tubb2a | 8130 |
| Tuba1b | 7873 |
| Tubb4b | 7622 |
| Tubb4a | 7517 |
| Tubb2b | 7504 |
| Tuba4a | 7208 |
| Tuba1a | 7067 |
| Tubb3 | 5842 |
| Gja1 | 5105 |
| Tuba1c | 4485 |
| Tubb6 | 1806 |
| Tuba8 | -5577 |
| Gjb2 | -8878 |
| GeneID | Gene Rank |
|---|---|
| Tubb2a | 8130 |
| Tuba1b | 7873 |
| Tubb4b | 7622 |
| Tubb4a | 7517 |
| Tubb2b | 7504 |
| Tuba4a | 7208 |
| Tuba1a | 7067 |
| Tubb3 | 5842 |
| Gja1 | 5105 |
| Tuba1c | 4485 |
| Tubb6 | 1806 |
| Tuba8 | -5577 |
| Gjb2 | -8878 |
BBSOME MEDIATED CARGO TARGETING TO CILIUM
| 92 | |
|---|---|
| set | BBSOME MEDIATED CARGO TARGETING TO CILIUM |
| setSize | 23 |
| pANOVA | 9.28e-06 |
| s.dist | 0.534 |
| p.adjustANOVA | 0.00028 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Mkks | 8028 |
| Bbs10 | 7881 |
| Cct5 | 7328 |
| Mchr1 | 7255 |
| Bbs9 | 7234 |
| Cct3 | 7150 |
| Arl6 | 6976 |
| Tcp1 | 6639 |
| Lztfl1 | 6504 |
| Cct8 | 6486 |
| Cct4 | 6252 |
| Rab3ip | 6224 |
| Ttc8 | 6172 |
| Bbs1 | 5926 |
| Smo | 5053 |
| Bbs7 | 4516 |
| Cct2 | 3832 |
| Bbs2 | 2160 |
| Bbip1 | 1835 |
| Bbs4 | 1657 |
| GeneID | Gene Rank |
|---|---|
| Mkks | 8028 |
| Bbs10 | 7881 |
| Cct5 | 7328 |
| Mchr1 | 7255 |
| Bbs9 | 7234 |
| Cct3 | 7150 |
| Arl6 | 6976 |
| Tcp1 | 6639 |
| Lztfl1 | 6504 |
| Cct8 | 6486 |
| Cct4 | 6252 |
| Rab3ip | 6224 |
| Ttc8 | 6172 |
| Bbs1 | 5926 |
| Smo | 5053 |
| Bbs7 | 4516 |
| Cct2 | 3832 |
| Bbs2 | 2160 |
| Bbip1 | 1835 |
| Bbs4 | 1657 |
| Sstr3 | -5368 |
| Bbs5 | -5698 |
| Bbs12 | -5783 |
CITRIC ACID CYCLE TCA CYCLE
| 154 | |
|---|---|
| set | CITRIC ACID CYCLE TCA CYCLE |
| setSize | 22 |
| pANOVA | 2.49e-05 |
| s.dist | 0.519 |
| p.adjustANOVA | 0.000636 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Idh2 | 8249 |
| Idh3a | 7988 |
| Fh1 | 7915 |
| Sucla2 | 6928 |
| Dld | 6906 |
| Idh3b | 6659 |
| Dlst | 6472 |
| Suclg2 | 5337 |
| Mdh2 | 5325 |
| Sdhd | 5079 |
| Aco2 | 4730 |
| Idh3g | 4298 |
| Sdha | 4003 |
| Cs | 3839 |
| Ogdh | 3656 |
| Suclg1 | 3555 |
| Nnt | 3360 |
| Sdhb | 2165 |
| Fahd1 | 1729 |
| Sdhc | 1198 |
| GeneID | Gene Rank |
|---|---|
| Idh2 | 8249 |
| Idh3a | 7988 |
| Fh1 | 7915 |
| Sucla2 | 6928 |
| Dld | 6906 |
| Idh3b | 6659 |
| Dlst | 6472 |
| Suclg2 | 5337 |
| Mdh2 | 5325 |
| Sdhd | 5079 |
| Aco2 | 4730 |
| Idh3g | 4298 |
| Sdha | 4003 |
| Cs | 3839 |
| Ogdh | 3656 |
| Suclg1 | 3555 |
| Nnt | 3360 |
| Sdhb | 2165 |
| Fahd1 | 1729 |
| Sdhc | 1198 |
| Me2 | -3407 |
| Me3 | -4847 |
NUCLEOBASE BIOSYNTHESIS
| 655 | |
|---|---|
| set | NUCLEOBASE BIOSYNTHESIS |
| setSize | 15 |
| pANOVA | 0.000668 |
| s.dist | 0.507 |
| p.adjustANOVA | 0.00803 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Umps | 7689 |
| Impdh2 | 7591 |
| Gart | 7383 |
| Paics | 7071 |
| Adss | 6927 |
| Gmps | 6784 |
| Atic | 6715 |
| Adsl | 5423 |
| Adssl1 | 5346 |
| Impdh1 | 3125 |
| Ppat | 1917 |
| Lhpp | 1163 |
| Dhodh | 1010 |
| Cad | -2095 |
| Pfas | -5437 |
| GeneID | Gene Rank |
|---|---|
| Umps | 7689 |
| Impdh2 | 7591 |
| Gart | 7383 |
| Paics | 7071 |
| Adss | 6927 |
| Gmps | 6784 |
| Atic | 6715 |
| Adsl | 5423 |
| Adssl1 | 5346 |
| Impdh1 | 3125 |
| Ppat | 1917 |
| Lhpp | 1163 |
| Dhodh | 1010 |
| Cad | -2095 |
| Pfas | -5437 |
KERATAN SULFATE BIOSYNTHESIS
| 505 | |
|---|---|
| set | KERATAN SULFATE BIOSYNTHESIS |
| setSize | 24 |
| pANOVA | 2.54e-05 |
| s.dist | 0.497 |
| p.adjustANOVA | 0.000636 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Prelp | 8307 |
| B4galt4 | 8133 |
| B4gat1 | 7867 |
| B4galt1 | 7206 |
| B4galt2 | 7053 |
| Chst2 | 6910 |
| B3gnt2 | 6456 |
| Chst1 | 5732 |
| St3gal4 | 5412 |
| Acan | 5261 |
| St3gal2 | 4804 |
| B4galt6 | 4181 |
| B3gnt4 | 4171 |
| Fmod | 4018 |
| Lum | 3386 |
| Slc35d2 | 3267 |
| B3gnt7 | 2820 |
| St3gal1 | 2423 |
| B4galt3 | 2030 |
| St3gal3 | 1871 |
| GeneID | Gene Rank |
|---|---|
| Prelp | 8307 |
| B4galt4 | 8133 |
| B4gat1 | 7867 |
| B4galt1 | 7206 |
| B4galt2 | 7053 |
| Chst2 | 6910 |
| B3gnt2 | 6456 |
| Chst1 | 5732 |
| St3gal4 | 5412 |
| Acan | 5261 |
| St3gal2 | 4804 |
| B4galt6 | 4181 |
| B3gnt4 | 4171 |
| Fmod | 4018 |
| Lum | 3386 |
| Slc35d2 | 3267 |
| B3gnt7 | 2820 |
| St3gal1 | 2423 |
| B4galt3 | 2030 |
| St3gal3 | 1871 |
| B4galt5 | 1637 |
| Chst5 | 1487 |
| Ogn | -1934 |
| St3gal6 | -7863 |
COPI INDEPENDENT GOLGI TO ER RETROGRADE TRAFFIC
| 182 | |
|---|---|
| set | COPI INDEPENDENT GOLGI TO ER RETROGRADE TRAFFIC |
| setSize | 44 |
| pANOVA | 1.48e-08 |
| s.dist | 0.493 |
| p.adjustANOVA | 1.16e-06 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Tubb2a | 8130 |
| Tuba1b | 7873 |
| Capza2 | 7704 |
| Tubb4b | 7622 |
| Tubb4a | 7517 |
| Tubb2b | 7504 |
| Actr1a | 7389 |
| Capza1 | 7253 |
| Tuba4a | 7208 |
| Dctn4 | 7177 |
| Tuba1a | 7067 |
| Rab6a | 6581 |
| Rab18 | 6537 |
| Dctn6 | 6465 |
| Dctn1 | 6188 |
| Rab3gap1 | 6072 |
| Tubb3 | 5842 |
| Dync1i1 | 5759 |
| Pla2g6 | 5480 |
| Dctn5 | 5433 |
| GeneID | Gene Rank |
|---|---|
| Tubb2a | 8130 |
| Tuba1b | 7873 |
| Capza2 | 7704 |
| Tubb4b | 7622 |
| Tubb4a | 7517 |
| Tubb2b | 7504 |
| Actr1a | 7389 |
| Capza1 | 7253 |
| Tuba4a | 7208 |
| Dctn4 | 7177 |
| Tuba1a | 7067 |
| Rab6a | 6581 |
| Rab18 | 6537 |
| Dctn6 | 6465 |
| Dctn1 | 6188 |
| Rab3gap1 | 6072 |
| Tubb3 | 5842 |
| Dync1i1 | 5759 |
| Pla2g6 | 5480 |
| Dctn5 | 5433 |
| Rab6b | 5302 |
| Capzb | 5208 |
| Pla2g4a | 4647 |
| Tuba1c | 4485 |
| Galnt1 | 4231 |
| Dynll1 | 3613 |
| Dctn2 | 3314 |
| Actr10 | 2962 |
| Pafah1b3 | 2884 |
| Galnt2 | 2757 |
| Dync1li1 | 2623 |
| Pafah1b1 | 2584 |
| Pafah1b2 | 2292 |
| Rab3gap2 | 2191 |
| Agpat3 | 1986 |
| Tubb6 | 1806 |
| Dync1h1 | 1341 |
| Dctn3 | 329 |
| Bicd2 | -362 |
| Dynll2 | -1891 |
| Dync1li2 | -3541 |
| Dync1i2 | -3902 |
| Bicd1 | -3999 |
| Tuba8 | -5577 |
COOPERATION OF PREFOLDIN AND TRIC CCT IN ACTIN AND TUBULIN FOLDING
| 180 | |
|---|---|
| set | COOPERATION OF PREFOLDIN AND TRIC CCT IN ACTIN AND TUBULIN FOLDING |
| setSize | 26 |
| pANOVA | 2.52e-05 |
| s.dist | 0.477 |
| p.adjustANOVA | 0.000636 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Cct6a | 8139 |
| Tubb2a | 8130 |
| Tuba1b | 7873 |
| Tubb4b | 7622 |
| Tubb4a | 7517 |
| Tubb2b | 7504 |
| Cct5 | 7328 |
| Tuba4a | 7208 |
| Cct3 | 7150 |
| Tuba1a | 7067 |
| Tcp1 | 6639 |
| Cct8 | 6486 |
| Cct4 | 6252 |
| Tubb3 | 5842 |
| Cct7 | 4843 |
| Pfdn4 | 4529 |
| Tuba1c | 4485 |
| Cct2 | 3832 |
| Vbp1 | 3176 |
| Tubb6 | 1806 |
| GeneID | Gene Rank |
|---|---|
| Cct6a | 8139 |
| Tubb2a | 8130 |
| Tuba1b | 7873 |
| Tubb4b | 7622 |
| Tubb4a | 7517 |
| Tubb2b | 7504 |
| Cct5 | 7328 |
| Tuba4a | 7208 |
| Cct3 | 7150 |
| Tuba1a | 7067 |
| Tcp1 | 6639 |
| Cct8 | 6486 |
| Cct4 | 6252 |
| Tubb3 | 5842 |
| Cct7 | 4843 |
| Pfdn4 | 4529 |
| Tuba1c | 4485 |
| Cct2 | 3832 |
| Vbp1 | 3176 |
| Tubb6 | 1806 |
| Pfdn1 | 574 |
| Pfdn5 | -3196 |
| Pfdn6 | -3809 |
| Pfdn2 | -4915 |
| Tuba8 | -5577 |
| Actb | -8390 |
HSP90 CHAPERONE CYCLE FOR STEROID HORMONE RECEPTORS SHR
| 435 | |
|---|---|
| set | HSP90 CHAPERONE CYCLE FOR STEROID HORMONE RECEPTORS SHR |
| setSize | 48 |
| pANOVA | 2.46e-08 |
| s.dist | 0.465 |
| p.adjustANOVA | 1.7e-06 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Hspa2 | 8280 |
| Hspa1b | 8162 |
| Tubb2a | 8130 |
| Dnaja2 | 7983 |
| Tuba1b | 7873 |
| Capza2 | 7704 |
| Tubb4b | 7622 |
| Dnaja4 | 7556 |
| Tubb4a | 7517 |
| Tubb2b | 7504 |
| Actr1a | 7389 |
| Dnaja1 | 7327 |
| Capza1 | 7253 |
| Tuba4a | 7208 |
| Dctn4 | 7177 |
| Tuba1a | 7067 |
| Stip1 | 6832 |
| Dctn6 | 6465 |
| Dctn1 | 6188 |
| Fkbp5 | 5985 |
| GeneID | Gene Rank |
|---|---|
| Hspa2 | 8280 |
| Hspa1b | 8162 |
| Tubb2a | 8130 |
| Dnaja2 | 7983 |
| Tuba1b | 7873 |
| Capza2 | 7704 |
| Tubb4b | 7622 |
| Dnaja4 | 7556 |
| Tubb4a | 7517 |
| Tubb2b | 7504 |
| Actr1a | 7389 |
| Dnaja1 | 7327 |
| Capza1 | 7253 |
| Tuba4a | 7208 |
| Dctn4 | 7177 |
| Tuba1a | 7067 |
| Stip1 | 6832 |
| Dctn6 | 6465 |
| Dctn1 | 6188 |
| Fkbp5 | 5985 |
| Tubb3 | 5842 |
| Dync1i1 | 5759 |
| Fkbp4 | 5611 |
| Dctn5 | 5433 |
| Capzb | 5208 |
| Hspa8 | 5004 |
| Tuba1c | 4485 |
| Dynll1 | 3613 |
| Ptges3 | 3550 |
| Dctn2 | 3314 |
| Actr10 | 2962 |
| Dync1li1 | 2623 |
| Nr3c2 | 2400 |
| Tubb6 | 1806 |
| Dnajb1 | 1793 |
| Dync1h1 | 1341 |
| Dctn3 | 329 |
| Ar | 266 |
| Nr3c1 | -1009 |
| Dynll2 | -1891 |
| Hsp90ab1 | -2348 |
| Hspa1l | -2920 |
| Hsp90aa1 | -2970 |
| Pgr | -3538 |
| Dync1li2 | -3541 |
| Dync1i2 | -3902 |
| Hspa1a | -5092 |
| Tuba8 | -5577 |
KERATAN SULFATE KERATIN METABOLISM
| 507 | |
|---|---|
| set | KERATAN SULFATE KERATIN METABOLISM |
| setSize | 30 |
| pANOVA | 1.46e-05 |
| s.dist | 0.457 |
| p.adjustANOVA | 0.000409 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Prelp | 8307 |
| B4galt4 | 8133 |
| B4gat1 | 7867 |
| B4galt1 | 7206 |
| B4galt2 | 7053 |
| Chst2 | 6910 |
| B3gnt2 | 6456 |
| Chst1 | 5732 |
| Hexa | 5632 |
| St3gal4 | 5412 |
| Acan | 5261 |
| St3gal2 | 4804 |
| Gns | 4656 |
| Hexb | 4301 |
| B4galt6 | 4181 |
| B3gnt4 | 4171 |
| Fmod | 4018 |
| Lum | 3386 |
| Slc35d2 | 3267 |
| B3gnt7 | 2820 |
| GeneID | Gene Rank |
|---|---|
| Prelp | 8307 |
| B4galt4 | 8133 |
| B4gat1 | 7867 |
| B4galt1 | 7206 |
| B4galt2 | 7053 |
| Chst2 | 6910 |
| B3gnt2 | 6456 |
| Chst1 | 5732 |
| Hexa | 5632 |
| St3gal4 | 5412 |
| Acan | 5261 |
| St3gal2 | 4804 |
| Gns | 4656 |
| Hexb | 4301 |
| B4galt6 | 4181 |
| B3gnt4 | 4171 |
| Fmod | 4018 |
| Lum | 3386 |
| Slc35d2 | 3267 |
| B3gnt7 | 2820 |
| St3gal1 | 2423 |
| Glb1 | 2200 |
| B4galt3 | 2030 |
| St3gal3 | 1871 |
| B4galt5 | 1637 |
| Chst5 | 1487 |
| Glb1l | 552 |
| Ogn | -1934 |
| Galns | -4080 |
| St3gal6 | -7863 |
CALNEXIN CALRETICULIN CYCLE
| 110 | |
|---|---|
| set | CALNEXIN CALRETICULIN CYCLE |
| setSize | 26 |
| pANOVA | 5.9e-05 |
| s.dist | 0.455 |
| p.adjustANOVA | 0.0012 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Calr | 8220 |
| Derl2 | 8209 |
| Pdia3 | 7888 |
| Prkcsh | 7715 |
| Ganab | 7291 |
| Rnf185 | 6706 |
| Os9 | 6588 |
| Canx | 6365 |
| Man1b1 | 6134 |
| Marchf6 | 5839 |
| Rnf5 | 5661 |
| Edem2 | 5636 |
| Amfr | 5428 |
| Rnf139 | 5303 |
| Uggt1 | 5299 |
| Syvn1 | 5168 |
| Ubc | 4500 |
| Edem3 | 2269 |
| Ubb | 1303 |
| Rps27a | -478 |
| GeneID | Gene Rank |
|---|---|
| Calr | 8220 |
| Derl2 | 8209 |
| Pdia3 | 7888 |
| Prkcsh | 7715 |
| Ganab | 7291 |
| Rnf185 | 6706 |
| Os9 | 6588 |
| Canx | 6365 |
| Man1b1 | 6134 |
| Marchf6 | 5839 |
| Rnf5 | 5661 |
| Edem2 | 5636 |
| Amfr | 5428 |
| Rnf139 | 5303 |
| Uggt1 | 5299 |
| Syvn1 | 5168 |
| Ubc | 4500 |
| Edem3 | 2269 |
| Ubb | 1303 |
| Rps27a | -478 |
| Rnf103 | -721 |
| Edem1 | -1059 |
| Sel1l | -2256 |
| Uggt2 | -2738 |
| Trim13 | -3011 |
| Uba52 | -8214 |
GLYCOGEN STORAGE DISEASES
| 391 | |
|---|---|
| set | GLYCOGEN STORAGE DISEASES |
| setSize | 12 |
| pANOVA | 0.00644 |
| s.dist | 0.454 |
| p.adjustANOVA | 0.0424 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Gyg | 7709 |
| Gaa | 7535 |
| Gbe1 | 7309 |
| Nhlrc1 | 6939 |
| G6pc3 | 6444 |
| Epm2a | 5095 |
| Ubc | 4500 |
| Ppp1r3c | 2878 |
| Gys1 | 1875 |
| Ubb | 1303 |
| Rps27a | -478 |
| Uba52 | -8214 |
| GeneID | Gene Rank |
|---|---|
| Gyg | 7709 |
| Gaa | 7535 |
| Gbe1 | 7309 |
| Nhlrc1 | 6939 |
| G6pc3 | 6444 |
| Epm2a | 5095 |
| Ubc | 4500 |
| Ppp1r3c | 2878 |
| Gys1 | 1875 |
| Ubb | 1303 |
| Rps27a | -478 |
| Uba52 | -8214 |
GAP JUNCTION ASSEMBLY
| 371 | |
|---|---|
| set | GAP JUNCTION ASSEMBLY |
| setSize | 21 |
| pANOVA | 0.000314 |
| s.dist | 0.454 |
| p.adjustANOVA | 0.00462 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Tubb2a | 8130 |
| Tuba1b | 7873 |
| Tubb4b | 7622 |
| Gjb6 | 7577 |
| Tubb4a | 7517 |
| Tubb2b | 7504 |
| Tuba4a | 7208 |
| Tuba1a | 7067 |
| Gjd2 | 6953 |
| Gjd3 | 5958 |
| Tubb3 | 5842 |
| Gja1 | 5105 |
| Tuba1c | 4485 |
| Gjb1 | 3853 |
| Gjc1 | 2485 |
| Tubb6 | 1806 |
| Gjc2 | 1414 |
| Gja4 | -1332 |
| Tuba8 | -5577 |
| Gja5 | -7589 |
| GeneID | Gene Rank |
|---|---|
| Tubb2a | 8130 |
| Tuba1b | 7873 |
| Tubb4b | 7622 |
| Gjb6 | 7577 |
| Tubb4a | 7517 |
| Tubb2b | 7504 |
| Tuba4a | 7208 |
| Tuba1a | 7067 |
| Gjd2 | 6953 |
| Gjd3 | 5958 |
| Tubb3 | 5842 |
| Gja1 | 5105 |
| Tuba1c | 4485 |
| Gjb1 | 3853 |
| Gjc1 | 2485 |
| Tubb6 | 1806 |
| Gjc2 | 1414 |
| Gja4 | -1332 |
| Tuba8 | -5577 |
| Gja5 | -7589 |
| Gjb2 | -8878 |
ENDOSOMAL VACUOLAR PATHWAY
| 284 | |
|---|---|
| set | ENDOSOMAL VACUOLAR PATHWAY |
| setSize | 10 |
| pANOVA | 0.0131 |
| s.dist | -0.453 |
| p.adjustANOVA | 0.0681 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| H2-T23 | -9188 |
| H2-M3 | -8824 |
| H2-Q7 | -7765 |
| B2m | -7131 |
| H2-Q10 | -6983 |
| H2-D1 | -5043 |
| Lnpep | -4287 |
| H2-Q2 | -2917 |
| Ctss | 2781 |
| Ctsl | 5335 |
| GeneID | Gene Rank |
|---|---|
| H2-T23 | -9188 |
| H2-M3 | -8824 |
| H2-Q7 | -7765 |
| B2m | -7131 |
| H2-Q10 | -6983 |
| H2-D1 | -5043 |
| Lnpep | -4287 |
| H2-Q2 | -2917 |
| Ctss | 2781 |
| Ctsl | 5335 |
RETROGRADE NEUROTROPHIN SIGNALLING
| 842 | |
|---|---|
| set | RETROGRADE NEUROTROPHIN SIGNALLING |
| setSize | 13 |
| pANOVA | 0.00477 |
| s.dist | 0.452 |
| p.adjustANOVA | 0.0339 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Ap2m1 | 7792 |
| Dnm2 | 7614 |
| Ap2b1 | 7522 |
| Dnal4 | 7381 |
| Ap2a2 | 6984 |
| Ap2a1 | 6110 |
| Cltc | 4483 |
| Clta | 3556 |
| Sh3gl2 | 2855 |
| Dnm3 | 2297 |
| Dnm1 | 814 |
| Ap2s1 | -3475 |
| Ntrk1 | -7720 |
| GeneID | Gene Rank |
|---|---|
| Ap2m1 | 7792 |
| Dnm2 | 7614 |
| Ap2b1 | 7522 |
| Dnal4 | 7381 |
| Ap2a2 | 6984 |
| Ap2a1 | 6110 |
| Cltc | 4483 |
| Clta | 3556 |
| Sh3gl2 | 2855 |
| Dnm3 | 2297 |
| Dnm1 | 814 |
| Ap2s1 | -3475 |
| Ntrk1 | -7720 |
GLYCOGEN SYNTHESIS
| 392 | |
|---|---|
| set | GLYCOGEN SYNTHESIS |
| setSize | 14 |
| pANOVA | 0.00363 |
| s.dist | 0.449 |
| p.adjustANOVA | 0.0274 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Pgm1 | 8318 |
| Ugp2 | 8093 |
| Gyg | 7709 |
| Gbe1 | 7309 |
| Nhlrc1 | 6939 |
| Pgm2 | 6644 |
| Epm2a | 5095 |
| Ubc | 4500 |
| Ppp1r3c | 2878 |
| Gys1 | 1875 |
| Ubb | 1303 |
| Rps27a | -478 |
| Pgm2l1 | -2578 |
| Uba52 | -8214 |
| GeneID | Gene Rank |
|---|---|
| Pgm1 | 8318 |
| Ugp2 | 8093 |
| Gyg | 7709 |
| Gbe1 | 7309 |
| Nhlrc1 | 6939 |
| Pgm2 | 6644 |
| Epm2a | 5095 |
| Ubc | 4500 |
| Ppp1r3c | 2878 |
| Gys1 | 1875 |
| Ubb | 1303 |
| Rps27a | -478 |
| Pgm2l1 | -2578 |
| Uba52 | -8214 |
SEALING OF THE NUCLEAR ENVELOPE NE BY ESCRT III
| 909 | |
|---|---|
| set | SEALING OF THE NUCLEAR ENVELOPE NE BY ESCRT III |
| setSize | 23 |
| pANOVA | 0.000265 |
| s.dist | 0.439 |
| p.adjustANOVA | 0.004 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Tubb2a | 8130 |
| Tuba1b | 7873 |
| Tubb4b | 7622 |
| Tubb4a | 7517 |
| Tubb2b | 7504 |
| Vps4a | 7252 |
| Tuba4a | 7208 |
| Chmp7 | 7151 |
| Chmp3 | 7107 |
| Tuba1a | 7067 |
| Chmp2b | 6346 |
| Chmp4b | 6041 |
| Spast | 5925 |
| Tubb3 | 5842 |
| Tuba1c | 4485 |
| Tubb6 | 1806 |
| Chmp6 | 1720 |
| Lemd2 | -1060 |
| Chmp2a | -2646 |
| Ist1 | -4378 |
| GeneID | Gene Rank |
|---|---|
| Tubb2a | 8130 |
| Tuba1b | 7873 |
| Tubb4b | 7622 |
| Tubb4a | 7517 |
| Tubb2b | 7504 |
| Vps4a | 7252 |
| Tuba4a | 7208 |
| Chmp7 | 7151 |
| Chmp3 | 7107 |
| Tuba1a | 7067 |
| Chmp2b | 6346 |
| Chmp4b | 6041 |
| Spast | 5925 |
| Tubb3 | 5842 |
| Tuba1c | 4485 |
| Tubb6 | 1806 |
| Chmp6 | 1720 |
| Lemd2 | -1060 |
| Chmp2a | -2646 |
| Ist1 | -4378 |
| Cc2d1b | -5268 |
| Tuba8 | -5577 |
| Chmp4c | -8521 |
LDL CLEARANCE
| 516 | |
|---|---|
| set | LDL CLEARANCE |
| setSize | 16 |
| pANOVA | 0.00246 |
| s.dist | 0.437 |
| p.adjustANOVA | 0.021 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Lipa | 8232 |
| Ap2m1 | 7792 |
| Ap2b1 | 7522 |
| Npc1 | 7221 |
| Ap2a2 | 6984 |
| Soat1 | 6714 |
| Ap2a1 | 6110 |
| Nceh1 | 5557 |
| Cltc | 4483 |
| Clta | 3556 |
| Ldlr | 1991 |
| Npc2 | 1627 |
| Lsr | 745 |
| Ap2s1 | -3475 |
| Pcsk9 | -4163 |
| Ldlrap1 | -6117 |
| GeneID | Gene Rank |
|---|---|
| Lipa | 8232 |
| Ap2m1 | 7792 |
| Ap2b1 | 7522 |
| Npc1 | 7221 |
| Ap2a2 | 6984 |
| Soat1 | 6714 |
| Ap2a1 | 6110 |
| Nceh1 | 5557 |
| Cltc | 4483 |
| Clta | 3556 |
| Ldlr | 1991 |
| Npc2 | 1627 |
| Lsr | 745 |
| Ap2s1 | -3475 |
| Pcsk9 | -4163 |
| Ldlrap1 | -6117 |
CHK1 CHK2 CDS1 MEDIATED INACTIVATION OF CYCLIN B CDK1 COMPLEX
| 146 | |
|---|---|
| set | CHK1 CHK2 CDS1 MEDIATED INACTIVATION OF CYCLIN B CDK1 COMPLEX |
| setSize | 10 |
| pANOVA | 0.0169 |
| s.dist | 0.436 |
| p.adjustANOVA | 0.08 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Sfn | 6246 |
| Chek1 | 6044 |
| Ywhaq | 5968 |
| Ywhab | 4891 |
| Ywhah | 3722 |
| Wee1 | 3716 |
| Ywhae | 2826 |
| Ywhaz | 1182 |
| Ywhag | 961 |
| Chek2 | -1400 |
| GeneID | Gene Rank |
|---|---|
| Sfn | 6246 |
| Chek1 | 6044 |
| Ywhaq | 5968 |
| Ywhab | 4891 |
| Ywhah | 3722 |
| Wee1 | 3716 |
| Ywhae | 2826 |
| Ywhaz | 1182 |
| Ywhag | 961 |
| Chek2 | -1400 |
OLFACTORY SIGNALING PATHWAY
| 664 | |
|---|---|
| set | OLFACTORY SIGNALING PATHWAY |
| setSize | 40 |
| pANOVA | 2.56e-06 |
| s.dist | -0.43 |
| p.adjustANOVA | 0.000112 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Rtp4 | -9185 |
| Olfr981 | -9130 |
| Olfr354 | -9066 |
| Olfr635 | -8967 |
| Olfr1310 | -8891 |
| Olfr1192-ps1 | -8827 |
| Olfr796 | -8547 |
| Olfr1564 | -8513 |
| Olfr2 | -8472 |
| Olfr735 | -8412 |
| Olfr63 | -8335 |
| Olfr1309 | -8324 |
| Olfr986 | -8079 |
| Olfr287 | -7681 |
| Olfr90 | -7344 |
| Olfr78 | -7306 |
| Olfr31 | -6758 |
| Olfr804 | -6712 |
| Gng13 | -6622 |
| Olfr1385 | -6534 |
| GeneID | Gene Rank |
|---|---|
| Rtp4 | -9185 |
| Olfr981 | -9130 |
| Olfr354 | -9066 |
| Olfr635 | -8967 |
| Olfr1310 | -8891 |
| Olfr1192-ps1 | -8827 |
| Olfr796 | -8547 |
| Olfr1564 | -8513 |
| Olfr2 | -8472 |
| Olfr735 | -8412 |
| Olfr63 | -8335 |
| Olfr1309 | -8324 |
| Olfr986 | -8079 |
| Olfr287 | -7681 |
| Olfr90 | -7344 |
| Olfr78 | -7306 |
| Olfr31 | -6758 |
| Olfr804 | -6712 |
| Gng13 | -6622 |
| Olfr1385 | -6534 |
| Olfr161 | -5851 |
| Olfr365 | -5455 |
| Olfr137 | -5449 |
| Olfr713 | -5014 |
| Reep4 | -4431 |
| Olfr648 | -4383 |
| Olfr147 | -3210 |
| Olfr558 | -2465 |
| Olfr1507 | -587 |
| Reep6 | -581 |
| Reep3 | -347 |
| Olfr446 | 176 |
| Olfr95 | 313 |
| Olfr552 | 353 |
| Reep1 | 2405 |
| Gnal | 4239 |
| Reep2 | 5124 |
| Olfr464 | 6000 |
| Gnb1 | 6352 |
| Reep5 | 6884 |
RHO GTPASES ACTIVATE IQGAPS
| 848 | |
|---|---|
| set | RHO GTPASES ACTIVATE IQGAPS |
| setSize | 23 |
| pANOVA | 0.000381 |
| s.dist | 0.428 |
| p.adjustANOVA | 0.00521 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Tubb2a | 8130 |
| Tuba1b | 7873 |
| Tubb4b | 7622 |
| Tubb4a | 7517 |
| Tubb2b | 7504 |
| Ctnna1 | 7489 |
| Tuba4a | 7208 |
| Tuba1a | 7067 |
| Ctnnb1 | 6810 |
| Men1 | 6234 |
| Rac1 | 6022 |
| Tubb3 | 5842 |
| Tuba1c | 4485 |
| Cdc42 | 3640 |
| Iqgap2 | 2145 |
| Actg1 | 1983 |
| Tubb6 | 1806 |
| Calm1 | 451 |
| Iqgap1 | -602 |
| Cdh1 | -3096 |
| GeneID | Gene Rank |
|---|---|
| Tubb2a | 8130 |
| Tuba1b | 7873 |
| Tubb4b | 7622 |
| Tubb4a | 7517 |
| Tubb2b | 7504 |
| Ctnna1 | 7489 |
| Tuba4a | 7208 |
| Tuba1a | 7067 |
| Ctnnb1 | 6810 |
| Men1 | 6234 |
| Rac1 | 6022 |
| Tubb3 | 5842 |
| Tuba1c | 4485 |
| Cdc42 | 3640 |
| Iqgap2 | 2145 |
| Actg1 | 1983 |
| Tubb6 | 1806 |
| Calm1 | 451 |
| Iqgap1 | -602 |
| Cdh1 | -3096 |
| Clip1 | -5312 |
| Tuba8 | -5577 |
| Actb | -8390 |
RECEPTOR MEDIATED MITOPHAGY
| 777 | |
|---|---|
| set | RECEPTOR MEDIATED MITOPHAGY |
| setSize | 11 |
| pANOVA | 0.0149 |
| s.dist | 0.424 |
| p.adjustANOVA | 0.0749 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Fundc1 | 6709 |
| Atg12 | 6464 |
| Csnk2a2 | 5876 |
| Csnk2b | 5064 |
| Ulk1 | 4360 |
| Map1lc3b | 3536 |
| Src | 2551 |
| Pgam5 | 2243 |
| Atg5 | 1480 |
| Map1lc3a | 861 |
| Csnk2a1 | -2742 |
| GeneID | Gene Rank |
|---|---|
| Fundc1 | 6709 |
| Atg12 | 6464 |
| Csnk2a2 | 5876 |
| Csnk2b | 5064 |
| Ulk1 | 4360 |
| Map1lc3b | 3536 |
| Src | 2551 |
| Pgam5 | 2243 |
| Atg5 | 1480 |
| Map1lc3a | 861 |
| Csnk2a1 | -2742 |
PURINE SALVAGE
| 758 | |
|---|---|
| set | PURINE SALVAGE |
| setSize | 12 |
| pANOVA | 0.0114 |
| s.dist | 0.422 |
| p.adjustANOVA | 0.0622 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Adk | 6834 |
| Pnp2 | 6409 |
| Gmpr2 | 6404 |
| Dck | 6351 |
| Dguok | 5001 |
| Hprt | 4960 |
| Gmpr | 3868 |
| Adal | 3166 |
| Ampd3 | 2029 |
| Ampd2 | 746 |
| Ada | -2926 |
| Aprt | -3368 |
| GeneID | Gene Rank |
|---|---|
| Adk | 6834 |
| Pnp2 | 6409 |
| Gmpr2 | 6404 |
| Dck | 6351 |
| Dguok | 5001 |
| Hprt | 4960 |
| Gmpr | 3868 |
| Adal | 3166 |
| Ampd3 | 2029 |
| Ampd2 | 746 |
| Ada | -2926 |
| Aprt | -3368 |
N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE
| 595 | |
|---|---|
| set | N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE |
| setSize | 35 |
| pANOVA | 1.74e-05 |
| s.dist | 0.42 |
| p.adjustANOVA | 0.000475 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Calr | 8220 |
| Derl2 | 8209 |
| Pdia3 | 7888 |
| Ngly1 | 7717 |
| Prkcsh | 7715 |
| Mlec | 7562 |
| Vcp | 7408 |
| Ganab | 7291 |
| Rnf185 | 6706 |
| Os9 | 6588 |
| Derl1 | 6478 |
| Canx | 6365 |
| Man1b1 | 6134 |
| Marchf6 | 5839 |
| Rnf5 | 5661 |
| Edem2 | 5636 |
| Amfr | 5428 |
| Rnf139 | 5303 |
| Uggt1 | 5299 |
| Syvn1 | 5168 |
| GeneID | Gene Rank |
|---|---|
| Calr | 8220 |
| Derl2 | 8209 |
| Pdia3 | 7888 |
| Ngly1 | 7717 |
| Prkcsh | 7715 |
| Mlec | 7562 |
| Vcp | 7408 |
| Ganab | 7291 |
| Rnf185 | 6706 |
| Os9 | 6588 |
| Derl1 | 6478 |
| Canx | 6365 |
| Man1b1 | 6134 |
| Marchf6 | 5839 |
| Rnf5 | 5661 |
| Edem2 | 5636 |
| Amfr | 5428 |
| Rnf139 | 5303 |
| Uggt1 | 5299 |
| Syvn1 | 5168 |
| Ubc | 4500 |
| Rad23b | 3835 |
| Edem3 | 2269 |
| Ubb | 1303 |
| Psmc1 | 753 |
| Rps27a | -478 |
| Rnf103 | -721 |
| Edem1 | -1059 |
| Ubxn1 | -2035 |
| Sel1l | -2256 |
| Uggt2 | -2738 |
| Trim13 | -3011 |
| Mogs | -3451 |
| Engase | -7024 |
| Uba52 | -8214 |
CD28 DEPENDENT VAV1 PATHWAY
| 125 | |
|---|---|
| set | CD28 DEPENDENT VAV1 PATHWAY |
| setSize | 11 |
| pANOVA | 0.0164 |
| s.dist | 0.418 |
| p.adjustANOVA | 0.0789 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Cd86 | 6435 |
| Pak1 | 6372 |
| Rac1 | 6022 |
| Pak2 | 5893 |
| Fyn | 4408 |
| Cdc42 | 3640 |
| Pak3 | 3584 |
| Lck | 3286 |
| Vav1 | 1300 |
| Grb2 | -450 |
| Cd80 | -4688 |
| GeneID | Gene Rank |
|---|---|
| Cd86 | 6435 |
| Pak1 | 6372 |
| Rac1 | 6022 |
| Pak2 | 5893 |
| Fyn | 4408 |
| Cdc42 | 3640 |
| Pak3 | 3584 |
| Lck | 3286 |
| Vav1 | 1300 |
| Grb2 | -450 |
| Cd80 | -4688 |
ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING
| 43 | |
|---|---|
| set | ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING |
| setSize | 11 |
| pANOVA | 0.0165 |
| s.dist | 0.417 |
| p.adjustANOVA | 0.0789 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Prkcsh | 7715 |
| Capza2 | 7704 |
| Mapk3 | 7701 |
| Capza1 | 7253 |
| Mapk1 | 7097 |
| Ddost | 5927 |
| App | 5597 |
| Hmgb1 | -1491 |
| Ager | -2689 |
| Lgals3 | -3826 |
| S100b | -5232 |
| GeneID | Gene Rank |
|---|---|
| Prkcsh | 7715 |
| Capza2 | 7704 |
| Mapk3 | 7701 |
| Capza1 | 7253 |
| Mapk1 | 7097 |
| Ddost | 5927 |
| App | 5597 |
| Hmgb1 | -1491 |
| Ager | -2689 |
| Lgals3 | -3826 |
| S100b | -5232 |
N GLYCAN ANTENNAE ELONGATION
| 593 | |
|---|---|
| set | N GLYCAN ANTENNAE ELONGATION |
| setSize | 15 |
| pANOVA | 0.00519 |
| s.dist | 0.417 |
| p.adjustANOVA | 0.0356 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| B4galt4 | 8133 |
| B4galt1 | 7206 |
| B4galt2 | 7053 |
| St8sia3 | 5894 |
| St3gal4 | 5412 |
| B4galt6 | 4181 |
| St8sia2 | 3411 |
| Mgat4b | 3296 |
| B4galt3 | 2030 |
| B4galt5 | 1637 |
| St8sia6 | 1391 |
| Mgat4c | 919 |
| Mgat4a | 5 |
| St6gal1 | -307 |
| Mgat5 | -1593 |
| GeneID | Gene Rank |
|---|---|
| B4galt4 | 8133 |
| B4galt1 | 7206 |
| B4galt2 | 7053 |
| St8sia3 | 5894 |
| St3gal4 | 5412 |
| B4galt6 | 4181 |
| St8sia2 | 3411 |
| Mgat4b | 3296 |
| B4galt3 | 2030 |
| B4galt5 | 1637 |
| St8sia6 | 1391 |
| Mgat4c | 919 |
| Mgat4a | 5 |
| St6gal1 | -307 |
| Mgat5 | -1593 |
TRANSLATION OF REPLICASE AND ASSEMBLY OF THE REPLICATION TRANSCRIPTION COMPLEX
| 1129 | |
|---|---|
| set | TRANSLATION OF REPLICASE AND ASSEMBLY OF THE REPLICATION TRANSCRIPTION COMPLEX |
| setSize | 12 |
| pANOVA | 0.0124 |
| s.dist | 0.417 |
| p.adjustANOVA | 0.0654 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Chmp7 | 7151 |
| Chmp3 | 7107 |
| Chmp2b | 6346 |
| Becn1 | 6136 |
| Chmp4b | 6041 |
| Uvrag | 5912 |
| Pik3c3 | 3997 |
| Map1lc3b | 3536 |
| Pik3r4 | 2154 |
| Chmp6 | 1720 |
| Chmp2a | -2646 |
| Chmp4c | -8521 |
| GeneID | Gene Rank |
|---|---|
| Chmp7 | 7151 |
| Chmp3 | 7107 |
| Chmp2b | 6346 |
| Becn1 | 6136 |
| Chmp4b | 6041 |
| Uvrag | 5912 |
| Pik3c3 | 3997 |
| Map1lc3b | 3536 |
| Pik3r4 | 2154 |
| Chmp6 | 1720 |
| Chmp2a | -2646 |
| Chmp4c | -8521 |
WNT5A DEPENDENT INTERNALIZATION OF FZD2 FZD5 AND ROR2
| 1173 | |
|---|---|
| set | WNT5A DEPENDENT INTERNALIZATION OF FZD2 FZD5 AND ROR2 |
| setSize | 13 |
| pANOVA | 0.00963 |
| s.dist | 0.415 |
| p.adjustANOVA | 0.0544 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Fzd2 | 8203 |
| Ap2m1 | 7792 |
| Ap2b1 | 7522 |
| Ap2a2 | 6984 |
| Fzd5 | 6688 |
| Ap2a1 | 6110 |
| Cltc | 4483 |
| Clta | 3556 |
| Ror2 | 3167 |
| Cltb | 3123 |
| Ap2s1 | -3475 |
| Wnt5a | -5644 |
| Ror1 | -6564 |
| GeneID | Gene Rank |
|---|---|
| Fzd2 | 8203 |
| Ap2m1 | 7792 |
| Ap2b1 | 7522 |
| Ap2a2 | 6984 |
| Fzd5 | 6688 |
| Ap2a1 | 6110 |
| Cltc | 4483 |
| Clta | 3556 |
| Ror2 | 3167 |
| Cltb | 3123 |
| Ap2s1 | -3475 |
| Wnt5a | -5644 |
| Ror1 | -6564 |
SYNTHESIS OF PYROPHOSPHATES IN THE CYTOSOL
| 1049 | |
|---|---|
| set | SYNTHESIS OF PYROPHOSPHATES IN THE CYTOSOL |
| setSize | 10 |
| pANOVA | 0.0235 |
| s.dist | 0.414 |
| p.adjustANOVA | 0.1 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Itpk1 | 7922 |
| Nudt11 | 7798 |
| Ip6k3 | 7087 |
| Nudt10 | 5333 |
| Nudt4 | 3963 |
| Ip6k1 | 2822 |
| Nudt3 | 2741 |
| Ippk | 610 |
| Ppip5k1 | -2554 |
| Ppip5k2 | -3534 |
| GeneID | Gene Rank |
|---|---|
| Itpk1 | 7922 |
| Nudt11 | 7798 |
| Ip6k3 | 7087 |
| Nudt10 | 5333 |
| Nudt4 | 3963 |
| Ip6k1 | 2822 |
| Nudt3 | 2741 |
| Ippk | 610 |
| Ppip5k1 | -2554 |
| Ppip5k2 | -3534 |
GLYCOGEN METABOLISM
| 390 | |
|---|---|
| set | GLYCOGEN METABOLISM |
| setSize | 25 |
| pANOVA | 0.000353 |
| s.dist | 0.413 |
| p.adjustANOVA | 0.00501 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Pgm1 | 8318 |
| Ugp2 | 8093 |
| Gyg | 7709 |
| Gaa | 7535 |
| Pygb | 7372 |
| Gbe1 | 7309 |
| Nhlrc1 | 6939 |
| Pygm | 6866 |
| Pgm2 | 6644 |
| Phkb | 5292 |
| Epm2a | 5095 |
| Ubc | 4500 |
| Phka1 | 3669 |
| Ppp1r3c | 2878 |
| Gys1 | 1875 |
| Phkg1 | 1377 |
| Phkg2 | 1354 |
| Ubb | 1303 |
| Agl | 1034 |
| Calm1 | 451 |
| GeneID | Gene Rank |
|---|---|
| Pgm1 | 8318 |
| Ugp2 | 8093 |
| Gyg | 7709 |
| Gaa | 7535 |
| Pygb | 7372 |
| Gbe1 | 7309 |
| Nhlrc1 | 6939 |
| Pygm | 6866 |
| Pgm2 | 6644 |
| Phkb | 5292 |
| Epm2a | 5095 |
| Ubc | 4500 |
| Phka1 | 3669 |
| Ppp1r3c | 2878 |
| Gys1 | 1875 |
| Phkg1 | 1377 |
| Phkg2 | 1354 |
| Ubb | 1303 |
| Agl | 1034 |
| Calm1 | 451 |
| Rps27a | -478 |
| Phka2 | -1545 |
| Pgm2l1 | -2578 |
| Pygl | -2603 |
| Uba52 | -8214 |
REGULATION OF TP53 ACTIVITY THROUGH ASSOCIATION WITH CO FACTORS
| 824 | |
|---|---|
| set | REGULATION OF TP53 ACTIVITY THROUGH ASSOCIATION WITH CO FACTORS |
| setSize | 14 |
| pANOVA | 0.00818 |
| s.dist | 0.408 |
| p.adjustANOVA | 0.0492 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Pou4f1 | 7924 |
| Banp | 7905 |
| Trp73 | 7773 |
| Ppp1r13b | 7716 |
| Pou4f2 | 5931 |
| Ppp1r13l | 4079 |
| Trp53 | 3770 |
| Akt1 | 2876 |
| Zfp385a | 2516 |
| Phf20 | 1127 |
| Akt3 | -553 |
| Akt2 | -867 |
| Trp53bp2 | -1465 |
| Trp63 | -4363 |
| GeneID | Gene Rank |
|---|---|
| Pou4f1 | 7924 |
| Banp | 7905 |
| Trp73 | 7773 |
| Ppp1r13b | 7716 |
| Pou4f2 | 5931 |
| Ppp1r13l | 4079 |
| Trp53 | 3770 |
| Akt1 | 2876 |
| Zfp385a | 2516 |
| Phf20 | 1127 |
| Akt3 | -553 |
| Akt2 | -867 |
| Trp53bp2 | -1465 |
| Trp63 | -4363 |
CYTOSOLIC TRNA AMINOACYLATION
| 204 | |
|---|---|
| set | CYTOSOLIC TRNA AMINOACYLATION |
| setSize | 24 |
| pANOVA | 0.000542 |
| s.dist | 0.408 |
| p.adjustANOVA | 0.00694 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Hars | 8296 |
| Rars | 7470 |
| Aimp2 | 7422 |
| Farsb | 7200 |
| Ppa1 | 7100 |
| Eef1e1 | 6693 |
| Yars | 6613 |
| Mars1 | 6307 |
| Wars | 6255 |
| Aars | 5085 |
| Iars | 5037 |
| Qars | 4241 |
| Gars | 3840 |
| Dars | 3101 |
| Kars | 2794 |
| Nars | 1886 |
| Lars | 954 |
| Aimp1 | -438 |
| Tars | -1336 |
| Cars | -1854 |
| GeneID | Gene Rank |
|---|---|
| Hars | 8296 |
| Rars | 7470 |
| Aimp2 | 7422 |
| Farsb | 7200 |
| Ppa1 | 7100 |
| Eef1e1 | 6693 |
| Yars | 6613 |
| Mars1 | 6307 |
| Wars | 6255 |
| Aars | 5085 |
| Iars | 5037 |
| Qars | 4241 |
| Gars | 3840 |
| Dars | 3101 |
| Kars | 2794 |
| Nars | 1886 |
| Lars | 954 |
| Aimp1 | -438 |
| Tars | -1336 |
| Cars | -1854 |
| Sars | -2074 |
| Eprs | -2545 |
| Vars | -2868 |
| Farsa | -3226 |
INSERTION OF TAIL ANCHORED PROTEINS INTO THE ENDOPLASMIC RETICULUM MEMBRANE
| 455 | |
|---|---|
| set | INSERTION OF TAIL ANCHORED PROTEINS INTO THE ENDOPLASMIC RETICULUM MEMBRANE |
| setSize | 22 |
| pANOVA | 0.000958 |
| s.dist | 0.407 |
| p.adjustANOVA | 0.0105 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Get1 | 8075 |
| Stx1a | 7268 |
| Prnp | 7171 |
| Get3 | 7133 |
| Bag6 | 5899 |
| App | 5597 |
| Ubl4a | 5381 |
| Sgta | 5139 |
| Cyb5a | 5083 |
| Vamp2 | 4705 |
| Emd | 4453 |
| Serp1 | 4344 |
| Vapa | 3068 |
| Sec61g | 2203 |
| Hmox1 | 1080 |
| Stx5a | 589 |
| Caml | 501 |
| Otof | -913 |
| Get4 | -945 |
| Sec61b | -1209 |
| GeneID | Gene Rank |
|---|---|
| Get1 | 8075 |
| Stx1a | 7268 |
| Prnp | 7171 |
| Get3 | 7133 |
| Bag6 | 5899 |
| App | 5597 |
| Ubl4a | 5381 |
| Sgta | 5139 |
| Cyb5a | 5083 |
| Vamp2 | 4705 |
| Emd | 4453 |
| Serp1 | 4344 |
| Vapa | 3068 |
| Sec61g | 2203 |
| Hmox1 | 1080 |
| Stx5a | 589 |
| Caml | 501 |
| Otof | -913 |
| Get4 | -945 |
| Sec61b | -1209 |
| Aldh3a2 | -2412 |
| Ube2j2 | -2804 |
GLYCOSPHINGOLIPID METABOLISM
| 395 | |
|---|---|
| set | GLYCOSPHINGOLIPID METABOLISM |
| setSize | 38 |
| pANOVA | 1.44e-05 |
| s.dist | 0.407 |
| p.adjustANOVA | 0.000409 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| B3galnt1 | 8049 |
| B4galnt1 | 7752 |
| Ugt8a | 7448 |
| Galc | 7210 |
| Neu2 | 7012 |
| Smpd1 | 6878 |
| Gba2 | 6789 |
| Arsa | 6740 |
| Arsb | 6727 |
| Neu1 | 6712 |
| Asah1 | 6628 |
| Esyt1 | 6584 |
| Gltp | 6313 |
| Gm2a | 6086 |
| Neu4 | 5752 |
| Psap | 5640 |
| Hexa | 5632 |
| Gba | 5555 |
| Gla | 4912 |
| Hexb | 4301 |
| GeneID | Gene Rank |
|---|---|
| B3galnt1 | 8049 |
| B4galnt1 | 7752 |
| Ugt8a | 7448 |
| Galc | 7210 |
| Neu2 | 7012 |
| Smpd1 | 6878 |
| Gba2 | 6789 |
| Arsa | 6740 |
| Arsb | 6727 |
| Neu1 | 6712 |
| Asah1 | 6628 |
| Esyt1 | 6584 |
| Gltp | 6313 |
| Gm2a | 6086 |
| Neu4 | 5752 |
| Psap | 5640 |
| Hexa | 5632 |
| Gba | 5555 |
| Gla | 4912 |
| Hexb | 4301 |
| Smpd3 | 4201 |
| Ugcg | 2966 |
| Neu3 | 2480 |
| Sumf1 | 2210 |
| Glb1 | 2200 |
| Sumf2 | 2175 |
| Arsk | 1769 |
| Glb1l | 552 |
| Esyt3 | -116 |
| Cptp | -917 |
| Smpd4 | -2131 |
| Ctsa | -2132 |
| Arsj | -2309 |
| Asah2 | -2426 |
| Smpd2 | -2819 |
| Arsg | -3310 |
| Cerk | -4543 |
| Esyt2 | -6870 |
WNT LIGAND BIOGENESIS AND TRAFFICKING
| 1172 | |
|---|---|
| set | WNT LIGAND BIOGENESIS AND TRAFFICKING |
| setSize | 21 |
| pANOVA | 0.00161 |
| s.dist | 0.398 |
| p.adjustANOVA | 0.0157 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Wnt11 | 8332 |
| Wls | 8074 |
| Wnt9b | 7248 |
| Snx3 | 7021 |
| Vps35 | 6713 |
| Vps26a | 4676 |
| Wnt7b | 4599 |
| Vps29 | 4572 |
| Wnt9a | 3777 |
| Wnt3 | 3484 |
| Wnt10a | 2478 |
| Wnt2b | 2458 |
| Wnt2 | 2439 |
| Wnt7a | 2245 |
| Wnt4 | 1511 |
| Wnt16 | 1064 |
| Porcn | 771 |
| Tmed5 | 170 |
| Wnt5b | 161 |
| Wnt6 | -1598 |
| GeneID | Gene Rank |
|---|---|
| Wnt11 | 8332 |
| Wls | 8074 |
| Wnt9b | 7248 |
| Snx3 | 7021 |
| Vps35 | 6713 |
| Vps26a | 4676 |
| Wnt7b | 4599 |
| Vps29 | 4572 |
| Wnt9a | 3777 |
| Wnt3 | 3484 |
| Wnt10a | 2478 |
| Wnt2b | 2458 |
| Wnt2 | 2439 |
| Wnt7a | 2245 |
| Wnt4 | 1511 |
| Wnt16 | 1064 |
| Porcn | 771 |
| Tmed5 | 170 |
| Wnt5b | 161 |
| Wnt6 | -1598 |
| Wnt5a | -5644 |
SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS
| 1051 | |
|---|---|
| set | SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS |
| setSize | 20 |
| pANOVA | 0.00211 |
| s.dist | 0.397 |
| p.adjustANOVA | 0.0191 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Acsl4 | 7747 |
| Acsbg1 | 7636 |
| Hsd17b12 | 7631 |
| Elovl1 | 7473 |
| Tecr | 7018 |
| Hacd2 | 6515 |
| Acsl6 | 6049 |
| Hacd3 | 5881 |
| Elovl4 | 5850 |
| Acsl5 | 4917 |
| Acsl3 | 4277 |
| Elovl6 | 2861 |
| Acsl1 | 2715 |
| Elovl5 | 2632 |
| Elovl2 | 2613 |
| Slc27a3 | 2119 |
| Acsf3 | -1821 |
| Hacd4 | -3874 |
| Elovl7 | -8098 |
| Hacd1 | -8737 |
| GeneID | Gene Rank |
|---|---|
| Acsl4 | 7747 |
| Acsbg1 | 7636 |
| Hsd17b12 | 7631 |
| Elovl1 | 7473 |
| Tecr | 7018 |
| Hacd2 | 6515 |
| Acsl6 | 6049 |
| Hacd3 | 5881 |
| Elovl4 | 5850 |
| Acsl5 | 4917 |
| Acsl3 | 4277 |
| Elovl6 | 2861 |
| Acsl1 | 2715 |
| Elovl5 | 2632 |
| Elovl2 | 2613 |
| Slc27a3 | 2119 |
| Acsf3 | -1821 |
| Hacd4 | -3874 |
| Elovl7 | -8098 |
| Hacd1 | -8737 |
GLYCOGEN BREAKDOWN GLYCOGENOLYSIS
| 389 | |
|---|---|
| set | GLYCOGEN BREAKDOWN GLYCOGENOLYSIS |
| setSize | 14 |
| pANOVA | 0.0108 |
| s.dist | 0.394 |
| p.adjustANOVA | 0.0596 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Gyg | 7709 |
| Gaa | 7535 |
| Pygb | 7372 |
| Pygm | 6866 |
| Pgm2 | 6644 |
| Phkb | 5292 |
| Phka1 | 3669 |
| Phkg1 | 1377 |
| Phkg2 | 1354 |
| Agl | 1034 |
| Calm1 | 451 |
| Phka2 | -1545 |
| Pgm2l1 | -2578 |
| Pygl | -2603 |
| GeneID | Gene Rank |
|---|---|
| Gyg | 7709 |
| Gaa | 7535 |
| Pygb | 7372 |
| Pygm | 6866 |
| Pgm2 | 6644 |
| Phkb | 5292 |
| Phka1 | 3669 |
| Phkg1 | 1377 |
| Phkg2 | 1354 |
| Agl | 1034 |
| Calm1 | 451 |
| Phka2 | -1545 |
| Pgm2l1 | -2578 |
| Pygl | -2603 |
SUPPRESSION OF PHAGOSOMAL MATURATION
| 1029 | |
|---|---|
| set | SUPPRESSION OF PHAGOSOMAL MATURATION |
| setSize | 12 |
| pANOVA | 0.0183 |
| s.dist | 0.393 |
| p.adjustANOVA | 0.0839 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Rab5a | 7203 |
| Atp6v1h | 6959 |
| Rab7 | 5493 |
| Hgs | 5340 |
| Kpna1 | 5148 |
| Ubc | 4500 |
| Coro1a | 3187 |
| Kpnb1 | 3095 |
| Vps33b | 2935 |
| Ubb | 1303 |
| Rps27a | -478 |
| Uba52 | -8214 |
| GeneID | Gene Rank |
|---|---|
| Rab5a | 7203 |
| Atp6v1h | 6959 |
| Rab7 | 5493 |
| Hgs | 5340 |
| Kpna1 | 5148 |
| Ubc | 4500 |
| Coro1a | 3187 |
| Kpnb1 | 3095 |
| Vps33b | 2935 |
| Ubb | 1303 |
| Rps27a | -478 |
| Uba52 | -8214 |
CS DS DEGRADATION
| 192 | |
|---|---|
| set | CS DS DEGRADATION |
| setSize | 14 |
| pANOVA | 0.0124 |
| s.dist | 0.386 |
| p.adjustANOVA | 0.0653 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Ids | 7281 |
| Arsb | 6727 |
| Vcan | 6689 |
| Bgn | 6560 |
| Hexa | 5632 |
| Cspg4 | 4947 |
| Bcan | 4794 |
| Cspg5 | 4632 |
| Hexb | 4301 |
| Hyal3 | 1783 |
| Hyal1 | -217 |
| Dcn | -2326 |
| Ncan | -3335 |
| Idua | -5808 |
| GeneID | Gene Rank |
|---|---|
| Ids | 7281 |
| Arsb | 6727 |
| Vcan | 6689 |
| Bgn | 6560 |
| Hexa | 5632 |
| Cspg4 | 4947 |
| Bcan | 4794 |
| Cspg5 | 4632 |
| Hexb | 4301 |
| Hyal3 | 1783 |
| Hyal1 | -217 |
| Dcn | -2326 |
| Ncan | -3335 |
| Idua | -5808 |
IRE1ALPHA ACTIVATES CHAPERONES
| 499 | |
|---|---|
| set | IRE1ALPHA ACTIVATES CHAPERONES |
| setSize | 50 |
| pANOVA | 2.69e-06 |
| s.dist | 0.384 |
| p.adjustANOVA | 0.000113 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Tpp1 | 8361 |
| Pdia6 | 8350 |
| Dnajc3 | 8341 |
| Hspa5 | 8305 |
| Xbp1 | 8257 |
| Srprb | 7690 |
| Atp6v0d1 | 7589 |
| Dnajb11 | 7552 |
| Gfpt1 | 7055 |
| Dnajb9 | 7051 |
| Srpr | 6286 |
| Lmna | 6276 |
| Dctn1 | 6188 |
| Preb | 6171 |
| Hyou1 | 6156 |
| Kdelr3 | 6076 |
| Ppp2r5b | 5757 |
| Yif1a | 5615 |
| Ssr1 | 5263 |
| Cxxc1 | 5183 |
| GeneID | Gene Rank |
|---|---|
| Tpp1 | 8361 |
| Pdia6 | 8350 |
| Dnajc3 | 8341 |
| Hspa5 | 8305 |
| Xbp1 | 8257 |
| Srprb | 7690 |
| Atp6v0d1 | 7589 |
| Dnajb11 | 7552 |
| Gfpt1 | 7055 |
| Dnajb9 | 7051 |
| Srpr | 6286 |
| Lmna | 6276 |
| Dctn1 | 6188 |
| Preb | 6171 |
| Hyou1 | 6156 |
| Kdelr3 | 6076 |
| Ppp2r5b | 5757 |
| Yif1a | 5615 |
| Ssr1 | 5263 |
| Cxxc1 | 5183 |
| Syvn1 | 5168 |
| Gosr2 | 4982 |
| Add1 | 4819 |
| Gsk3a | 4754 |
| Serp1 | 4344 |
| Fkbp14 | 3752 |
| Klhdc3 | 3596 |
| Sec31a | 2662 |
| Hdgf | 2607 |
| Extl2 | 1797 |
| Zbtb17 | 1437 |
| Shc1 | 1324 |
| Tln1 | 568 |
| Pla2g4b | 350 |
| Extl3 | 129 |
| Ddx11 | -7 |
| Tspyl2 | -19 |
| Cul7 | -176 |
| Mydgf | -424 |
| Sult1a1 | -440 |
| Ctdsp2 | -499 |
| Arfgap1 | -632 |
| Edem1 | -1059 |
| Ern1 | -1073 |
| Tatdn2 | -2662 |
| Wfs1 | -2872 |
| Extl1 | -3822 |
| Acadvl | -5474 |
| Wipi1 | -6579 |
| Pdia5 | -6746 |
KERATAN SULFATE DEGRADATION
| 506 | |
|---|---|
| set | KERATAN SULFATE DEGRADATION |
| setSize | 11 |
| pANOVA | 0.0284 |
| s.dist | 0.382 |
| p.adjustANOVA | 0.114 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Prelp | 8307 |
| Hexa | 5632 |
| Acan | 5261 |
| Gns | 4656 |
| Hexb | 4301 |
| Fmod | 4018 |
| Lum | 3386 |
| Glb1 | 2200 |
| Glb1l | 552 |
| Ogn | -1934 |
| Galns | -4080 |
| GeneID | Gene Rank |
|---|---|
| Prelp | 8307 |
| Hexa | 5632 |
| Acan | 5261 |
| Gns | 4656 |
| Hexb | 4301 |
| Fmod | 4018 |
| Lum | 3386 |
| Glb1 | 2200 |
| Glb1l | 552 |
| Ogn | -1934 |
| Galns | -4080 |
ACTIVATION OF AMPK DOWNSTREAM OF NMDARS
| 15 | |
|---|---|
| set | ACTIVATION OF AMPK DOWNSTREAM OF NMDARS |
| setSize | 20 |
| pANOVA | 0.00336 |
| s.dist | 0.379 |
| p.adjustANOVA | 0.0262 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Tubb2a | 8130 |
| Tuba1b | 7873 |
| Tubb4b | 7622 |
| Tubb4a | 7517 |
| Tubb2b | 7504 |
| Tuba4a | 7208 |
| Tuba1a | 7067 |
| Prkab1 | 6043 |
| Tubb3 | 5842 |
| Prkag2 | 5796 |
| Tuba1c | 4485 |
| Tubb6 | 1806 |
| Prkag1 | 1594 |
| Prkaa1 | 1545 |
| Prkaa2 | 1347 |
| Calm1 | 451 |
| Mapt | -5193 |
| Tuba8 | -5577 |
| Prkab2 | -5817 |
| Camkk2 | -7039 |
| GeneID | Gene Rank |
|---|---|
| Tubb2a | 8130 |
| Tuba1b | 7873 |
| Tubb4b | 7622 |
| Tubb4a | 7517 |
| Tubb2b | 7504 |
| Tuba4a | 7208 |
| Tuba1a | 7067 |
| Prkab1 | 6043 |
| Tubb3 | 5842 |
| Prkag2 | 5796 |
| Tuba1c | 4485 |
| Tubb6 | 1806 |
| Prkag1 | 1594 |
| Prkaa1 | 1545 |
| Prkaa2 | 1347 |
| Calm1 | 451 |
| Mapt | -5193 |
| Tuba8 | -5577 |
| Prkab2 | -5817 |
| Camkk2 | -7039 |
RECYCLING PATHWAY OF L1
| 783 | |
|---|---|
| set | RECYCLING PATHWAY OF L1 |
| setSize | 40 |
| pANOVA | 3.41e-05 |
| s.dist | 0.379 |
| p.adjustANOVA | 0.00082 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Rps6ka6 | 8267 |
| Tubb2a | 8130 |
| Tuba1b | 7873 |
| Ap2m1 | 7792 |
| Tubb4b | 7622 |
| Dnm2 | 7614 |
| Ap2b1 | 7522 |
| Tubb4a | 7517 |
| Tubb2b | 7504 |
| Rps6ka4 | 7347 |
| Tuba4a | 7208 |
| Mapk1 | 7097 |
| Tuba1a | 7067 |
| Ap2a2 | 6984 |
| Ezr | 6776 |
| Ap2a1 | 6110 |
| Tubb3 | 5842 |
| Tuba1c | 4485 |
| Cltc | 4483 |
| Clta | 3556 |
| GeneID | Gene Rank |
|---|---|
| Rps6ka6 | 8267 |
| Tubb2a | 8130 |
| Tuba1b | 7873 |
| Ap2m1 | 7792 |
| Tubb4b | 7622 |
| Dnm2 | 7614 |
| Ap2b1 | 7522 |
| Tubb4a | 7517 |
| Tubb2b | 7504 |
| Rps6ka4 | 7347 |
| Tuba4a | 7208 |
| Mapk1 | 7097 |
| Tuba1a | 7067 |
| Ap2a2 | 6984 |
| Ezr | 6776 |
| Ap2a1 | 6110 |
| Tubb3 | 5842 |
| Tuba1c | 4485 |
| Cltc | 4483 |
| Clta | 3556 |
| L1cam | 3330 |
| Sh3gl2 | 2855 |
| Src | 2551 |
| Dnm3 | 2297 |
| Rps6ka5 | 2127 |
| Actg1 | 1983 |
| Tubb6 | 1806 |
| Numb | 1403 |
| Dnm1 | 814 |
| Msn | 773 |
| Shtn1 | 78 |
| Rps6ka2 | -976 |
| Rps6ka3 | -1313 |
| Rdx | -1895 |
| Ap2s1 | -3475 |
| Rps6ka1 | -4789 |
| Tuba8 | -5577 |
| Dpysl2 | -5750 |
| Actb | -8390 |
| Kif4 | -8456 |
POST CHAPERONIN TUBULIN FOLDING PATHWAY
| 725 | |
|---|---|
| set | POST CHAPERONIN TUBULIN FOLDING PATHWAY |
| setSize | 17 |
| pANOVA | 0.00701 |
| s.dist | 0.378 |
| p.adjustANOVA | 0.0449 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Tubb2a | 8130 |
| Tuba1b | 7873 |
| Tubb4b | 7622 |
| Tubb4a | 7517 |
| Tubb2b | 7504 |
| Tuba4a | 7208 |
| Tuba1a | 7067 |
| Tbcd | 7046 |
| Tubb3 | 5842 |
| Tuba1c | 4485 |
| Tubb6 | 1806 |
| Arl2 | -1610 |
| Tbcb | -1675 |
| Tbcc | -2972 |
| Tbca | -5113 |
| Tuba8 | -5577 |
| Tbce | -5838 |
| GeneID | Gene Rank |
|---|---|
| Tubb2a | 8130 |
| Tuba1b | 7873 |
| Tubb4b | 7622 |
| Tubb4a | 7517 |
| Tubb2b | 7504 |
| Tuba4a | 7208 |
| Tuba1a | 7067 |
| Tbcd | 7046 |
| Tubb3 | 5842 |
| Tuba1c | 4485 |
| Tubb6 | 1806 |
| Arl2 | -1610 |
| Tbcb | -1675 |
| Tbcc | -2972 |
| Tbca | -5113 |
| Tuba8 | -5577 |
| Tbce | -5838 |
COPI MEDIATED ANTEROGRADE TRANSPORT
| 183 | |
|---|---|
| set | COPI MEDIATED ANTEROGRADE TRANSPORT |
| setSize | 91 |
| pANOVA | 5.78e-10 |
| s.dist | 0.376 |
| p.adjustANOVA | 5.23e-08 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Tmed9 | 8187 |
| Tubb2a | 8130 |
| Arf4 | 8012 |
| Tmed2 | 7972 |
| Tuba1b | 7873 |
| Cog4 | 7856 |
| Capza2 | 7704 |
| Tmed7 | 7627 |
| Tubb4b | 7622 |
| Cog1 | 7546 |
| Tubb4a | 7517 |
| Tubb2b | 7504 |
| Copb1 | 7477 |
| Actr1a | 7389 |
| Capza1 | 7253 |
| Tuba4a | 7208 |
| Dctn4 | 7177 |
| Tuba1a | 7067 |
| Cog6 | 6960 |
| Arf1 | 6877 |
| GeneID | Gene Rank |
|---|---|
| Tmed9 | 8187 |
| Tubb2a | 8130 |
| Arf4 | 8012 |
| Tmed2 | 7972 |
| Tuba1b | 7873 |
| Cog4 | 7856 |
| Capza2 | 7704 |
| Tmed7 | 7627 |
| Tubb4b | 7622 |
| Cog1 | 7546 |
| Tubb4a | 7517 |
| Tubb2b | 7504 |
| Copb1 | 7477 |
| Actr1a | 7389 |
| Capza1 | 7253 |
| Tuba4a | 7208 |
| Dctn4 | 7177 |
| Tuba1a | 7067 |
| Cog6 | 6960 |
| Arf1 | 6877 |
| Kdelr1 | 6862 |
| Uso1 | 6853 |
| Dctn6 | 6465 |
| Arcn1 | 6445 |
| Cd55 | 6367 |
| Rab1b | 6316 |
| Dctn1 | 6188 |
| Rab1a | 6145 |
| Kdelr3 | 6076 |
| Tmed10 | 6028 |
| Napg | 5982 |
| Tubb3 | 5842 |
| Dync1i1 | 5759 |
| Arfgap3 | 5741 |
| Napa | 5703 |
| Folr1 | 5697 |
| Dctn5 | 5433 |
| Arfgap2 | 5268 |
| Capzb | 5208 |
| Gosr2 | 4982 |
| Nsf | 4518 |
| Tmed3 | 4493 |
| Tuba1c | 4485 |
| Tmem115 | 4275 |
| Ykt6 | 4251 |
| Copa | 4198 |
| Gorasp1 | 4112 |
| Copb2 | 3644 |
| Dynll1 | 3613 |
| Copz1 | 3591 |
| Gbf1 | 3363 |
| Dctn2 | 3314 |
| Cope | 3293 |
| Cog5 | 3262 |
| Copg1 | 3114 |
| Actr10 | 2962 |
| Dync1li1 | 2623 |
| Napb | 2381 |
| Tubb6 | 1806 |
| Arf3 | 1385 |
| Dync1h1 | 1341 |
| Sptbn5 | 1069 |
| Cog2 | 852 |
| Copg2 | 838 |
| Sptan1 | 630 |
| Stx5a | 589 |
| Dctn3 | 329 |
| Cog7 | 83 |
| Bet1 | -245 |
| Gosr1 | -355 |
| Arfgap1 | -632 |
| Sptbn1 | -845 |
| Arf5 | -1490 |
| Cog8 | -1844 |
| Dynll2 | -1891 |
| Cog3 | -2028 |
| Sptbn2 | -2336 |
| Sptb | -2663 |
| Golga2 | -3175 |
| Sptbn4 | -3397 |
| Copz2 | -3435 |
| Dync1li2 | -3541 |
| Dync1i2 | -3902 |
| Ank1 | -5320 |
| Cd59b | -5413 |
| Tuba8 | -5577 |
| Kdelr2 | -5779 |
| Ank2 | -6065 |
| Bet1l | -7424 |
| Golgb1 | -7435 |
| Ank3 | -8754 |
Here is the session info with all the versions of packages used.
sessionInfo()
## R version 4.1.3 (2022-03-10)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 20.04.4 LTS
##
## Matrix products: default
## BLAS: /usr/lib/x86_64-linux-gnu/blas/libblas.so.3.9.0
## LAPACK: /usr/lib/x86_64-linux-gnu/lapack/liblapack.so.3.9.0
##
## locale:
## [1] LC_CTYPE=en_US.UTF-8 LC_NUMERIC=C
## [3] LC_TIME=en_US.UTF-8 LC_COLLATE=en_US.UTF-8
## [5] LC_MONETARY=en_US.UTF-8 LC_MESSAGES=en_US.UTF-8
## [7] LC_PAPER=en_US.UTF-8 LC_NAME=C
## [9] LC_ADDRESS=C LC_TELEPHONE=C
## [11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=C
##
## attached base packages:
## [1] parallel stats4 stats graphics grDevices utils datasets
## [8] methods base
##
## other attached packages:
## [1] pkgload_1.2.4 GGally_2.1.2
## [3] gtools_3.9.2 echarts4r_0.4.3
## [5] beeswarm_0.4.0 vioplot_0.3.7
## [7] sm_2.2-5.7 kableExtra_1.3.4
## [9] topconfects_1.8.0 limma_3.48.3
## [11] eulerr_6.1.1 mitch_1.4.1
## [13] MASS_7.3-55 fgsea_1.18.0
## [15] gplots_3.1.1 DESeq2_1.32.0
## [17] SummarizedExperiment_1.22.0 Biobase_2.52.0
## [19] MatrixGenerics_1.4.3 matrixStats_0.61.0
## [21] GenomicRanges_1.44.0 GenomeInfoDb_1.28.4
## [23] IRanges_2.26.0 S4Vectors_0.30.2
## [25] BiocGenerics_0.38.0 reshape2_1.4.4
## [27] forcats_0.5.1 stringr_1.4.0
## [29] dplyr_1.0.8 purrr_0.3.4
## [31] readr_2.1.2 tidyr_1.2.0
## [33] tibble_3.1.6 ggplot2_3.3.5
## [35] tidyverse_1.3.1 zoo_1.8-9
##
## loaded via a namespace (and not attached):
## [1] readxl_1.3.1 backports_1.4.1 fastmatch_1.1-3
## [4] systemfonts_1.0.3 plyr_1.8.6 polylabelr_0.2.0
## [7] splines_4.1.3 BiocParallel_1.26.2 digest_0.6.29
## [10] htmltools_0.5.2 fansi_1.0.2 magrittr_2.0.2
## [13] memoise_2.0.1 tzdb_0.2.0 Biostrings_2.60.2
## [16] annotate_1.70.0 modelr_0.1.8 svglite_2.1.0
## [19] prettyunits_1.1.1 colorspace_2.0-2 blob_1.2.2
## [22] rvest_1.0.2 haven_2.4.3 xfun_0.29
## [25] crayon_1.4.2 RCurl_1.98-1.6 jsonlite_1.7.3
## [28] genefilter_1.74.1 survival_3.2-13 glue_1.6.1
## [31] polyclip_1.10-0 gtable_0.3.0 zlibbioc_1.38.0
## [34] XVector_0.32.0 webshot_0.5.2 DelayedArray_0.18.0
## [37] scales_1.1.1 DBI_1.1.2 Rcpp_1.0.8
## [40] progress_1.2.2 viridisLite_0.4.0 xtable_1.8-4
## [43] bit_4.0.4 htmlwidgets_1.5.4 httr_1.4.2
## [46] RColorBrewer_1.1-2 ellipsis_0.3.2 farver_2.1.0
## [49] pkgconfig_2.0.3 reshape_0.8.8 XML_3.99-0.8
## [52] sass_0.4.0 dbplyr_2.1.1 locfit_1.5-9.4
## [55] utf8_1.2.2 labeling_0.4.2 tidyselect_1.1.1
## [58] rlang_1.0.1 later_1.3.0 AnnotationDbi_1.54.1
## [61] munsell_0.5.0 cellranger_1.1.0 tools_4.1.3
## [64] cachem_1.0.6 cli_3.1.1 generics_0.1.2
## [67] RSQLite_2.2.9 broom_0.7.12 evaluate_0.14
## [70] fastmap_1.1.0 yaml_2.2.2 knitr_1.37
## [73] bit64_4.0.5 fs_1.5.2 caTools_1.18.2
## [76] KEGGREST_1.32.0 mime_0.12 xml2_1.3.3
## [79] compiler_4.1.3 rstudioapi_0.13 png_0.1-7
## [82] reprex_2.0.1 geneplotter_1.70.0 bslib_0.3.1
## [85] stringi_1.7.6 highr_0.9 desc_1.4.0
## [88] lattice_0.20-45 Matrix_1.4-0 vctrs_0.3.8
## [91] pillar_1.7.0 lifecycle_1.0.1 jquerylib_0.1.4
## [94] data.table_1.14.2 bitops_1.0-7 httpuv_1.6.5
## [97] R6_2.5.1 promises_1.2.0.1 KernSmooth_2.23-20
## [100] gridExtra_2.3 assertthat_0.2.1 rprojroot_2.0.2
## [103] withr_2.4.3 GenomeInfoDbData_1.2.6 hms_1.1.1
## [106] grid_4.1.3 rmarkdown_2.11 shiny_1.7.1
## [109] lubridate_1.8.0
END of report